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termination sites for the proteins and RNAs. Two pairs of genes are coded by the 
same region of DNA using different reading frames.” 
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 ABSTRACT	  
 
Bacterial small regulatory RNAs (sRNAs) are known to have regulatory functions in a 
variety of processes including metabolic reactions, stress responses and 
pathogenesis in response to environmental signals. Recent genome-wide studies to 
identify sRNAs have been largely based on tiling arrays and RNA sequencing (RNA-
seq) technologies. The latter approach, in particular, has revolutionized sRNA 
discovery by enabling interrogation of the transcriptome at unprecedented depths. 
The size and complexity of the P. aeruginosa genome suggests that it encodes many 
hitherto undetected sRNAs. In this study, RNA-seq is used to identify sRNAs in P. 
aeruginosa using a combination of three different sequencing libraries. Over 750 
novel sRNAs (including intergenic and cis-encoded sRNAs) have been identified with 
this approach in this study. The results also reflect that although the use of three 
libraries increased the number of novel transcripts identified, there were significant 
differences in the subset of transcripts detected in each library, underscoring the 
importance of library preparation strategy and relative sRNA abundance for 
successful sRNA detection. These data will be useful for the study of regulatory 
sRNAs in P. aeruginosa and the approach described here may be applied to identify 
sRNAs in any bacterium under different growth and stress conditions.  
 
In addition the role of sRNA OsiS was investigated. OsiS was identified in our 
genome-wide search of sRNAs in P. aeruginosa. OsiS is highly transcribed during 
oxidative stress conditions. We show that by inducing the expression of OsiS the 
levels of the sRNA PhrS are greatly reduced. PhrS activates the translation of the 
pqsR gene under low oxygen concentrations, which in turn activates the synthesis of 
the Pseudomonas quinolone signal (PQS). Thus, OsiS links the oxygen levels to the 
production of quorum sensing (QS) molecules. It is hypothesized that the interaction 
is by direct base-pairing between the two sRNAs, with a predicted recognition site of 
OsiS at the highly conserved-region of PhrS. However, more experiments are 
required to know the exact nature of the interaction between these two sRNAs. 
Notably, OsiS is, to the best of our knowledge, the first sRNA whose main function 
seems to be regulating the cellular levels of another sRNA.  
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 RESUMÉ	  
 
Bakterielle små regulatoriske RNA (sRNA) molekyler er involveret i regulering i en 
række forskellige processer, heriblandt metaboliske, stress relaterede samt patogene 
som svar på eksterne signaler. Nylige teknologier anvendt til global genom-
identificering af sRNA molekyler har overvejende været baseret på tiling arrays og 
RNA sekventering (RNA-seq). Specielt sidstnævnte teknologi har revolutioneret 
opdagelsen af sRNA molekyler ved at efterforske transkriptomet med et hidtil uhørt 
tilbundsgående detektionsniveau. Størrelsen og kompleksiteten af P. aeruginosas 
genom antyder at det kan kode for hidtil uopdagede sRNA molekyler. I dette studie 
har vi anvendt RNA-seq til at identificere sRNA molekyler i P. aeruginosa via en 
kombination af tre forskellige sekventeringsbiblioteker. Over 750 nye sRNA 
molekyler (inklusive intergeniske og cis-kodede sRNA molekyler) er blevet 
identificeret med denne metode. Studiet viser desuden at selvom brugen af tre 
forskellige biblioteker forøgede detektionen af antallet af nye transkripter, så var der 
betydelige forskelle i detekterede transkripter bibliotekerne imellem. Dette 
understreger at strategien for valg af bibliotek samt den relative mængde af sRNA 
molekyler har stor betydning for en succesfuld detektion af sRNA molekyler. Vi 
forventer at de præsenterede data vil være brugbare i studiet af regulatoriske sRNA 
molekyler i P. aeruginosa og at den beskrevne metode kan anvendes til 
identifikationen af sRNA molekyler i enhver given bakterie under forskellige vækst og 
stress forhold. 
 
Et specifikt sRNA molekyle, OsiS, som blev identificeret i vores globale genom-
undersøgelse af sRNA molekyler i P. aeruginosa, blev yderligere karakteriseret. Det 
viser sig at transkriptionen af OsiS er betydelig under oxidative stress forhold og vi 
viser at induktion af OsiS ekspression fører til stærkt reduceret ekspression af et 
andet sRNA molekyle, PhrS. PhrS aktiverer translationen af PqsR under lave ilt 
koncentrationer, hvilket aktiverer syntesen af Pseudomonas quinolone signal (PQS). 
OsiS repræsenterer derfor et link mellem oxygen niveauet og produktionen af 
quorum sensing (QS) molekyler. Det er vores hypotese at interaktionen mellem de to 
sRNA molekyler foregår via direkte base parring og OsiS har da også et forudsagt 
bindings-site i den meget konserverede del af PhrS. Yderligere eksperimenter er til 
gengæld nødvendige for at kunne bevise den eksakte interaktion mellem de to sRNA 
7
 molekyler. OsiS er desuden, ud fra vores viden, det første sRNA molekyle hvis 
overordnede funktion er at regulere det cellulære niveau af et andet sRNA molekyle. 
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 1.	  INTRODUCTION	  &	  OUTLINE	  	  
 
Historically, research on regulation of bacterial transcription focused on protein-
based systems, and RNA was believed to be a relatively inactive information carrier. 
However, that has changed in the last decade due to the discovery of regulatory 
RNA activity. The regulatory role of certain bacterial RNA molecules has been known 
since the early 70s. However, until 2001, only about a dozen regulatory small RNAs 
(sRNAs) were identified in bacteria, representing biochemically abundant species 
and anecdotal discoveries. Technological advances such as DNA microarrays and 
RNA sequencing (RNA-seq) have recently allowed researchers to discover hundreds 
of sRNAs in all organisms studied so far. Bacterial sRNAs, which typically range from 
70 to 500 nt in length, have been mainly found to function in post-transcriptional 
control of gene expression and control a variety of processes including metabolic 
reactions, stress responses and pathogenesis in response to environmental signals 
(reviewed in (1)). The main focus of this thesis was to identify novel transcripts in 
Pseudomonas aeruginosa and, in order to do so, the existing RNA-seq protocols 
have been optimized to increase the sensitivity of the method. As a result more than 
700 novel sRNAs have been discovered in this clinically-relevant opportunistic 
pathogen. The optimized RNA-seq method can be used to study the transcriptome 
any bacterium in any growth condition. 
 
This thesis is divided in six sections. Section 2 (RNA sequencing and technology) 
introduces some general theory on transcriptomics and specifically on RNA-seq. The 
section serves as a fundamental theoretical background for the experimental 
investigations presented in the following chapters. Section 3 (Bacterial small RNAs) 
provides basic information about the classification and the mechanisms of action of 
sRNAs in bacteria, and describes the traditional methods used to identify bacterial 
sRNAs and the current considerations when using RNA-seq to detect sRNAs. 
Section 4 (Pseudomonas aeruginosa) focuses on the bacterium used for the 
investigations presented in this work, with an emphasis on antibiotic resistance, 
quorum sensing and known sRNAs. Section 5 (Conclusions and perspectives) 
summarizes the main conclusions obtained from the research articles presented. 
Finally, section 6 (Research articles) consists of the full-length research articles that 
were prepared as part of this PhD project.  
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 2.	  TRANSCRIPTOMICS	  
 
2.1	  RNA	  comes	  in	  more	  than	  3	  flavours	  
 
The “central dogma” of molecular biology was first enunciated by Francis Crick in 
1958 (2), but was first sketched already in 1952 by James Watson (3) (Figure 1). The 
“central dogma” at that time postulated that the DNA information can be copied into 
RNA, and proteins can be synthesized using the information in the RNA in the 
cytoplasm. It was clear that although DNA was located in the eukaryotic nucleus, 
proteins were synthesized in the cytoplasm where there was no DNA, but there was 
lots of RNA (4). Most of the cytoplasmatic RNA could be found as discrete particles, 
which were later shown to be the ribosomes (5). 
 
 
Figure 1. A diagram of the central dogma of molecular biology in 1958 (2). Solid arrows 
represent probable transfers, dotted arrows possible transfers. 
 
Francis Crick predicted the existence of a second class of functional RNA, a 
molecule that acts as an adaptor between the triplet genetic code and the encoded 
amino acid (5). Interestingly, Crick hypothesized that the adaptor might be an RNA, 
because base pairing made RNA exceptionally fit for a role as a small, specific RNA 
recognition molecule (5). This hypothesis could be proven by Hoagland and 
colleagues, and Crick’s adaptors are now known as transfer RNAs (tRNAs) (6). 
 
A few years later ribosomes were found to be composed largely of stable ribosomal 
RNAs (rRNAs), and to have no variety compared to the great variety found in genes 
12
 (7). It was shown that ribosomes were general-purpose RNA/protein machines, and 
that they were able to synthesize proteins when in contact with diverse unstable 
messenger RNAs (mRNA), which are only a small fraction of the total RNA 
population (7). 
 
Therefore, in only a few years, RNA changed from coming in just one flavor (the 
messenger intermediate in the “central dogma”) to having three flavors, all 
exclusively involved in protein synthesis: rRNA, tRNA, and everything else, which 
was thought to be mRNA. The non-ribosomal and non-transfer RNA fraction is 
complex, non-abundant and very unstable, and for decades there has been no 
interest in or no skills for investigating if it contained more than mRNA. Today, it is 
widely accepted that not all RNAs in the cell are involved in the synthesis of proteins 
as there are abundant small non-messenger RNAs (sRNAs), different from rRNA and 
tRNA, that regulate translation initiation, transcription termination, mRNA stability, or 
can sequester and modify proteins.  
 
 
2.2	  Transcriptomic	  technologies	  
 
Altering the levels of gene expression is one of the main mechanisms of cell 
regulation as it leads to all kinds of changes in the cellular machinery. The entire pool 
of transcribed sequences in a specific condition (termed transcriptome), provides 
enormous information about the physiological state of the cells. The first studies 
investigating transcription in cells used cDNA synthesis of specific mRNA transcripts, 
combined with cloning and Sanger sequencing (8). The transcriptomic field 
experienced a huge revolution when DNA microarrays were developed, providing a 
powerful tool to quantify expression of all annotated genes (9). DNA microarrays 
consist of immobilized gene-specific DNA probes that hybridize to their 
corresponding cDNA, producing a change in fluorescence. The measurement of 
fluorescence produced after hybridization correlates to the relative abundance of the 
transcript (Figure 2). The first cDNA microarrays had probes that hybridize to known 
or predicted mRNAs, and provided no information about transcription in intergenic 
regions or about transcription from the complementary strand of known mRNAs.  
 
Several years later, the development of high-density tiled probes (tiling arrays) 
overcame this limitation. Tiling arrays contain probes that cover the entire genome of 
13
 an organism, so they are able to detect novel genes and sRNA species in intergenic 
regions in all organisms for which there was a tiling array available. Microarray-based 
studies provided the first global transcriptomic analyses in pathogens such as 
Escherichia coli (10), Vibrio cholera (11), Borrelia burgdorferi (12), Chlamydia 
trachomatis (13), Chlamydia pneumoniae (14), Listeria monocytogenes (15)  and 
Salmonella enterica (16). In addition, transcriptomic studies using tiling arrays were 
able to provide accurate strand-specific information from 2006 thanks to the use of 
actinomycin D in the reverse transcription reaction to inhibit DNA polymerase activity 
(17). 
 
While microarrays have been instrumental for the study of transcription, there are 
some major limitations to this approach. In microarray analysis, as with any other a 
probe-dependent method, the relative abundance of a given labeled transcript is 
inferred from the fluorescent signal produced following hybridization to immobilized 
probes. Transcript quantification is limited because the fluorescent intensity has both 
a lower (sensitivity) and upper (saturation) threshold. On the contrary, when using 
RNA-seq, which is a digital and probe-independent method, direct counting of 
sequencing reads for a given transcript has a much higher dynamic range. In 
addition, microarrays are usually designed to include sequences from a single strain, 
which will not be optimal for other strains of the same species as mismatches can 
significantly affect hybridization efficiency.  There are microarrays that contain probes 
for multiple strains, but this may lead to a high background noise due to non-specific 
or cross-hybridization. Another limitation is the high cost of tiling arrays. Until 
recently, our interest was limited to mRNAs, tRNAs and rRNAs, and these RNAs 
could easily be probed with arrays at a reasonable cost. However, now it is known 
that mRNAs, tRNAs and rRNAs represent only part of the functional transcriptome. 
The study of the complete transcriptome at high resolution, including intergenic 
regions, requires microarrays with a very high density of probes (in the order of 
hundreds of millions), which currently exceeds the cost of RNA-seq experiments. 
Furthermore, the problem of cross-hybridization is increased in tiling arrays. 
Background noise due to cross-hybridization limits even more the dynamic range of 
microarrays (18). Also probe-based methods cannot discriminate between different 
mRNA isoforms or define transcript borders and splice junctions with high resolution.  
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Figure 2. Fundamental differences between microarray and RNA-Seq technologies. 
Figure adapted from (19). 
 
 
 
RNA-seq was introduced in 2008, and has already become the method of choice for 
studying transcriptomes as it overcomes many of the limitations of tiling arrays. It 
provides high resolution of the coordinates of transcripts, a higher dynamic range, 
lower cost, it does not have background noise due to cross-hybridization, and it is not 
a strain-specific method (reviewed in (20)). In addition to providing full-genome 
coverage, RNA-seq is very sensitive and has a high resolution. RNA-seq can identify 
novel transcripts and allows gene structure to be refined through accurate 
determination of transcript borders. 
 
RNA-seq involves deep sequencing of cDNA generated from RNA preparations 
(reviewed in (21)). The design of library preparation methods is crucial when 
performing a high-quality RNA-seq experiment, as the data generated will depend 
greatly on the way libraries are prepared. The accuracy and precision of gene 
expression quantification and transcript identification are greatly influenced by cDNA 
library construction methods. The steps of a typical library preparation for RNA-seq 
are shown in figure 3.  
 
15
  
Figure 3. The data generation and analysis steps of a typical RNA-seq experiment. 
Figure adapted from (21). 
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Typically, total RNA is treated with DNase in order to remove any possible DNA 
contamination. In order to increase the genome coverage and the sensitivity of the 
experiment, rRNAs are usually removed during at this step of library preparation. 
Poly-A selection is very effective at enriching mRNAs in eukaryotes, but this 
approach does not retain sRNAs and mRNAs that lack a poly-A tail, and it is not 
suitable for prokaryotes. Instead rRNA can be removed by subtractive hybridization 
(Section 3.2 and Article 2 provide more details about successful rRNA-depletion in 
prokaryotes). If quantification of rRNAs is a goal of the study, then the sequencing of 
non-depleted libraries will be required. Following rRNA depletion, the RNA mixture is 
fragmented and converted into a library of cDNAs containing sequencing adaptors. 
Generally, the cDNA molecules are amplified before deep sequencing using primer 
complementary to the ligated adaptors. The cDNA library is then sequenced by high-
throughput sequencers to produce millions of short reads from one end or both ends 
of the cDNA fragments. If both ends of the cDNAs are sequenced, then paired-end 
reads are generated. Paired-end reads are useful as they greatly reduce the 
complexity of transcriptome assembly. After the sequencing reaction has taken 
place, the obtained sequence reads are filtered by removing low-quality reads and 
artifacts, such as adaptor sequences and PCR duplicates. The filtered reads are then 
mapped onto a reference genome and assembled into transcripts. The expression 
level of each transcript is then estimated by counting the number of reads that align 
to each transcript. Section 3.2 provide information about optimal library preparation 
specific for sRNA identification, and Article 2 presented in this thesis describes in 
detail how to construct libraries specific for sRNA identification as well as how to 
analyze the data generated with them. 
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Figure 4. Flowchart illustrating technical improvements used to preserve the polarity of 
RNA molecules for transcriptome analysis. Figure adapted from (22). 
 
 
An important step in the study of transcriptomes was the development of strand- 
specific RNA-seq protocols, which preserves information about the directionality of a 
transcript. Retaining strand-specificity is essential for studying for antisense 
transcription. In fact, by 2007, only about 30 antisense sRNAs (asRNAs) were known 
in bacteria (reviewed in (23)). After the introduction of strand-specific RNA-seq 
protocols the number of asRNAs detected has increased exponentially, with tens to 
hundreds of asRNAs detected in every bacterium studied (15,24-30). Strand-
specificity is retained if the cDNA library is prepared using a directional protocol 
(Figure 4). During first-strand cDNA synthesis from RNA molecules by reverse 
transcription, unintended second-strand cDNA synthesis could occur using the first-
18
 strand cDNA as a template. To avoid this, directional libraries can be prepared with 
the two following protocols: (i) first strand cDNA synthesis can be performed in the 
presence of actinomycin D, which specifically inhibits the DNA-dependent DNA 
polymerase activity of the reverse transcriptase enzyme (17). Then second strand 
cDNA synthesis is carried out in the presence of dUTP, which allows the selective 
removal of the strand with UNG (uracil-N-glycosylase) after ligation of 5' and 3' 
adaptors, leaving the first cDNA strand intact (31). Random oligonucleotides are 
used for the synthesis of first and second cDNA strands. (ii) Direct labeling of the 
RNA molecules with different adapters at the 5' and 3' ends before cDNA synthesis, 
which preserves the strand orientation of each RNA molecule (29,32). The 
transcripts are ligated to different RNA adapters in the 5’ and the 3’ ends using T4 
RNA ligase. In this approach oligonucleotides complementary to the 5’ and 3’ 
adaptors are used for the synthesis of cDNA, considerably reducing the bias 
introduced by use of random primers to synthesize the cDNA. 
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 3.	  BACTERIAL	  SMALL	  RNAs	  
 
The regulatory role of RNAs was first reported around 40 years ago in E. coli, when 
the plasmid- and transposon-encoded antisense sRNAs RNAI and CopA were found 
to negatively regulate plasmid copy number (33,34). However, there has not been 
much interest on this kind of regulation until the beginning of this century. Nowadays 
it is known that RNA-mediated regulation is found in all kingdoms of life, maybe in all 
species. In eukaryotes, microRNAs (miRNAs) are a large class of very short (21-25 
nt) non-coding RNAs that affect translation and degradation of target mRNAs by 
antisense base pairing. The first miRNA was discovered in C. elegans in 1993 (35), 
but it was not until the early 2000s that miRNAs were recognized as a conserved 
class of biological regulators. Today miRNAs are known to be pivotal regulators of 
processes such as development and disease in eukaryotes (36,37). 
In contrast to the eukaryotic miRNAs, bacterial sRNAs range in size approximately 
from 70 to 500 nucleotides (nt), though some sRNAs are shorter or longer than that. 
Bacterial sRNAs can modulate gene expression and most of them function through 
base-pairing interactions with mRNA targets that can affect translation initiation, 
transcription termination or mRNA stability (reviewed in (1,38)). There are examples 
of sRNAs involved in transcription reprogramming, carbon metabolism, iron 
homeostasis, cell envelope homeostasis and coordination of virulence (reviewed in 
(39)). At present, sRNAs have been found in all bacterial species investigated, and in 
some cases regulatory sRNAs may exceed protein regulators in number as well as 
diversity. Other RNA regulatory elements found in bacteria include riboswitches 
encoded in untranslated regions (UTRs) of mRNAs and CRISPR elements, and the 
reader is directed to fantastic existing reviews (40,41). 
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 3.1	  Mechanisms	  of	  action	  of	  bacterial	  small	  
RNAs	  
 
Numerous bacterial sRNAs and all eukaryotic miRNAs regulate expression of 
mRNAs that are transcribed from a different genomic location, and are therefore 
named trans-encoded regulatory RNAs. There are also examples of cis-encoded 
sRNAs. They are transcribed from the reverse complementary strand of their target 
RNAs, thus generating fully complementary RNAs. Both trans- and cis-encoded 
sRNAs regulate the activity of a different RNA molecule, thus they are trans-acting 
regulators. There are also cis-encoded and cis-acting RNA elements, for example 
riboswitches encoded in UTRs of mRNAs.  
A strand of DNA that is transcribed into an mRNA is called sense. Transcription from 
the opposite DNA strand (the antisense strand) of an mRNA-coding locus generates 
a cis-encoded antisense RNA that is fully complementary to the mRNA. However, 
trans-encoded antisense sRNAs also base pair to sense RNAs with limited 
complementarity. Thus, antisense sRNAs can be either trans- or cis-encoded.  
In an effort to make the classification of sRNAs easier, trans-encoded and trans-
acting sRNAs with limited complementarity with their targets are sometimes referred 
to as intergenic sRNAs, due to the fact that most of these sRNAs are encoded in 
intergenic regions. Cis-encoded and trans-acting sRNAs are normally referred to as 
antisense sRNAs, to emphasize that they are encoded from the antisense strand of 
the target RNA. These types of nomenclature, though not scrupulous, are easier and 
more widely used than the exact ones. In this thesis I sometimes refer to trans-
encoded and trans-acting sRNAs as intergenic sRNAs, and to cis-encoded and 
trans-acting sRNAs as antisense sRNAs (asRNAs). I prefer not to use the term non-
coding RNAs to refer to regulatory RNAs as some trans- and cis-encoded sRNAs 
also encode small peptides and are therefore dual-function sRNAs (reviewed in 
(42)).  
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Figure 5. Regulatory RNAs can act on other RNA molecules (trans-acting) or on themselves 
(cis-acting), and can be expressed from a separate locus (trans-encoded) or from the same 
locus as the target RNA (cis-encoded). Regulatory RNA, mRNA, and DNA are shown in grey 
arrows, black arrows, and white boxes, respectively. Figure adapted from (43). 
 
3.1.1 Trans-encoded sRNAs 
 
After the discovery in the 1970s that the life cycle or copy number of bacterial 
transposons and plasmids is regulated by asRNAs, a similar regulatory RNA, MicF, 
was found to be encoded in the chromosome of E. coli (44). Unlike the asRNAs of 
transposons and plasmids, MicF was not transcribed from the DNA strand opposite 
its target gene ompF, which encodes the outer membrane protein F, but it was 
encoded in an intergenic region. Furthermore, MicF had incomplete and imperfect 
sequence complementarity to its target, but its base pairing strongly inhibited the 
translation of the ompF mRNA. Nowadays, most of the identified bacterial sRNAs are 
known to be encoded in different genomic loci (usually intergenic regions) than their 
target mRNAs and share only limited complementarity with their targets, like MicF.  
Base pairing between the sRNA and its target mRNA can promote or inhibit 
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 translation, and can decrease or increase mRNA stability. Most of the intergenic 
sRNAs characterized to date, bind to the 5’ UTR of mRNAs most often inhibiting 
translation by base pairing with the ribosome-binding site (RBS) or upstream of the 
AUG codon of the mRNA (45,46). Trans-encoded sRNAs can also activate 
translation of their target mRNAs when base pairing of the sRNA disrupts an 
inhibitory secondary structure that sequesters the RBS (47-49). sRNA-mRNA 
duplexes are often degraded by RNase E or RNase III, the two major 
endoribonucleases in bacteria. The first, RNase III, specifically degrades double-
stranded RNA complexes, which makes it an ideal candidate for processing asRNAs 
base paired with their targets. The asRNA-directed cleavage can generate two target 
RNA halves that are both less stable, both more stable, or differentially stabilized 
relative to each other. RNase E, which cleaves single-stranded RNA, is the other 
endonuclease involved in asRNA-directed processing. RNase E is a component of 
the degradosome, a multiprotein complex that affects mRNA stability and interacts 
with Hfq (reviewed in (50)). However it is not exactly clear how RNase E activity is 
stimulated by double-stranded RNA regions, though it is presumed that the 5’ end of 
an base-pairing sRNA could provide a monophosphate, which has been shown to 
stimulate RNase E activity (51). Trans-encoded sRNAs can also increase the stability 
of mRNAs, by inducing cleavage by endonucleases that generates a mRNA with a 
different 5’ structure that increases stability (52), or by protecting the 5’ end of 
mRNAs from nucleases (53). For example, base pairing between the sRNA and its 
target mRNA might be able to block an RNase E recognition site, leading to 
increased stability of the target RNA. Theoretically, base pairing between a trans-
encoded sRNA and its target could also promote transcription termination or 
antitermination, as has been found for some cis-encoded sRNAs.  
There is little correlation between the genomic location of trans-encoded sRNAs and 
their target mRNA genes. In fact, several trans-encoded sRNAs are known to base 
pair with multiple mRNAs. This results from the fact that trans-encoded sRNAs have 
limited complementarity with their target mRNAs, usually in discontinuous patches, 
rather than extended regions of perfect complementarity, as for cis-encoded sRNAs. 
The region of base pairing between trans-encoded sRNAs and target mRNAs is 
typically 10–25 nt, but only some of the nucleotides seem to be critical for regulation. 
For example, although the SgrS sRNA can form 23 base pairs with the ptsG mRNA, 
only changes in 4 of these nucleotides in SgrS affects downregulation of ptsG (54). 
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Figure 6. Mechanisms of action of trans-encoded sRNAs. Genes encoding trans-encoded 
sRNAs (red) are located separately from the genes encoding their target RNAs (blue) and 
only have limited complementarity. Trans-encoded sRNA can act negatively by base pairing 
with the 5’UTR and blocking ribosome binding (left panel) and/or targeting the sRNA-mRNA 
duplex for degradation by RNases (middle panel). Trans-encoded sRNA can also act 
positively by preventing the formation of an inhibitory structure, which sequesters the 
ribosome-binding site (RBS) (right panel). Figure adapted from (1). 
 
In Gram-negative bacteria, the RNA binding protein Hfq is very frequently required 
for the function and stability of trans-encoded sRNAs (reviewed in (55)). However the 
detailed mechanisms by which Hfq promotes base pairing of sRNAs and their targets 
are still not well characterized. Hfq has been shown to facilitate base pairing by 
increasing annealing rates (56,57), by stabilizing sRNA-mRNA duplexes (58), and by 
promoting changes in secondary structure of one of the RNAs (59). Many trans-
encoded sRNAs have been identified in studies that precipitate Hfq along with its 
bound RNAs (60-63). It is possible that there is a significant number of sRNAs that 
do not require Hfq to regulate mRNAs, but the most studied sRNAs so far are the 
ones that bind Hfq. Studies of Hfq in a range of organisms other than E. coli are 
necessary to uncover its full role as RNA chaperone. The E. coli ProQ protein has 
also been suggested to be an RNA chaperone, as it has a C-terminal domain with 
similar to Hfq (64). The YbeY protein, which is ubiquitous in bacteria, impacts gene 
expression similarly to Hfq in Sinorhizobium meliloti (65). Other proteins also may act 
as RNA chaperones bacterial species where there is no Hfq homolog. 
24
 3.1.2 Cis-encoded sRNAs 
 
A significant number of protein-coding genes are also transcribed from the reverse 
complementary strand in a wide range of bacterial species (15,24-30). In general, 
overlapping transcription results in the generation of a cis-encoded asRNA whose 
size usually varies between various tens to hundreds of nucleotides (nt). By 2007, 
only about 30 bacterial asRNAs had been identified (reviewed in (23)). Antisense 
transcription detected in initial tiling array experiments was suspected to be an 
experimental artifact generated during cDNA synthesis. This problem was overcome 
by the development of strand- specific cDNA synthesis protocols (17). The number of 
reported asRNAs has lately exploded due to the use of RNA-seq. However 
characterization of the physiological function of individual asRNAs is growing at a 
much slower speed.  
 
AsRNAs are known to affect the expression of the target gene by different 
mechanisms (Figure 7) (reviewed in (66)). (i) One is transcription interference, in 
which transcription from one promoter is suppressed by a second promoter located 
in the opposite strand. Transcription interference does not involve base-pairing and 
does not occur when the asRNA is provided in trans. This effect was first detected in 
two convergent bacteriophage promoters that produce transcripts which have an 
overlap of 62 bp at their 5’ ends (67). It was observed that the stronger promoter 
significantly reduced the activity of the weaker promoter. When the promoters were 
oriented divergently, the transcription from both promoters was not affected despite 
the transcripts still maintained their regions of complementarity. Moreover, the 
introduction of a terminator before the convergent weak promoter resulted in reduced 
interference. These results led to the conclusion that the convergent orientation of 
the promoters was the source of the interference rather than base pairing. (ii) 
Antisense RNAs also can alter induce mRNA transcription attenuation, in which base 
pairing of the asRNA to the target mRNA causes premature transcription termination. 
In some cases base pairing of the asRNA to the mRNA has been shown to induce 
the formation of a terminator structure in the target mRNA. One example of this type 
of regulation is the asRNA RNAβ, encoded opposite to the fatDCBA-angRT iron 
transport-biosynthesis operon in the fish pathogen Vibrio anguillarum (99). 
Premature transcription termination results in increased levels of the fatDCBA 
fraction of the mRNA compared to the down-stream angRT, providing a mechanism 
for discoordinate expression within an operon. (iii) AsRNAs can also promote 
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 changes in the target RNA stability by the same mechanism as intergenic sRNAs, 
where the asRNA either promotes or blocks degradation or cleavage of the mRNA by 
ribonucleases. As example, RNase III is known to be responsible for the of the 
plasmid-encoded copT-copA and hok-sok asRNA pairs (68,69). The AmgR RNA of 
Salmonella enterica induces degradation of the mgtC mRNA in a manner that 
requires RNase E but not RNase III (70). (iv) Just as trans-encoded sRNAs, asRNAs 
whose complementarity extends into the 5’ UTR of their target RNA can impact on 
ribosome binding to the target mRNA (either positively or negatively) by affecting the 
target RNA structure.  
 
In addition, regulating the expression of the opposite gene is not the only function of 
certain asRNAs. As intergenic sRNAs, some asRNAs encode small proteins (71), 
and some have the potential to act on multiple targets in trans (72-76). The number 
of existing asRNAs is far from complete, and other mechanisms of action will 
probably be found. Some possibilities are that antisense transcription serves to 
stabilize certain regions of the chromosome or as a defense against plasmids 
containing complementary regions. 
 
 
Figure 7. Mechanisms of action of antisense RNAs. Sense RNAs are depicted in dark 
blue while asRNA in light blue. Figure adapted from (66). 
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 3.1.3 Protein-binding sRNAs 
 
The number of sRNAs that directly regulate the activity of proteins is much lower 
than the number of intergenic sRNAs and asRNAs. However, their regulatory roles 
are by no means less powerful. sRNAs can regulate RNA binding proteins by 
containing the protein recognition sequence (molecular mimicry), often in multiple 
copies. This is the case of E. coli CsrB RNA, which has 18 binding sites for the RNA 
binding protein CsrA, which regulates mRNA translation and stability (reviewed in 
(77)). The P. aeruginosa CrcZ RNA is another example of this kind of regulation. 
CrcZ contains 5 CA-rich motifs which can bind up to 5 copies of the translation 
repressor protein Crc (78). Other sRNAs bind enzymes, and can inhibit, activate or 
modify protein activity. The most studied example is 6S RNA, which binds to the 
house-keeping form of RNA polymerase (σ70-RNAP) by mimicking the secondary 
structure of DNA during transcription initiation (reviewed in (79)). The changes on 
transcription after binding 6S RNA are very complex, which indicates that σ70-RNAP 
activity is modified rather than simply inhibited (80). It is expected that the number of 
sRNAs that bind to proteins will increase, and that more modes of regulation will be 
discovered. For example, it is proposed that sRNA binding to proteins might also 
modulate proteins by allosteric regulation or by tethering proteins close to each other 
(Figure 8).  
 
 
Figure 8. Mechanisms of action of sRNAs that modulate protein activity. Figure adapted 
from (81). 
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 3.2	  Identification	  of	  bacterial	  small	  RNAs	  
 
Until very recently, bacterial sRNAs have been overlooked mainly because there was 
no systematic technical skills to detect them. Despite the fact that the first bacterial 
sRNAs have been known for four decades, earlier studies to identify sRNAs have 
often depended on serendipity, direct detection due to high abundance, protein co-
purification, and computational predictions based on sequence conservation 
(reviewed in (82)). Computational predictions of sRNAs often search exclusively 
within intergenic regions and only detect sRNAs that fall into a certain definition, 
based on a combination of sequence conservation, specific promoters and Rho-
independent terminators (83-86). Although various sRNAs have been identified in 
bioinformatics predictions, sRNAs that are transcribed within or antisense to already 
annotated loci are missed. In addition, sRNAs whose 3’ ends are formed by Rho-
dependent terminators or processed by RNases are missed by computational 
methods that search for Rho-independent terminators. Similarly, studies that rely on 
chaperone-binding to find sRNAs will miss chaperone-independent sRNAs. 
Until 2001 only a dozen of sRNAs were known in bacteria, 10 of them identified in E. 
coli (reviewed in (87)). Most of these sRNAs were identified serendipitously while 
analyzing flanking protein-coding genes. In 2001, the first genome-wide systematic 
searches for sRNAs were performed in E. coli by three independent groups, and 
more than 50 sRNAs were identified (62,88,89). These studies predicted the 
existence of sRNAs based on sequence conservation between E. coli intergenic 
regions and those of the closely related bacteria Salmonella typhimurium and 
Yersinia pestis, for which complete genome sequences had been published at the 
time. By 2007, only 140 bacterial sRNAs had been discovered (reviewed in (90)). 
 
The first transcriptomic studies investigating sRNAs used cDNA synthesis from RNA 
samples, combined with cloning and Sanger sequencing (60,91). Recent genome-
wide studies to identify sRNAs have been based on tiling arrays and, since 2008, 
primarily on RNA-seq. As mentioned in section 2.2, RNA-seq has many advantages 
over tiling arrays, and has enabled the study of the transcriptome at unprecedented 
depths and in a strand-specific manner. RNA-seq has revealed several hundreds of 
previously undetected transcripts in diverse bacteria including Bacillus subtilis (92), 
Chlamydia trachomatis (28), Helicobacter pylori (24), Legionella pneumophila (93), 
Listeria monocytogenes (94,95), Salmonella enterica (96-98), Streptomyces 
28
 coelicolor (99), Synechocystis (100), Vibrio cholerae (91,101), Yersinia 
pseudotuberculosis (102), Escherichia coli (103,104), Mycobacterium tuberculosis 
(105), Staphylococcus aureus (29), and Agrobacterium tumefaciens (106).  
 
Special attention must be paid to the way RNA-seq experiments are designed, as 
different protocols will yield a very different number of detected sRNAs. Many of the 
RNA-seq studies published so far are not optimal for the identification of sRNAs, 
even if some are identified. One of the first considerations when designing an RNA-
seq experiment to study sRNAs is the method used to extract total RNA. Historically 
RNA extraction methods have been optimized to exclude sRNAs under the 
assumption that they were products of degradation of no interest or importance. 
Many commercially available kits for RNA isolation do not quantitatively retain the 
short RNAs. This is the case for most of the kits that use spin columns. Spin-column 
kits provide very quick and efficient methods for extracting high-quality RNA, but are 
not suitable to study sRNAs since their size exclusion limit is too large. 
Transcriptomic studies that use this kind of RNA extraction cannot detect most of the 
sRNAs transcribed by both prokaryotic and eukaryotic cells. There are commercially 
available spin-column kits specially designed for the study of eukaryotic miRNAs (20-
22 nt). These kits are not suitable for the study of prokaryotic sRNAs, as these 
typically range in size from 70 to 500 nt. Methods as the hot-phenol protocol or the 
guanidinium thiocyanate-phenol-chloroform extraction allow retention of all RNA 
species (see Article 2 presented in this thesis for details). Another important 
consideration is that strand-specific library preparations are necessary for the 
accurate determination of the direction of the transcripts, as well as the identification 
of antisense transcription events, as mentioned in section 2. 
Other consideration when designing RNA-seq experiments is whether or not it is 
desirable to include highly abundant rRNAs in the library preparation. The relative 
abundance of mRNAs in bacterial total RNA can be as low as 5%, being the rest 
rRNAs and tRNAs (107). This results in a major technical challenge for RNA-seq. 
Unlike eukaryotic mRNAs, which can be selectively synthesized into cDNA by virtue 
of their poly-A tails (108), bacterial and archaeal cDNA synthesis results 
predominantly in rRNA sequences (109). To improve mRNA and sRNA detection 
sensitivity, prokaryotic rRNAs are often removed before preparing RNA-seq libraries 
(32,91,97,110,111). Successful reduction of the rRNA fraction can result in a ten-fold 
enrichment of the mRNA and sRNA output, and that ensures sufficient transcript 
coverage. Although mRNA enrichment is not absolutely necessary, it can 
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 substantially increase transcript coverage and therefore increase the sensitivity of the 
experiment. The downside of enrichment might be unanticipated biases in the 
sequenced transcriptome. Other possibility would be to compensate the lower 
coverage in non-enriched samples by sequencing more cDNA, but this will 
significantly increase the cost of the experiment.  Different methods have been used 
to eliminate prokaryotic rRNA, including subtractive hybridization with rRNA-specific 
probes, digestion with exonuclease that acts on processed transcripts, and gel 
electrophoresis size separation and extraction of non-rRNA fractions, which has the 
drawback of excluding also transcripts similar in size to rRNAs. A study compared 
the effectiveness and fidelity of the two most commonly used approaches, 
subtractive hybridization and exonuclease digestion (Figure 9), on  two different 
synthetic metatranscriptomes and found that only subtractive hybridization 
adequately preserved relative transcript abundance for quantitative analyses, 
whereas the exonuclease treatment greatly compromised mRNA abundance fidelity 
(112). This is not surprising since many non-ribosomal transcripts (including sRNAs) 
are processed, and treatment with exonuclease results in the loss of these. Article 2 
presented in this thesis describes how to use subtractive hybridization to efficiently 
deplete 23S, 16S and 5S rRNAs from total RNA samples. 
 
 
Figure 9. Methods for non-rRNA enrichment in prokaryotes (113).  
 
Size is a key factor when detecting novel sRNAs using RNA-seq. RNA size 
fractionation prior to library preparation allows a greater coverage of small size RNAs 
and of transcripts expressed at low levels, increasing the number of novel RNAs 
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 detected (29,32,91). As mentioned further, our study of the transcriptome of P. 
aeruginosa involved the use of three different types of sequencing libraries, with 
different degrees of RNA size selection (32). The libraries that contained the fraction 
of shorter RNAs were clearly superior in detecting sRNAs compared to a library that 
contained the full transcriptome, which highlights the importance of adequate library 
preparation to detect sRNAs (see Article 1 presented in this thesis for details). Thus, 
RNA-seq libraries that contain all the transcriptome will detect only a fraction of 
highly expressed sRNAs, unless using an enormous sequencing depth, which 
normally results in increased economic costs. RNA-size fractionation should be 
performed prior to rRNA-depletion, as the larger rRNA molecules will be excluded 
during size selection. The smaller rRNAs, like 5S rRNA, can be excluded after the 
size selection (see Article 2 presented in this thesis for details). 
 
Figure 10. Summary flowchart suggesting an experimental design to define a complete 
transcriptional map. Figure adapted from (22). 
 
To summarize, the sensitivity of RNA-seq for detecting sRNAs greatly depends on 
the design of the experiment. The most important factors when designing such 
experiments are: 
 
(i) The choice of a method for RNA extraction that does retain all sRNA 
species. Methods as the hot-phenol protocol or the guanidinium 
thiocyanate-phenol-chloroform extraction allow retention of all RNA 
species. 
(ii) Removal of abundant rRNAs increases the relative abundance of mRNA 
and sRNA species and ensures sufficient transcript coverage. Subtractive 
hybridization depletion methods are preferred over the use of 
exonuclease, as exonuclease digestion results in the loss of many non-
ribosomal transcripts (including sRNAs) that are processed. 
(iii) RNA size fractionation prior to library preparation also allows a greater 
coverage of small size RNAs and of transcripts expressed at low levels, 
and thus the sensitivity of the experiment increases. 
Complete((
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 (iv) The use of a strand-specific method for library preparation retains the 
directionality of RNA molecules, making possible to detect antisense 
transcription. Direct labeling of the RNA molecules with different adapters 
at the 5' and 3' ends is preferred over other methods as oligonucleotides 
complementary to the 5’ and 3’ adaptors are used for the synthesis of 
cDNA, considerably reducing the bias introduced by use of random 
primers to synthesize the cDNA. 
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 4.	  PSEUDOMONAS	  AERUGINOSA	  
	  
This Gram-negative bacillus can be found in a wide variety of environmental sources, 
from water to soil. It grows on a wide range of media over a wide range of 
temperature. It is an important opportunistic pathogen in humans, causing urinary 
tract infections, respiratory system infections, systemic infections in burn patients as 
well as being the major cause of morbidity and mortality in cystic fibrosis patients 
(114).  
 
The increasing clinical relevance of P. aeruginosa as an opportunistic human 
pathogen is based in several reasons: its adaptability, its innate resistance to many 
antibiotics and disinfectants, its armoury of virulence factors, an increasing number of 
patients compromised by age, disease or immunosuppressive therapy, and its ability 
to persist and multiply in a great variety of moist environments and equipment in 
hospital wards, bathrooms and kitchens, which is of particular importance in cross-
infection control. The genome of P. aeruginosa is one of the largest among bacteria: 
it contains approximately 6.2 million base pairs and 5,570 genes, including a high 
proportion of regulatory genes which most likely reflect its adaptability (115). The 
choice of P. aeruginosa in this study was mainly motivated by the fact that it 
possesses vast and complex regulatory networks, whose mechanisms are not 
entirely understood, and by the low number of regulatory sRNAs identified in this 
bacterium prior to our study (reviewed in (116)). We hypothesized that P. aeruginosa 
must have many unknown sRNAs encoded in its large genome, and that has been 
shown to be true.  
 
 
4.1	  Antibiotic	  resistance	  
 
P. aeruginosa is intrinsically resistant to many antimicrobial agents and acquired 
resistance is frequently developed during antibiotic therapy (117). The mechanisms 
of resistance consist of chromosomally encoded β-lactamases, multidrug efflux 
systems, low outer membrane permeability and lipopolysaccharide (LPS) 
modification. Antibiotics such as piperacillin, aztreonam, ceftazidime, meropenem, 
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 ciprofloxacin, colistin, azithromycin or tobramycin are usually active against P. 
aeruginosa, but resistance often develops in the case of chronic infected CF patients 
(118-122). P. aeruginosa has more than 10 resistance-nodulation-division (RND) 
family transporters, of which 9 transport multiple antibiotics. These pumps export 
antibiotics but also biocides, dyes, detergents, metabolic inhibitors, organic solvents 
and molecules involved in bacterial cell-to-cell communication. Despite drug efflux 
not being the natural function of RND pumps, these pumps enable many pathogens 
to resist antimicrobial drugs and thus compromise treatment of infectious diseases 
(123). P. aeruginosa also produces a chromosomally encoded cephalosporinase 
designated AmpC. The expression of AmpC is highly inducible by certain β-lactams, 
such as cefoxitin, imipenem or ampicillin. The antipseudomonal penicillins (such as 
piperacillin) and cephalosporins (such as ceftazidime) are very weak AmpC inducers, 
despite the fact that this enzyme hydrolyzes them. However, during treatment with 
these weak inducers, mutants showing high expression of AmpC (AmpC-
derepressed mutants) are frequently selected, leading to the failure of antimicrobial 
therapy (124). In addition P. aeruginosa is able to modify its outer-membrane 
lipopolysaccharides (LPS) leading to increased tolerance towards cationic 
antimicrobial peptides, like colistin, and increased inflammatory responses (125). 
 
 
4.2	  Quorum	  sensing	  
 
Quorum sensing (QS) has been defined as the chemical-mediated cell-to-cell 
communication systems to coordinate gene expression and group activities within 
bacterial communities (126). P. aeruginosa produces at least three small molecules 
that function as cell-to-cell communication signals. The acyl homoserine lactone 
signals 3-oxo-C12-HSL and C4-HSL have been well studied and function in 
combination with the LasR and RhlR proteins, respectively (127-131). Together, 
these two HSLs control up to 11% of the P. aeruginosa genes (132-134). The third P. 
aeruginosa cell-to-cell signal, named the Pseudomonas quinolone signal (PQS), is a 
quinolone compound that was identified as 2-heptyl-3-hydroxy-4-quinolone (135). 
PQS is synthesized from anthranilate by the products of the pqs operon 
pqsABCDEH. The precursor of the PQS molecule is 4-hydroxy-2-heptyl-quinoline 
(HHQ), which is released from and taken up by bacterial cells (136). The expression 
of pqsABCDE is regulated by the transcriptional regulator PqsR (also designated as 
MvfR) (137). By contrast, pqsH, which is necessary for the conversion of HHQ to 
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 PQS, is positively regulated by LasR (138). PQS controls numerous virulence factors 
and it serves as a regulatory link between the las and rhl QS systems (139,140). 
PQS is produced in the lungs of CF patients infected with P. aeruginosa (141), it is 
required for virulence in nematodes, plants, and mice (137,138,142-144), and it also 
induces apoptosis and decreases viability in eukaryotic cells (145). 
 
 
 
 
Figure 11. Model of the P. aeruginosa QS signaling hierarchy. Plus and minus symbols 
indicate positive and negative effects, respectively. The QS system consists of two HSL 
regulatory circuits (las and rhl) linked to a 2-alkyl-4-quinolone (PQS) system. In complex 
interactions with additional regulators, including Vfr, GacA, RsaL, and RpoS, the QS systems 
regulate the expression of several of virulence factors. Figure adapted from (146). 
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 4.3	  Small	  RNAs	  in	  P.	  aeruginosa	  
 
Only 44 sRNAs were identified in P. aeruginosa up to 2012. A variety of approaches 
were used to identify these 44 sRNAs in P. aeruginosa (reviewed in (116)) including 
those based on direct detection due to high abundance (147), similarity with a known 
sRNA of E. coli (148), computational predictions (149), and co-purification with a 
protein (60). Three systematic searches for sRNAs were undertaken in P.aeruginosa, 
where all focused on intergenic regions. In two studies sRNAs were predicted on the 
basis of sequence conservation, as well as the presence of rho-independent 
terminators, putative promoters and conserved secondary structure (85,86). A third 
study used a combined bioinformatics and RNomics approach, where total RNA was 
size-fractionated, co-immunoprecipitated with Hfq, cloned and sequenced (60). 
 
Of the 44 sRNAs known in P. aeruginosa, only the role of 12 sRNAs is characterized, 
where 4 are classical sRNAs (6S, 4.5S, RNase P and tmRNA) (reviewed in (116)). In 
P. aeruginosa, sRNAs are known to be involved in the regulation of virulence genes 
(RsmY/Z), carbon catabolite repression (CrcZ), iron metabolism (PrrF1, PrrF2, PrrH), 
nitrogen assimilation (NrsZ), and QS regulation (PhrS) (47,78,149-152). PhrS is a 
213-nt long sRNA, predicted by biocomputation (85,86) and isolated by an RNomics 
approach (60). PhrS is highly transcribed under low oxygen conditions, and its 
expression requires the oxygen-responsive regulator ANR (47) (Figure 12). PhrS 
activates the translation of the pqsR gene by base-pairing with a short untranslated 
open reading frame (uof) to which the pqsR gene is translationally coupled (47). 
PqsR is one of the key QS regulators in P. aeruginosa and its synthesis induces the 
PQS synthetic operon pqsABCDE (138,153). Beside its function in inter-bacterial 
signaling, PQS is required for full synthesis of the P. aeruginosa virulence factor 
pyocianin, which can react with molecular oxygen to generate oxidative stress (154). 
In addition to its function as a regulatory RNA, PhrS encodes a highly conserved 37 
amino-acid peptide (60). The peptide contains a predicted transmembrane segment 
and sub-cellular fractionation revealed that the peptide is indeed located in the 
cytoplasmic membrane (CM). In Article 4 presented in this thesis we investigated the 
role of sRNA OsiS, which was first identified in the genome-wide search presented in 
Article 1. OsiS is highly transcribed during oxidative stress conditions, including 
treatment with sublethal concentration of hydrogen peroxide and lethal 
concentrations of ciprofloxacin. We show that by inducing the expression of OsiS the 
levels of the sRNA PhrS are greatly reduced. We predict that the interaction is by 
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 direct base-pairing between the two sRNAs, with a recognition site of OsiS at the 
highly conserved-region of PhrS (155). However, more experiments are required to 
know the exact mechanism of interaction between these two sRNAs. OsiS is, to the 
best of our knowledge, the first sRNA whose main function seems to be regulating 
the cellular levels of another sRNA.  
 
 
 
Figure 12. Quorum sensing regulation by PhrS. Figure adapted from (156). 
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 The size and complexity of the P. aeruginosa genome suggested that there were 
many undetected sRNAs in this bacterium. In 2012, we published the first genome-
wide search of sRNAs using RNA-seq in P. aeruginosa (32). RNA isolated from 
exponential and early-stationary phase cells was used to prepare three different 
types of libraries for sequencing. The sequencing libraries were named LIB>100, 
LIB<500 and LIB<200 to denote the transcript sizes in nucleotides that are included 
in each preparation. Library LIB>100 contained all mRNAs transcribed. Libraries 
LIB<500 and LIB<200 were each prepared with size selection steps and contain 
transcripts shorter than 500 and 200 nt respectively. We found over 500 novel 
intergenic sRNAs in the three libraries, where a different number of transcripts were 
detected in each library. The two libraries that do not include larger transcripts 
(LIB<500 and LIB<200) were clearly superior in detecting sRNAs. Our data suggests 
that the set of identified RNAs obtained depends strongly on the specific library 
preparation strategy used, and that RNA fractionation increases the sequencing 
depth favoring identification of trasncripts expressed at low copies (see Article 1 in 
Chapter 2 for details). In addition we identified 249 antisense sRNAs (asRNAs) in P. 
aeruginosa PAO1 grown in 13 different conditions, including osmotic and oxidative 
stress, early and stationary phases, and a variety of antibiotics clinically used (see 
Article 3 in Chapter 2 for details). In this study only one library type was used, which 
contained transcripts shorter than 500 nt (library LIB<500). 
 
Later in 2012, two independent studies that used RNA-seq in P. aeruginosa were 
published. One of the studies investigated strains PAO1 and PA14 at early stationary 
phase using a similar preparation than that of library LIB<500. The authors found 163 
novel sRNAs, of which 60 were antisense sRNAs (asRNAs) (157). Interestingly, the 
authors found that a number of these sRNAs were strain-specific or showed strain-
specific expression (157). The other study sequenced P. aeruginosa PA14 grown at 
28ºC and at 37ºC using a strategy similar to library LIB>100. This study identified 165 
intergenic sRNAs and 384 antisense transcriptional start sites (TSS) (158). The 
strategy used to prepare the libraries only detected the strand specificity of TSS, thus 
the authors could only identify antisense TSS, but not the full length of asRNAs. The 
strategy used by Wurtzel et al (2012) enabled the identification of TSSs thanks to the 
differential treatment of RNA with tobacco acid pyrophosphatase (TAP). TSSs can be 
detected by selecting for primary RNA transcripts that have a 5′-triphosphate 
(processed RNAs have a 5′-monophosphate) (24). In conclusion, our sequencing 
approach was the most sensitive, identifying novel sRNAs, both intergenic sRNAs 
and full-length asRNAs, compared to the other two genome-wide studies in P. 
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 aeruginosa. However our library preparations could be further improved by 
sequencing differential cDNA library pairs (one fraction treated with TAP or with 
terminator exonuclease, and the other fraction left untreated) to discriminate primary 
from processed 5’ ends. It would be interesting to make a comparison between the 
three studies to assess the level of overlap between them, as well as for creating a 
single database with all the sRNAs detected so far in P. aeruginosa strains and their 
patterns of expression in the conditions studied. 
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 5.	  CONCLUSION	  AND	  PERSPECTIVES	  
 
Identifying the full set of transcripts, including large and small RNAs, is crucial for a 
comprehensive study of the transcriptome. Until recently, our knowledge of the 
transcriptome was largely derived from gene predictions based on sequence 
conservation and limited evidence, and has thus been partial. During the last decade, 
RNA-seq has revealed the complex landscape and dynamics of the transcriptome of 
all organisms studied at an unprecedented level of sensitivity and accuracy. 
Compared with traditional low-throughput Sanger sequencing technology, which only 
detects the more abundant transcripts, the enormous sequencing depth of a typical 
RNA-seq experiment can offer an almost complete snapshot of a transcriptome, if 
using appropriate library preparations. As mentioned earlier, the main focus of this 
thesis has been to investigate the number and characteristics of sRNAs in the highly 
adaptable pathogen P. aeruginosa. RNA-seq protocols have been optimized in order 
to increase their sensitivity and detect as many sRNAs as possible. The research 
articles written as part of this work are enclosed in the next section. Article 1 
describes how a combination of three different RNA-seq libraries is used to identify 
novel transcripts encoded in intergenic regions. Almost all known sRNAs and over 
500 novel intergenic sRNAs were identified with this approach. The use of three 
libraries in combination increased the number of novel transcripts identified. However 
there were significant differences in the subset of transcripts detected in each library, 
underscoring the importance of library preparation strategy and relative sRNA 
abundance for successful sRNA detection. Article 2 is a book chapter that provides 
detailed experimental procedures for preparing the three different sequencing 
libraries used in Article 1, as well as a computational pipeline to analyze the data 
generated and find both intergenic and asRNAs. One of the libraries (LIB>100) is 
prepared using a standard RNA-seq protocol for full transcriptomes and contains 
information on all mRNAs transcribed by the bacteria. The other two libraries 
(LIB<500 and LIB<200) are prepared from size-selected RNA containing transcripts 
shorter than 500 and 200 nt, respectively. The different libraries can either be used 
alone or in combination to increase the number of identified sRNAs. In Article 3 249 
asRNAs are identified using the library type LIB<500. P. aeruginosa PAO1 was 
grown in 13 different conditions to ensure a comprehensive characterization of the P. 
aeruginosa asRNA-ome. The conditions studied include exponential and early-
stationary phase, osmotic, oxidative and antibiotic stress. A considerable number of 
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 asRNAs were transcribed opposite to genes encoding membrane proteins and genes 
involved in the transport of small molecules, cell wall, lipopolysaccharide (LPS), and 
capsule biosynthesis. A substantial number of asRNAs significantly changed their 
expression under osmotic, oxidative and antibiotic stress, suggesting that asRNAs 
play a regulatory role during these conditions. Finally, Article 4 investigates the role 
of sRNA OsiS that was first identified in the genome-wide search presented in Article 
1. OsiS is highly transcribed during oxidative stress conditions. We show that by 
inducing the expression of OsiS the levels of the sRNA PhrS are greatly reduced. 
PhrS activates the translation of PqsR under low oxygen concentrations, which in 
turn activates the synthesis of PQS. Thus, OsiS links the oxygen levels to the 
production of QS molecules. OsiS is another example of a sRNA that responds to 
oxygen levels in bacteria, such as PhrS in P. aeruginosa (47), RgsA in P. fluorescens 
(86), OxyS, FnrS and MicF in E. coli (159-162), and RliB in L. monocytogenes (15). 
OsiS is, to the best of our knowledge, the first sRNA whose main function seems to 
be regulating the cellular levels of another sRNA.  
The study presented in Article 1 is the first to use RNA-seq to discover novel sRNAs 
in P. aeruginosa and utilized three types of sequencing libraries to maximize the 
number of detected sRNAs. Over 500 novel sRNA transcripts were identified, 
increasing the number of known sRNAs in P. aeruginosa by a factor of 12 and 
revealing a large set of potential regulatory molecules in an already highly regulated 
species. Two libraries that do not include larger transcripts (LIB<500 and LIB<200) 
were clearly superior in detecting sRNAs. Although the use of three libraries 
increased the number of novel transcripts identified, there were significant 
differences in the subset of transcripts detected in each library, underscoring the 
importance of library preparation strategy and relative sRNA abundance for 
successful sRNA detection. The limited extent of sRNA sequence conservation 
observed among pseudomonads highlights the challenges of sRNA bioinformatic 
prediction and emphasizes the importance of sRNAs at the species level in 
monitoring changes in environmental conditions. The approach described can be 
applied to identify sRNAs in any bacterium under different growth and stress 
conditions. 
 
The multitude of sRNAs found in Articles 1 and 3 suggests the involvement of sRNAs 
in probably all the regulatory networks in P. aeruginosa, and characterizing their role 
will be highly important for our understanding of an organism with such a versatile life 
style that can successfully move from the environment into the human body as a 
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 pathogen. There are many questions that remain to be answered regarding the 
physiological roles of bacterial sRNAs. Even with the recent advances in 
transcriptomics, the hundreds of sRNAs now being reported in all bacteria studied 
need to be further validated and functionally characterized before we can really grasp 
the importance/role of bacterial sRNAs.  
 
Interestingly, few of the known bacterial sRNAs genes have been identified by 
mutational screens. This might be due to the fact that most of the sRNA genes do not 
code for proteins and are thus immune to frameshift or nonsense mutations. In 
addition, sRNAs are often very small (few hundred nucleotides) and sometimes 
multicopy, which makes them difficult (even impossible) targets for mutational 
screens. This could also be a consequence of the regulatory rather than essential 
nature of many sRNAs. Marvig et al (2013) studied the transmissible P. aeruginosa 
DK2 clone isolated from Danish CF patients, and analyzed the genomes of 55 
bacterial isolates collected from 21 infected individuals over 38 years (163). 
Subsequent to transmission, sub-lineages of DK2 evolved independently for years in 
separate patients, enabling the study of parallel evolution and identification of genes 
targeted by mutations to increase pathogen fitness in the CF airway. The authors 
found that the genes targeted by mutations were related to antibiotic resistance, cell 
envelope, or regulatory functions, and that the prevalence of adaptive mutations 
correlated with the evolutionary success of the sub-lineages. We looked for 
conserved adaptive mutations in all the intergenic sRNAs in P. aeruginosa, the 
known sRNAs prior to our genome-wide study plus the 513 novel sRNAs detected by 
it. We could not find any conserved adaptive mutation in any of the sRNA genes, 
suggesting that though sRNAs play important roles in regulatory networks, they are 
not the primary targets of bacterial evolution. In agreement with this, a long-term 
evolution experiment with E. coli, still ongoing, has not yet revealed any relevant 
changes in sRNA genes (164). However, a short-term evolution experiment reported 
a spontaneous mutation in Myxococcus xanthus that eliminated the regulatory 
function of the Pxr RNA, affecting multicellular fruiting body development (165). It will 
be interesting to perform more evolution experiments in other species to assess the 
role of sRNA regulation in the long-term adaptation of bacteria. 
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 From our work with OsiS, we infer that P. aeruginosa most likely needs a tight and 
fine-tuned regulation of the mechanisms that allow adapting to shifts in oxygen 
tension, and that the sRNA OsiS is involved in this kind of regulation by responding 
to high oxygen tension and regulating the levels of sRNA PhrS. PhrS is assumed to 
counteract the low levels of PQS under hypoxic conditions, when PQS production is 
limited (47). The sRNA OsiS role seems to “counteract the counteracting effect” of 
sRNA PhrS at high oxygen tension. So both sRNAs OsiS and PhrS respond to 
oxygen levels and allow the fine-tuning of PQS synthesis. In laboratory conditions, 
the growth rate of mutants deficient in PhrS production is the same as the wild-type 
strain, though the deletion mutant produced less pyocianin. We could not produce a 
strain lacking the OsiS gene, however over-expression of OsiS does not affect any 
apparent phenotype. Does that mean that sRNAs PhrS and OsiS have a minor 
regulatory role? And what is the biological implication of oxygen-dependent fine-
tuning of PQS? During infection, P. aeruginosa is subject to constant shifts in oxygen 
tension due to the human airway structure, biofilm formation, antibiotic treatment and 
the host immune response. Thus, fine-tuning regulators as PhrS and OsiS make no 
extraordinary difference in controlled and steady laboratory conditions, however we 
hypothesized that they might be pivotal for a fast and fine-tuned regulation of the 
mechanisms necessary to survive during adaptation to an environment with such 
fluctuating levels of oxygen tension as the one inside the host.  
 
As the number of sRNAs detected increases day by day, it would be interesting to 
understand why RNA-based regulation is sometimes preferred over protein-based 
regulation. It has been suggested previously that sRNA regulation has benefits over 
using protein regulators. These benefits might include reduced metabolic cost, 
additional levels of regulation, faster regulation and unique regulatory properties 
(reviewed in (166)). The coupled degradation of both the regulatory sRNA and the 
target mRNAs allows to achieve responses that are different than those obtained 
with transcriptional factors (167). However, it seems that in many cases a 
combination of both types regulation seems to be the way in which bacteria regulate 
the cellular levels of certain proteins and RNAs. For example, PhrS RNA regulates 
the expression of the pqsR gene (47), which is also regulated by other transcriptional 
factors, such as LasR and RhlR (146). In this case the regulation by transcriptional 
factors and PhrS is counteractive, as PhrS promotes the expression of pqsR in 
conditions when the transcriptional regulators limit its expression.  Similarly, PhrS is 
regulated by both the oxygen-responsive regulator ANR and by OsiS RNA (Article 4). 
In this case the regulation of both protein and sRNA act in a complementary way, 
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 ANR activating the expression of PhrS under low oxygen conditions, and OsiS 
reducing the levels of PhrS under high oxygen conditions. Thus, regulating a target 
at two levels, with both a transcription regulator and base-pairing sRNA, allows 
modifying the dynamics of target gene expression (as the regulation of pqsR by 
transcriptional factors and PhrS RNA) as well as reducing leakiness (as the 
regulation of PhrS by ANR and OsiS RNA). 
As we start to solve some of the traditional challenges for studying sRNAs, such as 
the lack of technical skills to detect them, new challenges arise. One of them is the 
handling of RNA-seq data. Comparing these extremely large data sets between 
different studies is difficult, as library preparation protocols, sequencing platforms, 
and thresholds for detecting transcripts differ from study to study. It is necessary to 
address considerations like what is an appropriate threshold of reads for transcript 
detection, or how reproducibility should be reported. Ironically, we now have such an 
enormous volume of data that it is hard to use them. Universally available platforms 
are already and will be needed for sharing, analyzing, and storing transcriptomic 
data. An even greater challenge than sharing and comparing RNA-seq data, will be 
the validation and characterization of the hundreds of novel sRNAs reported by every 
new study. While Northern blot analysis has been the golden standard for validating 
RNAs, its sensitivity is significantly lower than that achieved by RNA-seq. 
Techniques such as 5’ and 3’ RACE experiments might be a good alternative for 
validating sRNAs. Just as Northern blots, RACE experiments provide information 
about the size and processing of a transcript. However, contrary to Northern 
analysis, RACE experiments provide single-base resolution of the coordinates of the 
transcripts. Without higher throughput techniques than the now available, it will take 
years, probably decades, to characterize the hundreds of sRNAs now being 
reported. The studies that characterize the function of sRNAs are mostly based in 
deletion strains and sRNA overexpression (168-170). Unfortunately, the phenotypes 
associated with decreased or increased expression of sRNAs are often subtle and 
might only be detected under specific conditions, as is the case of strains 
overexpressing PhrS and OsiS RNAs. The understanding of the molecular 
mechanisms of action of individual novel RNAs will most likely be one of the biggest 
challenges of current RNA research. 
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Summary
Bacterial small regulatory RNAs (sRNAs) function in
post-transcriptional control of gene expression and
control a variety of processes including metabolic
reactions, stress responses and pathogenesis in
response to environmental signals. A variety of
approaches have been used previously to identify
44 sRNAs in the opportunistic human pathogen
Pseudomonas aeruginosa. In this work, RNA sequenc-
ing (RNA-seq) is used to identify novel transcripts in
P. aeruginosa involving a combination of three differ-
ent sequencing libraries. Almost all known sRNAs and
over 500 novel intergenic sRNAs are identified with
this approach. Although the use of three libraries
increased the number of novel transcripts identified,
there were significant differences in the subset of
transcripts detected in each library, underscoring the
importance of library preparation strategy and relative
sRNA abundance for successful sRNA detection.
Nearly 90% of the novel sRNAs have no orthologous
bacterial sequences outside of P. aeruginosa, sup-
porting a limited degree of sequence conservation and
rapid evolution of sRNAs at the species level. We
anticipate that the data will be useful for the study of
regulatory sRNAs in bacteria and that the approach
described here may be applied to identify sRNAs in
any bacterium under different growth and stress con-
ditions.
Introduction
Bacteria contain numerous small regulatory RNAs
(sRNAs) ranging in size from 70 to 500 nucleotides
(nt) that modulate gene expression (Waters and Storz,
2009; Gottesman and Storz, 2011). Most sRNAs function
through base-pairing interactions with messenger RNA
(mRNA) targets that can affect translation initiation, tran-
scription termination or mRNA stability. Others function by
binding to and altering the activity of proteins that regulate
gene expression. Small RNAs are known to control
diverse adaptation processes, where bacterial physiology
is adjusted in response to environmental cues. There are
examples of sRNAs that are involved in transcription
reprogramming, carbon metabolism, iron homeostasis,
cell envelope homeostasis and coordination of virulence
(Repoila and Darfeuille, 2009). Although most current
information on sRNA function is derived from Escherichia
coli, progress is being made in the functional character-
ization of sRNAs in other bacteria (Papenfort and Vogel,
2010). In the important human pathogen Pseudomonas
aeruginosa, there is knowledge on the roles of 12 out of
the 44 sRNAs identified thus far, where four are classical
sRNAs (6S, 4.5S, RNase P and tmRNAs) and the others
function as regulators of primary and secondary metabo-
lism (Sonnleitner and Haas, 2011).
A variety of approaches have been used to identify
individual sRNAs in P. aeruginosa (reviewed in Sonnleit-
ner et al., 2010) including those based on direct detection
due to high abundance (Vogel et al., 1987), similarity with
a known sRNA of E. coli (Toschka et al., 1989), computa-
tional predictions (Wilderman et al., 2004) and copurifica-
tion with a protein (Sonnleitner et al., 2008). Three
systematic searches for sRNAs have been undertaken in
P. aeruginosa, where all have focused on intergenic
regions. In two studies sRNAs were predicted on the
basis of sequence conservation, as well as the presence
of rho-independent terminators, putative promoters and
conserved secondary structure. Although both studies
used similar computational approaches followed by
experimental verification by Northern blotting, two largely
distinct sets of novel sRNAs were identified (Livny et al.,
2006; González et al., 2008). A third study used a com-
bined bioinformatics and RNomics approach, where total
RNA was size-fractionated, co-immunoprecipitated with
Hfq, cloned and sequenced (Sonnleitner et al., 2008).
Recent genome-wide studies to identify sRNAs have
been largely based on tiling arrays and next-generation
sequencing technologies. The latter approach, in particu-
lar, has revolutionized sRNA discovery by enabling inter-
rogation of the transcriptome at unprecedented depths.
Deep sequencing has revealed hundreds of previously
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undetected transcripts in diverse bacteria including Bacil-
lus subtilis (Irnov et al., 2010), Chlamydia trachomatis
(Albrecht et al., 2010), Helicobacter pylori (Sharma et al.,
2010), Legionella pneumophila (Weissenmayer et al.,
2011), Listeria monocytogenes (Oliver et al., 2009;
Mraheil et al., 2011), Salmonella enterica (Sittka et al.,
2008; Perkins et al., 2009), Streptomyces coelicolor
(Vockenhuber et al., 2011), Synechocystis (Mitschke
et al., 2011), Vibrio cholerae (Liu et al., 2009; Bradley
et al., 2011) and Yersinia pseudotuberculosis (Koo et al.,
2011). The detected transcripts derive from reads that
map to both intergenic and coding regions, and in the
sense and antisense directions relative to annotated
genes. The many newly reported transcripts have uncov-
ered new concepts on bacterial transcriptomes, including
the presence of pervasive antisense transcription
(Croucher and Thomson, 2010), but also raise issues of
how to define sRNAs and the extent to which detected
transcripts are functional (Storz et al., 2011).
The size and complexity of the P. aeruginosa genome
suggests that it encodes many hitherto undetected
sRNAs. In this study, we have used high-throughput
cDNA sequencing (RNA-seq) to identify sRNAs in
P. aeruginosa. RNA isolated from exponential and early-
stationary phase cells was used to prepare three different
types of libraries for sequencing. We find a total of over
500 novel intergenic sRNAs in the three libraries, where
a different number of transcripts are detected in each
library. As a significant number of unique sRNAs are
detected in each library, the data suggest that the set of
identified RNAs obtained depends strongly on the specific
library preparation strategy used.
Results and discussion
Experimental approach for global sRNA identification
In order to optimize sRNA detection, three different types
of sequencing libraries were generated using RNA iso-
lated from P. aeruginosa grown to exponential and early-
stationary phase in broth culture at 37°C (Fig. 1, Table 1).
All steps including cell growth, RNA isolation and library
preparation were performed in triplicate for each growth
condition and sequenced using the Illumina HiSeq2000
platform. The sequencing libraries are named LIB>100,
LIB<500 and LIB<200 to denote the transcript sizes in
nucleotides that are not excluded from each, but do not
imply that all transcripts in these size ranges are neces-
sarily detected in the corresponding library. The LIB>100
library contains all mRNAs transcribed by the bacteria and
was prepared using a standard RNA-seq protocol for full
transcriptomes. This library does not contain sRNA tran-
scripts shorter than 100 nt because the corresponding
cDNA fragments are not retained during the protocol. The
LIB<500 and LIB<200 libraries were each prepared with
size selection steps and contain transcripts shorter than
500 and 200 nt respectively. These two libraries were
prepared by ligating specific adapters to the 5′ and 3′ ends
of the transcripts before cDNA synthesis, enabling reten-
tion of fragments corresponding to transcripts shorter than
100 nt. They are therefore strand-specific, where the
information about the strand from which the sRNA is
transcribed is retained. In addition, the RNA used to
prepare the LIB<500 and LIB<200 libraries was treated
with Tobacco Acid Pyrophosphatase to ensure the inclu-
sion of primary transcripts containing a 5′-triphosphate.
Although primary and processed transcripts are not dis-
tinguishable in these libraries, it is possible to modify the
approach with additional libraries to obtain this informa-
tion. The library preparation protocols also differ in terms
of whether they include fragmentation steps. The proto-
cols for preparation of the LIB>100 and LIB<500 libraries
include fragmentation steps using divalent cations and
RNase III respectively, whereas preparation of the
LIB<200 library does not involve a fragmentation step due
to the short lengths of the transcripts. Thus, library
LIB<200 does not have any biases associated with
fragmentation.
On average, 16.7 million sequence reads were gener-
ated from each library, and of these 12.3 million were of
sufficient quality to be mapped onto the P. aeruginosa
PAO1 genome (Table S1). As ribosomal RNAs (rRNAs)
account for the vast majority of total RNA in a bacterial cell
(Karpinets et al., 2006), these RNAs were removed by
subtractive hybridization to enrich samples for sRNAs.
Although depletion of 16S and 23S rRNAs using this
approach is common (He et al., 2010), the 5S rRNA was
also depleted in this work using a total of five oligonucle-
otides complementary to the P. aeruginosa rRNA
sequences (Fig. S1, Table S2). The average percentage
of read coverage corresponding to 23S, 16S and 5S
rRNAs was 7.1%, 3.8% and 0.15% (Table S1) respec-
tively, indicating that the rRNA depletion procedure func-
tioned satisfactorily in the case of 23S and 16S rRNAs
and efficiently in the case of 5S rRNA. A previous study
used an oligonucleotide-directed RNase H digestion
approach to deplete 5S rRNA and transfer RNAs (tRNAs),
involving 4 and 25 oligonucleotides respectively (Liu
et al., 2009). Although no attempt was made to deplete
tRNAs in this work, the average percentage of read cov-
erage corresponding to tRNAs was 2.7% (Table S1), indi-
cating that these RNAs represent only a minor fraction of
the total reads in non-depleted samples, and that their
targeted removal is not necessary.
Identification of previously annotated sRNAs
Forty-four sRNAs have been identified previously in
P. aeruginosa (reviewed in Sonnleitner and Haas, 2011)
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Fig. 1. Library preparation scheme. Three different sequencing libraries were generated (LIB>100, LIB<500 and LIB<200) using RNA isolated
from P. aeruginosa cells grown to exponential and early-stationary phase in broth culture at 37°C. Each library was prepared using triplicates
for each condition.
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(Table S3). In order to test the accuracy and specificity of
the sequencing approaches used here, the expression of
the already identified sRNAs was inspected visually. All of
the sRNAs except one could be visually identified in at
least one of the three libraries. The sRNA that could not be
identified, PA2744.1 (P13), was predicted and validated
by Northern blotting in an earlier study, but the transcript
length was unclear (Livny et al., 2006). The present
data indicate that there is a 190 nt sRNA encoded in the
same intergenic region on the same strand as PA2744.1.
This sRNA partially overlaps with PA2744.1, but the
coordinates do not correspond to those predicted previ-
ously (Table S3). This suggests that the coordinates of
PA2744.1 may be 3106752–3106942.
Visual inspection of RNA-Seq data is not convenient for
a genome-wide search of novel transcripts, where a sys-
tematic and reproducible method must be used. We have
developed a custom-made script designed to detect
intergenic sRNAs (see Experimental procedures). We
checked how many already known sRNAs our systematic
script would detect. Of the 44 already reported sRNAs,
four would not be identified by the script (P26, PA4451.1,
P32, PA5316.1). The reason for this is that the peaks
corresponding to these sRNAs do not start and/or
terminate within an intergenic region and these are not
detected by the script to prevent misclassification of
untranslated regions (UTRs) as ncRNAs. The sRNAs
detected in each library type using the script are shown in
Fig. 2. A total of 20, 34 and 36 sRNAs were detected in the
LIB>100, LIB<200 and LIB<500 libraries respectively,
where 18 were detected in all three libraries and 33 were
detected in more than one library (Fig. 2). Thus, 39 out of
44 already annotated sRNAs could be detected in only
two experimental conditions with the RNA-seq approach
used here. The results, in particular those from the
LIB<500 and LIB<200 libraries, are a validation of the
sensitivity of RNA-seq at detecting sRNAs.
Identification of novel intergenic sRNAs
As the specific focus of this work was to identify novel
intergenic sRNAs, a script was designed to analyse tran-
scripts from all of the intergenic regions of P. aeruginosa
PAO1 (see Experimental procedures). The script only
detects transcripts that begin and end within an intergenic
region in order to minimize misclassification of UTRs
as sRNAs. A total of 513 novel sRNAs were identified by
this approach and were named pant (for P. aeruginosa
novel transcript) followed by an identification number
(Table S4). The set of novel transcripts may include those
corresponding to hitherto un-annotated genes and dual-
function sRNAs coding for small proteins. It is also pos-
sible that a subset of the RNAs identified here derive from
5′ or 3′ UTRs. However, this does not preclude that these
RNAs are functionally important or could function as
sRNAs, as there is precedence for cis-acting RNA ele-
ments functioning as trans-acting RNAs. This suggests
that the regulatory function of a particular RNA sequence
is context-dependent and the division between cis- and
trans-acting RNAs is not always sharp. For instance, the
fate of riboswitch RNAs that function by transcription ter-
mination is unknown, but evidence in the literature sug-
gests that their stability and half-lives in the cell vary
(reviewed in Bastet et al., 2011). A specific example is that
of SAM riboswitches in L. monocytogenes that function
as trans-acting sRNAs to regulate the expression of the
virulence regulator PrfA (Loh et al., 2009).
The plethora of novel sRNAs identified in this work
raises the issue of how many of these are functional and
play regulatory roles in the cell. Determination of the frac-
tion of functional transcripts requires the characterization
and detailed analysis of each sRNA. Although functional
assignment may be challenging and expression of some
RNAs may only be induced under specific conditions, it
is likely that the majority of novel transcripts represent
functional sRNAs. New and unexpected functional roles
for RNA are continuously being discovered. This includes
Table 1. Library characteristics.
Library
LIB>100
Library
LIB<500
Library
LIB<200
Length of transcripts sequenced >100 nt <500 nt <200 nt
Fragmentation Divalent
cations
RNase
III
No
Strand specificity retained No Yes Yes
Fig. 2. Venn diagram summarizing the already annotated sRNAs
detected in the three different libraries.
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RNAs that are relatively well understood, as recently in
the case of mammalian tRNAs that, in addition to their
well-known housekeeping roles in translation, can also
function as regulators of gene expression (Rudinger-
Thirion et al., 2011).
Although many novel transcripts are identified, not all
transcripts are detected in all three libraries and there are
significant differences in the set of transcripts detected in
each library. A total of 63, 415 and 412 novel transcripts
are detected in the LIB>100, LIB<500 and LIB<200 librar-
ies respectively, indicating that significantly more tran-
scripts are detected in the latter two libraries compared
with the first (Fig. 3A). This is consistent with the fact that
the LIB>100 library contains the full transcriptome, and
hence a lower relative percentage of sRNAs compared
with the other libraries. The lengths of the detected sRNAs
range from 70 to 1117 nt with an average length of 188 nt.
The length distribution of detected sRNAs in each library
is shown in Fig. 3B. The lengths of the sRNAs detected in
the LIB<500 and LIB<200 libraries are similar and for the
most part shorter than 200 nt, whereas a significant frac-
tion of those detected in the LIB>100 library are longer
than 200 nt.
A significant overlap in sRNAs detected between the
libraries is observed (Fig. 3A) with 326 novel sRNAs
being identified in more than one library. A more surprising
result is that 36% of the novel sRNAs were only detected
in one library. Most of these novel sRNAs were detected
either in the LIB<200 or LIB<500 libraries, but the length
distributions of the novel RNAs detected in these libraries
are nearly identical showing that these RNAs are not
uniquely detected on the basis of length (data not shown).
Rather, the basis of unique detection is likely due to the
different library preparation strategies, in particular the
inclusion of size selection and fragmentation steps. More-
over, there is an inverse relationship between the size
range of RNA molecules represented in a library and its
sensitivity in detecting transcripts expressed at low levels.
Thus, the LIB<200 library is more sensitive than the other
two libraries, and the LIB<500 library is more sensitive
than the LIB>100 library. Although this work is centred on
intergenic sRNAs, the LIB<500 and LIB<200 libraries can
also be used to identify cis-encoded sRNAs because they
are strand-specific and lack larger transcripts that could
mask sRNAs.
Some different examples of sRNA detection in the three
libraries are illustrated in Fig. 4. The already annotated
sRNA PA1112.1 is only detected in the LIB>100 library, but
based on its size (300 nt) it is also expected to be
detected in the LIB<500 library. The probable explanation
for this is the different fragmentation methods used in
preparation of the LIB>100 and LIB<500 libraries, where
transcripts sensitive to RNase III cleavage will not be
detected in the latter. The pant154 transcript is only
detected in the LIB<500 library (Fig. 4). It is not detected
in the LIB<200 and LIB>100 libraries due to its size
(234 nt) and relative low abundance relative to mRNA
respectively. The pant55 transcript is only detected in the
LIB<200 library, probably due to its small size (89 nt) and
low abundance. However, it should be noted that there is
also a weak signal for pant55 in the LIB<500 library that is
below the cut-off value, indicating that sRNAs with a low
Fig. 3. A. Venn diagram illustrating the novel sRNAs detected in the three different libraries.
B. Length distributions of the sRNAs detected in each library.
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Fig. 4. Examples of sRNAs detected in the three different sequencing libraries LIB>100, LIB<500 and LIB<200. The y-axes of the plots
denote normalized coverage at each nucleotide position. The x-axes denote the genomic positions according to the P. aeruginosa PAO1
genome coordinates (NC_002516.2). The left column of plots corresponds to the results from library LIB>100, the middle column to library
LIB<500 and the right column to library LIB<200. PA1112.1, AmiL, SsrS and RgsA are already annotated sRNAs in P. aeruginosa. Legend:
-, not detected in the library; +, detected in the library; orange lines, exponential phase; red lines, early-stationary phase; dashed green lines,
sRNA coordinates; dashed blue lines, intergenic region coordinates; blue arrows, direction of flanking genes; green arrows, direction of the
sRNA (if known). The peaks next to PA1112.1 correspond to the novel sRNAs pant120 (*) and pant121 (•) detected in this study.
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relative abundance will go undetected in libraries contain-
ing more and larger transcripts. Likewise, AmiL is only
identified in the LIB<200 and LIB<500 libraries due to its
size (100 nt). The RgsA sRNA would have been misiden-
tified as a UTR in the LIB>100 library, as the expression
level of the sRNA is similar to the flanking gene (Fig. 4).
This does not occur in the LIB<500 and LIB<200 libraries
because the flanking gene is not included due to the size
selection steps. Two examples of transcripts detected in
all three libraries are SsrS and pant24 (Fig. 4). The inten-
sity of pant24 is lower in the LIB>100 library than in the
LIB<500 and LIB<200 libraries, which illustrates the
increased sensitivity of the latter two libraries.
sRNA orientation and validation
The data from the LIB<500 and LIB<200 libraries were
used to determine the orientation of the sRNAs whose
coordinates and orientation were previously defined. The
annotated orientations of all these sRNAs were confirmed
with two exceptions, PhrY and RgsA. In the sequencing
data the orientation of the PhrY sRNA is unclear and the
RgsA sRNA appears to be encoded on the minus strand,
contrary to its previous annotation (Livny et al., 2006;
González et al., 2008; Sonnleitner et al., 2008). RgsA was
previously predicted using the computational tool RNAz
(Sonnleitner et al., 2008) and detected with Northern blots
(Livny et al., 2006; González et al., 2008). Here, 5′-RACE
was performed to determine the coding strand of RgsA.
The 5′ ends of RgsA could be validated on both strands,
suggesting that there is another sRNA encoded just oppo-
site of RgsA (Table S5).
The strand specificity of the LIB<500 and LIB<200
libraries was utilized to determine the orientation of the
513 novel sRNAs identified in this study. Almost all of
the sRNAs (506/513) were identified in the LIB<500
and/or LIB<200 libraries. It was possible to determine
the orientation of 388 of the 506 sRNAs. For the others,
assignment of orientation was precluded by the inability
to determine the accurate limits of the transcripts.
The coding strand and the 5′ ends of six novel sRNAs
(pant44, pant66, pant217, pant381, pant441, pant503)
were determined using 5′-RACE. These sRNAs were
chosen because their direction could be predicted from
the LIB<200 and LIB<500 libraries and the average
expression levels of four of them (pant44, pant66,
pant217, pant381) were close to the cut-offs used for
transcript detection. In all cases the coding strand
detected by RACE was the same as the one predicted by
the RNA-seq data. Moreover, the genomic coordinates
are identical to or fall within 12 nt of the transcript 5′ end
predicted by sequencing (Table S5).
The sRNAs pant43 and pant304 have similar coordi-
nates and identical orientations to P2 and P17 sRNAs
respectively. These sRNAs were predicted computation-
ally in an earlier study, but could not be validated by
Northern blotting (Livny et al., 2006). Here, pant43 (P2)
was detected in the LIB<200 library and pant304 (P17)
was detected in the LIB<500 and LIB<200 libraries, indi-
cating that the RNA-seq libraries specific for sRNA detec-
tion (libraries LIB<500 and LIB<200) are more sensitive
than Northern blots.
Growth phase-dependent expression of sRNAs
A Student’s t-test was performed on the average expres-
sion of the transcripts to determine those with differential
expression between the two conditions tested. Of the
513 novel transcripts, 178 are differentially expressed
between the conditions tested (Table S4). Around 80% of
these were significantly more expressed in early-
stationary relative to exponential phase. Out of the 44
previously identified sRNAs, three (1059, P27 and
PA5316.1) were found to be differentially expressed
between the conditions tested (Table S3). Importantly, the
three sequencing libraries were very consistent in the
quantification of transcripts. Of the many sRNAs detected
in more than one library type, most showed similar
expression patterns in all libraries in which they were
detected, or in other words, the libraries were congruent in
whether the sRNAs were differentially expressed or not.
This suggests that RNA-seq can be reliably used to quan-
tify transcript abundance and concurs with other studies
in which RNA-seq has been proven to be a very good
method to quantify expression levels. Marioni and col-
leagues investigated the technical variance associated
with Illumina sequencing and compared its ability to iden-
tify differentially expressed genes with Affymetrix arrays
(Marioni et al., 2008). Illumina sequencing data were
found to be highly reproducible, with relatively little tech-
nical variation and comparable to that from the arrays in
enabling identification of differentially expressed genes
(Marioni et al., 2008).
Conservation and homologue identification of the
novel sRNAs
The sequence conservation of novel sRNAs in other
bacteria was investigated using the BLASTN algorithm.
The sequences of 12% (62/513) of the sRNAs are con-
served in other bacteria, and 4% (22/513) are conserved
in organisms outside the Pseudomonadaceae family
(Table S6). The data show that 88% of the sRNAs are
not conserved outside P. aeruginosa, indicating that the
extent of sequence conservation between sRNAs in
P. aeruginosa and other Pseudomonas spp. is limited.
As P. aeruginosa is the only pseudomonad that is an
opportunistic human pathogen, it is likely that some of
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the specific sRNAs play a role in pathogenesis or confer
an advantage inside the host. An example of an sRNA
specific to P. aeruginosa is PrrH, a heme-regulated
RNA encoded by the two identical sRNA genes prrF1
and prrF2. These genes have a unique tandem organi-
zation in P. aeruginosa but are encoded at distal loci in
the genomes of all other sequenced pseudomonads
(Oglesby-Sherrouse and Vasil, 2010). There are no
orthologous sequences in P. aeruginosa to previously
characterized sRNAs in enterobacteria such as E. coli
and Salmonella, suggesting that the sequence con-
servation among these sRNAs does not extend to
the pseudomonads. The results illustrate the limitations
in identifying sRNAs using bioinformatic prediction
methods that are often based on sequence conserva-
tion. Moreover, they are consistent with the view that
organisms have evolved species-specific regulatory net-
works involving sRNAs, and that these are necessary for
niche adaptation, including host interactions in the case
of pathogens.
Concluding remarks
This study is the first to use RNA-seq to discover novel
sRNAs in P. aeruginosa and utilized three types of
sequencing libraries to maximize the number of detected
sRNAs. Over 500 novel sRNA transcripts are identified,
increasing the number of known sRNAs in P. aeruginosa
by a factor of 12 and revealing a large set of potential
regulatory molecules in an already highly regulated
species. Two libraries that do not include larger transcripts
(LIB<500 and LIB<200) are clearly superior in detecting
sRNAs, whereas the LIB>100 library contains information
on the full transcriptome. Although RNA-seq enables the
identification of novel transcripts, it is not well suited for
accurately defining transcript length. As RNA-seq allows
for detection of transcripts expressed at low levels, the
sensitivity of existing validation methods is therefore a
limitation for further characterization of these transcripts.
Roughly one-third of the novel transcripts are differentially
expressed between exponential and early-stationary
growth phases, underscoring that RNA-seq is a sensi-
tive method to monitor changes in gene expression.
The limited extent of sequence conservation among
pseudomonads highlights the challenges of sRNA bioin-
formatic prediction and emphasizes the importance of
sRNAs at the species level in monitoring changes in envi-
ronmental conditions. The approach described here can
be used to characterize the sRNAome of any bacterium
under highly diverse growth and stress conditions. In con-
clusion, the multitude of sRNAs in P. aeruginosa suggests
the presence of a vast and complex regulatory network
that will be highly important for our understanding of
an organism with such a versatile life style that can
successfully move from the environment into the human
body as a pathogen.
Experimental procedures
RNA isolation
Single colonies of P. aeruginosa strain PAO1 were grown
overnight in Luria–Bertani (LB) medium at 37°C. The
cultures were diluted to a starting OD600 of 0.01 in 50 ml
of LB media and grown at 37°C in separate 250 ml baffled
Erlenmeyer flasks with shaking at 240 r.p.m. Cells were
harvested from cultures grown to an OD600 of 0.6 (exponen-
tial phase) or 3.0 (early-stationary phase). Harvested
cells were mixed immediately with 0.2 volumes of STOP
solution (95% ethanol, 5% phenol) and pelleted by centrifu-
gation. Total RNA was extracted with Trizol (Invitrogen).
Removal of DNA was carried out by treatment with DNase
I (Fermentas) in combination with the RNase inhibitor
RiboLock (Fermentas). The integrity of total RNA, the pres-
ence of 5S rRNA and tRNAs, and DNA contamination
were assessed with an Agilent 2100 Bioanalyzer (Agilent
Technologies).
Removal of 23S, 16S and 5S rRNAs
The 23S, 16S and 5S rRNAs were removed by subtractive
hybridization using the MICROBExpress kit (Ambion) with
modifications. Capture oligonucleotides complementary to
the rRNAs were designed specifically for P. aeruginosa
(Table S2). For preparation of library LIB>100 (described
below), 5 mM of each capture oligonucleotide was used, for
a total capture oligonucleotide concentration of 25 mM.
Compared with the standard protocol, 25% more capture
oligonucleotides and magnetic beads were used. For prepa-
ration of libraries LIB<500 and LIB<200 (described below),
5 mM of the 5S rRNA capture oligonucleotide and 50% less
magnetic beads were used relative to the standard protocol.
Removal of rRNAs was confirmed with an Agilent 2100 Bio-
analyzer (Agilent Technologies) (Fig. S1).
Library preparation and RNA sequencing
The sequencing libraries LIB>100, LIB<500 and LIB<200
were constructed using three different protocols (Fig. 1,
Table 1). Each library type was prepared with RNA isolated
from cells grown in triplicate for each condition (exponential
and early-stationary phase). After each step the samples
were validated using an Agilent 2100 Bioanalyzer (Agilent
Technologies), and the final concentration was measured
using a Qubit 2.0 Fluorometer (Invitrogen). The libraries were
sequenced using the Illumina HiSeq2000 platform with a
paired-end protocol and read lengths of 100 nt.
LIB>100 library. This type of library contains transcripts
longer than 100 nt and was prepared using the TruSeq RNA
Sample Preparation kit (Illumina). Briefly, the rRNA-depleted
RNA is fragmented using divalent cations under elevated
temperature. The cleaved RNA fragments are copied into
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cDNA using reverse transcriptase and random primers, fol-
lowed by second-strand cDNA synthesis using DNA poly-
merase I and RNase H. After this step, transcripts shorter
than 100 nt are not retained due to the purification performed
with the Agencourt AMPure XP beads (Beckman Coulter
Genomics). The cDNA fragments then go through an end
repair process, 3′-addition of single ‘A’ bases and adapter
ligation. This is followed by product purification and PCR
amplification to generate the final cDNA library.
LIB<500 library. This type of library contains transcripts
shorter than 500 nt. RNA size selection was performed by
running total RNA on 10% polyacrylamide gels containing
10 M urea. Gel slices corresponding to RNAs up to 500 nt
were excised, followed by elution of RNA in 0.4 M NaCl and
precipitation with ethanol. The 5S rRNA was depleted as
previously described, followed by treatment with Tobacco
Acid Pyrophosphatase (Epicentre Technologies) at 37°C for
90 min. Tobacco Acid Pyrophosphatase (TAP) is used to
convert 5′-triphosphate RNA into 5′-monophosphate RNA,
which is important for correct adapter ligation. This was fol-
lowed by treatment with RNase III (Ambion) for 10 min at
37°C to fragment the RNA. RNase III fragments RNA into
smaller pieces containing a 5′-phosphoryl group and a
3′-hydroxyl group, which is important for specific adapter
ligation in the next step. Sequential ligation of RNA 3′ and 5′
adapters was performed using the adapters and enzymes
from the TruSeq Small RNA Sample Preparation kit (Illu-
mina). Next, reverse transcription followed by PCR amplifi-
cation was performed to form cDNA constructs based on
the RNA fragments ligated with 3′ and 5′ adapters, selec-
tively enriching fragments with adapter molecules on both
ends. The reverse transcription and subsequent PCR ampli-
fication were performed using the enzymes and reagents
from the TruSeq Small RNA Sample Preparation kit (Illu-
mina). Agencourt AMPure XP beads (Beckman Coulter
Genomics) were used for the post-PCR clean-up. In this
and the LIB<200 libraries, the fragments corresponding to
transcripts shorter than 100 nt are retained due to ligated
RNA adapters that increase the length of the fragments by
125 nt.
LIB<200 library. This type of library contains transcripts
shorter than 200 nt. Size selection of RNAs up to 200 nt from
total RNA was carried out with the mirVana miRNA Isolation
Kit (Ambion), followed by depletion of 5S rRNA as previously
described. The TAP treatment, RNA adapter ligation, reverse
transcription and PCR amplification and clean-up steps were
performed as described for library LIB<500.
Read mapping
Reads were mapped onto the P. aeruginosa PAO1 genome
(RefSeq Accession No. NC_002516.2) using the Bowtie short
read aligner (Langmead et al., 2009). For the LIB<500 and
LIB<200 libraries, the adapters had to be trimmed in the
reads with inserts shorter than 100 nt. Reads with only one
alignment reported were retained. Read alignments from
Bowtie were handled using SAMtools (Li et al., 2009). Read
alignments onto the reference genome were visualized using
Tablet 1.11.08.10 (Milne et al., 2010).
Transcript quantification
In order to obtain normalized expression intensities of the
read coverage depth at each position in the genome, the
number of reads in each replicate was normalized according
to the total number of reads in the library, and expression
intensities from replicate samples were averaged. The
average expression of each already annotated sRNA tran-
script was calculated by dividing the normalized coverage
depth of the transcript by the length of the transcript.
Identification of intergenic sRNAs
Already annotated sRNAs were identified by visual inspection
of the read coverage of the reference genome at the relevant
loci. A custom-made script was designed to detect novel
transcripts in intergenic regions. According to this, a transcript
was detected if the coverage depth at each base was higher
than a certain cut-off. The cut-off was set for each library
based on the average expression intensities of the 44 previ-
ously validated sRNAs in P. aeruginosa in each library type
(Table S7). In addition, the average expression intensities of
the detected transcript had to be twice the previously men-
tioned cut-off. This ensures detection of abrupt increases in
read coverage depths. To define the length of the transcripts
more accurately, the lowest chosen cut-off (the one for library
LIB>100) was applied to the peaks previously found in librar-
ies LIB<500 and LIB<200. To prevent misclassification of
UTRs as ncRNAs, the script only detects transcripts that
begin and end within an intergenic region. Transcripts of at
least 100 nt (LIB>100) or 70 nt (LIB<500, LIB<200) were con-
sidered further. The resulting transcripts from automatic clas-
sification were re-evaluated by visual inspection using Tablet
1.11.08.10 (Milne et al., 2010).
Differential expression of intergenic sRNAs
The average expression of each sRNA was calculated by
dividing the normalized read coverage depth by the length of
the transcript. A two-sample Student’s t-test was performed
on the average expression of the sRNAs to determine those
with differential expression between the two conditions tested
(P-value < 0.05 and fold change > 2). The Benjamini–
Hochberg multiple testing correction was applied (Benjamini,
1995). The triplicates of the conditions were not averaged for
this analysis. The expression of a sRNA was considered
significantly different, if the sRNA was differentially expressed
in all the libraries in which it was detected.
Homologue identification
The novel sRNAs were searched against the Rfam database
to look for homologies to ncRNA entries. Putative homo-
logues of each novel transcriptional unit were predicted via
BLASTN comparison of each sequence to all sequenced
bacterial genomes (E = 10-6, word = 11). Only hits with nucle-
otide identity higher than 60% combined with coverage
between query and subject sequence higher than 80% were
considered to be conserved.
2014 M. Gómez-Lozano, R. L. Marvig, S. Molin and K. S. Long
© 2012 Society for Applied Microbiology and Blackwell Publishing Ltd, Environmental Microbiology, 14, 2006–2016
66
Validation of coding strand and 5 ends of sRNAs
We applied a RACE procedure to determine the 5′ ends of a
selection of the novel sRNAs. The protocol used is based on
the method of Gerhart and colleagues with modifications
(Gerhart et al., 2005). In brief, DNase-treated total RNA
(described above) was incubated with Tobacco Acid Pyro-
phosphatase (Epicentre Technologies) at 37°C for 60 min. A
short RNA adapter was ligated to the 5′ ends using T4 RNA
ligase (New England Biolabs). The 5′ adapter-ligated RNA
was reverse-transcribed using a primer complementary to the
sRNA (GSP1) and the Thermoscript RT-PCR system (Invitro-
gen). Primers were removed using the NucleoSpin Gel and
PCR Clean-up kit (Macherey-Nagel). The resulting cDNA was
used as the template in PCR reactions using strand-specific
primers to the sRNA (GSP2) along with an adapter-specific
primer. Negative controls were performed using the adapter-
ligated RNA as template. The oligonucleotides used for RACE
are listed in Table S2. PCR clean-up was carried out using the
NucleoSpin Gel and PCR Clean-up kit (Macherey-Nagel). The
PCR products were resolved using an Agilent 2100 Bioana-
lyzer High Sensitivity DNA assay (Agilent Technologies) to
determine their lengths. Products were sequenced with the
primer used in PCR (GSP2) and with the adapter-specific
primer by LGC Genomics GmbH (Germany).
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Supplementary	  Table	  1.	  Sequencing	  results.	  
	  
Library	   Condition	  
Number	  
of	  
replicates	  
Average	  
total	  
number	  of	  
reads	  
Average	  
number	  of	  
mapped	  
reads	  	  
Average	  %	  of	  read	  coverage	  corresponding	  to	  
23S	  rRNA	   16S	  rRNA	   5S	  rRNA	   tRNAs	  
LIB>100	  
Exponential	   3	   16961351	   14676650	   12.60%	   6.74%	   0.07%	   2.53%	  
Early-­‐stationary	   3	   24030975	   21001129	   15.60%	   7.88%	   0.01%	   1.15%	  
LIB<500	  
Exponential	   3	   16577877	   13119470	   3.50%	   1.62%	   0.16%	   3.69%	  
Early-­‐stationary	   3	   14758047	   10822645	   1.79%	   1.29%	   0.19%	   3.28%	  
LIB<200	  
Exponential	   3	   12822325	   7564110	   5.18%	   3.01%	   0.25%	   3.80%	  
Early-­‐stationary	   3	   15070347	   6755123	   3.91%	   2.62%	   0.21%	   1.89%	  
Average	   16703487	   12323187	   7.10%	   3.86%	   0.15%	   2.72%	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Supplementary	  Table	  2.	  Oligonucleotides	  used	  in	  this	  study.	  	  	  
Name	   Sequence	  (5'	  -­‐>	  3')	   Use	  
23S-­‐1954	   AAAAAAAAAAAAAAAAAAACTTACCCGACAAGGAATTTCGC	   Removal	  of	  23S	  rRNA	  
23S-­‐2511	   AAAAAAAAAAAAAAAAAAGAGCCGACATCGAGGTGCCAAAC	   Removal	  of	  23S	  rRNA	  
16S-­‐807	  	   AAAAAAAAAAAAAAAAAATGGACTACCAGGGTATCTAATCC	   Removal	  of	  16S	  rRNA	  
16S-­‐1114	  	   AAAAAAAAAAAAAAAAAAGGGTTGCGCTCGTTACGGGACTT	   Removal	  of	  16S	  rRNA	  
5S	   AAAAAAAAAAAAAAAAAAGCGTTTCACTTCTGAGTTCGGCA	   Removal	  of	  5S	  rRNA	  
RNA	  adapter	   AUAUGCGCGAAUUCCUGUAGAACGAACACUAGAAGAAA	   RNA	  ligation	  in	  5'-­‐RACE	  
Adapter-­‐specific	  primer	   GCGCGAATTCCTGTAGA	   PCR	  in	  5'-­‐RACE	  
GSP1	  pant44	   TCAGGAAGCGTTCTTGTTGG	   RT	  in	  5'-­‐RACE	  
GSP2	  pant44	   AGCGTTCTTGTTGGATTTCTAGC	   PCR	  in	  5'-­‐RACE	  
GSP1	  pant66	   GCGAGAATCCCCCAGACT	   RT	  in	  5'-­‐RACE	  
GSP2	  pant66	   GAATCCCCCAGACTCCGT	   PCR	  in	  5'-­‐RACE	  
GSP1	  pant217	   GTACGGCAACCCCTGCAT	   RT	  in	  5'-­‐RACE	  
GSP2	  pant217	   GCAACCCCTGCATCGACCG	   PCR	  in	  5'-­‐RACE	  
GSP1	  pant381	   AGGAGACAGGTTGGGA	   RT	  in	  5'-­‐RACE	  
GSP2	  pant381	   GACAGGTTGGGAGGGAGTT	   PCR	  in	  5'-­‐RACE	  
GSP1	  pant441	   GCGACTCCCCAAGCATAGCCG	   RT	  in	  5'-­‐RACE	  
GSP2	  pant441	   CCAAGCATAGCCGGCGGGAC	   PCR	  in	  5'-­‐RACE	  
GSP1	  pant503	   CTGGCACTACGACGAATGG	   RT	  in	  5'-­‐RACE	  
GSP2	  pant503	   CACTACGACGAATGGCCAAC	   PCR	  in	  5'-­‐RACE	  
GSP1	  RgsA	  (forward)	   ATCCGGGTCAAGACCAT	   RT	  in	  5'-­‐RACE	  
GSP2	  RgsA	  (forward)	   GTCAAGACCATTAGGAG	   PCR	  in	  5'-­‐RACE	  
GSP1	  RgsA	  (reverse)	   AGTACCCAGCCAGTGAAG	   RT	  in	  5'-­‐RACE	  
GSP2	  RgsA	  (reverse)	   CAGCCAGTGAAGGTAC	   PCR	  in	  5'-­‐RACE	  	  
	  	  
3
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Supplementary	  Table	  3.	  Annotated	  sRNAs	  in	  Pseudomonas	  aeruginosa.
Name Starta Enda
Intergenic	  
region	  
start
Intergenic	  
region	  
end
Lengthb
5'	  
flanking	  
gene
3'	  flanking	  
gene
Di
re
ct
io
nc
Di
st
an
ce
	  to
	  
5'
	  fl
an
ki
ng
	  
ge
ne
	  (n
t)
Di
st
an
ce
	  to
	  
3'
	  fl
an
ki
ng
	  
ge
ne
	  (n
t)
De
te
ct
io
n	  
in
	  
Li
br
ar
y	  
A
De
te
ct
io
n	  
in
	  
Li
br
ar
y	  
B
De
te
ct
io
n	  
in
	  
Li
br
ar
y	  
C
Di
ffe
re
nt
ia
l	  
ex
pr
es
si
on
d
Fo
ld
	  
ch
an
ge
e
Reference
P1 -­‐ -­‐ 334456 334733 300 PA0296 PA0297 <<> ? ? -­‐ + + -­‐ -­‐ (Livny	  et	  al.,	  2006)
rsmY 586867 586990 586664 587016 124 PA0527 PA0528 <>< 203 26 -­‐ + + -­‐ -­‐ (Kay	  et	  al.,	  2006;	  Livny	  et	  al.,	  2006;	  Sonnleitner	  et	  al.,	  2008)
phrD 785498 785570 785174 785969 73 PA0714 PA0715 >>> 324 399 -­‐ + + -­‐ -­‐ (Sonnleitner	  et	  al.,	  2008)
ssrA 901520 901872 901047 901933 353f PA0826 PA0827 <<< 473 61 + + + -­‐ -­‐ (Sonnleitner	  et	  al.,	  2008;	  Wiilliams	  and	  Bartel	  1996)
P5 -­‐ -­‐ 912780 913085 90 PA0836 PA0837 <>> ? ? + + + -­‐ -­‐ (González	  et	  al.,	  2008;	  Livny	  et	  al.,	  2006)
P7 -­‐ -­‐ 971625 972166 140 PA0887 PA0888 >>> ? ? -­‐ + + -­‐ -­‐ (Livny	  et	  al.,	  2006)
P8 -­‐ -­‐ 1117319 1118157 130 PA1030 PA1031 >>> ? ? + + + -­‐ -­‐ (Livny	  et	  al.,	  2006)
sRNA622 -­‐ -­‐ 1140860 1141267 200,300 PA1052 PA1053 >>> ? ? + + + -­‐ -­‐ (González	  et	  al.,	  2008)
PA1112.1 1205031 1205330 1204782 1205770 300 PA1112 PA1113 ><> 249 440 + -­‐ -­‐ -­‐ -­‐ (González	  et	  al.,	  2008)
P9 1436491 1436618 1436397 1436663 128 PA1324 PA1325 >>> 94 45 + + + -­‐ -­‐ (Livny	  et	  al.,	  2006;	  Sonnleitner	  et	  al.,	  2008)
ffs 1668935 1669048 1668833 1669085 173	  (113)g PA1530 PA1531 >>< 102 37 -­‐ + + -­‐ -­‐ (Toschka	  1989;	  González	  et	  al.,	  2008;	  Sonnleitner	  et	  al.,	  2008)
P11 -­‐ -­‐ 1928627 1928893 100 PA1781 PA1782 <<< ? ? -­‐ + + -­‐ -­‐ (Livny	  et	  al.,	  2006;	  Sonnleitner	  et	  al.,	  2008)
sRNA1059 -­‐ -­‐ 1996807 1997508 150,200,300 PA1838 PA1839 <<< ? ? + + + + 9 (González	  et	  al.,	  2008)
sRNA1466 -­‐ -­‐ 2918212 2918603 300 PA2581 PA2581.1 >?< ? ? + -­‐ -­‐ -­‐ -­‐ (González	  et	  al.,	  2008;	  Sonnleitner	  et	  al.,	  2008)
PA2744.1 3106919 3106994 3106752 3107002 76 PA2744 PA2745 <<< 1 60 -­‐ -­‐ -­‐ -­‐ -­‐ (Livny	  et	  al.,	  2006)
sRNA1559 -­‐ -­‐ 3112151 3112876 250,300 PA2750 PA2751 >?> ? ? -­‐ + + -­‐ -­‐ (González	  et	  al.,	  2008)
P14 -­‐ -­‐ 3206497 3206915 300 PA2852.1 PA2853 <>> ? ? -­‐ + + -­‐ -­‐ (Livny	  et	  al.,	  2006)
P15 -­‐ -­‐ 3298922 3299492 180 PA2942 PA2943 <>> ? ? + + + -­‐ -­‐ (Livny	  et	  al.,	  2006;	  Sonnleitner	  et	  al.,	  2008)
rgsA 3318747 3318868 3318657 3318881 122 PA2958 PA2959 >>< 90 13 -­‐ + + -­‐ -­‐ (Livny	  et	  al.,	  2006;	  González	  et	  al.,	  2008;	  Sonnleitner	  et	  al.,	  2008)
sRNA1714 -­‐ -­‐ 3360654 3360873 200 PA3001 PA3002 <?> ? ? -­‐ -­‐ + -­‐ -­‐ (González	  et	  al.,	  2008)
P18 -­‐ -­‐ 3702951 3703166 100 PA3304 PA3305 <<< ? ? -­‐ -­‐ + -­‐ -­‐ (Livny	  et	  al.,	  2006)
phrS	   3705309 3705521 3705161 3705888 213 PA3305 PA3306 <<< 148 367 + + + -­‐ -­‐ (Livny	  et	  al.,	  2006;	  González	  et	  al.,	  2008;	  Sonnleitner	  et	  al.,	  2008)
amiL 3778034 3778133 3778000 3778265 100 PA3366 PA3367 <<> 34 132 -­‐ + + -­‐ -­‐ (Sonnleitner	  et	  al.,	  2008)
rsmZ 4057543 4057658 4057483 4057910 116 PA3621 PA3622 ><< 60 252 -­‐ + + -­‐ -­‐ (Heurlier	  et	  al.,	  2004;	  Livny	  et	  al.,	  2006)
P24 -­‐ -­‐ 4444597 4444977 300 PA3964 PA3965 ><> ? ? + + + -­‐ -­‐ (Livny	  et	  al.,	  2006;	  Sonnleitner	  et	  al.,	  2008)
sRNA2315 -­‐ -­‐ 4536493 4536919 180 PA4055 PA4056 <<< ? ? + + + -­‐ -­‐ (González	  et	  al.,	  2008;	  Sonnleitner	  et	  al.,	  2008)
P26 -­‐ -­‐ 4780618 4780838 250 PA4270 PA4271 <<< ? ? -­‐ -­‐ -­‐ -­‐ -­‐ (Livny	  et	  al.,	  2006)
P27 -­‐ -­‐ 4781786 4781985 90 PA4272 PA4273 <>< ? ? -­‐ + -­‐ + 0.3 (Livny	  et	  al.,	  2006)
PA4406.1 4939194 4939277 4939188 4939299 84 PA4406 PA4407 <>< 6 22 -­‐ -­‐ + -­‐ -­‐ (Sonnleitner	  et	  al.,	  2008)
rnpB -­‐ -­‐ 4956029 4956732 350 PA4421 PA4422 <<< ? ? + + + -­‐ -­‐ (Livny	  et	  al.,	  2006;	  González	  et	  al.,	  2008;	  Sonnleitner	  et	  al.,	  2008)
PA4451.1 4985782 4985843 4985731 4985846 62 PA4451 PA4452 <<< 51 3 -­‐ -­‐ -­‐ -­‐ -­‐ (Livny	  et	  al.,	  2006)
sRNA2626 -­‐ -­‐ 5196833 5197184 200 PA4628 PA4629 >>> ? ? + + + -­‐ -­‐ (González	  et	  al.,	  2008;	  Sonnleitner	  et	  al.,	  2008)
prrH 5283960 5284319 5283906 5284368 360 PA4703 PA4704 >>< 54 49 -­‐ + + -­‐ -­‐ (Oglesby-­‐Sherrouse	  and	  Vasil	  et	  al.,	  2010)
prrF1 5283960 5284110 5283906 5284368 151 PA4704 PA4705 >>< 54 258 -­‐ + + -­‐ -­‐ (Livny	  et	  al.,	  2006;	  González	  et	  al.,	  2008;	  Sonnleitner	  et	  al.,	  2008;	  Wilderman	  et	  al.,	  2004)
prrF2 5284172 5284319 5283906 5284368 148 PA4704 PA4705 >>< 266 49 -­‐ + + -­‐ -­‐ (Livny	  et	  al.,	  2006;	  Sonnleitner	  et	  al.,	  2008)
crcZ 5308587 5308993 5308425 5309326 407 PA4727 PA4728 >>> 162 333 + + + -­‐ -­‐ (Sonnleitner	  et	  al.,	  2009)
P30 -­‐ -­‐ 5308425 5309326 180 PA4726 PA4727 ><> ? ? + + + -­‐ -­‐ (Livny	  et	  al.,	  2006;	  Sonnleitner	  et	  al.,	  2008)
P32 -­‐ -­‐ 5344904 5345085 80 PA4758 PA4759 <<< ? ? -­‐ -­‐ -­‐ -­‐ -­‐ (Livny	  et	  al.,	  2006;	  Sonnleitner	  et	  al.,	  2008)
P34 -­‐ -­‐ 5835071 5835481 150 PA5181 PA5182 ><> ? ? -­‐ + + -­‐ -­‐ (Livny	  et	  al.,	  2006)
PhrX 5836429 5836579 5836402 5836909 151 PA5183 PA5184 ><> 27 330 + + + -­‐ -­‐ (Sonnleitner	  et	  al.,	  2008)
PhrY 5859480 5859674 5859457 5859792 195 PA5204 PA5205 <>> 23 118 + + + -­‐ -­‐ (Sonnleitner	  et	  al.,	  2008)
ssrS 5884320 5884502 5884286 5884508 183 PA5227 PA5228 >>> 34 6 + + + -­‐ -­‐ (Sonnleitner	  et	  al.,	  2008;	  Vogel	  et	  al.,	  1987)
PA5316.1 5986120 5986170 5986120 5986474 51 PA5316 PA5317 <>> 0 304 -­‐ -­‐ -­‐ + 0.3 (Sonnleitner	  et	  al.,	  2008)
Putative	  	  spot42 -­‐ -­‐ 6183520 6183784 265 PA5492 PA5493 ><< 0 0 + + + -­‐ -­‐ (Gottesman	  et	  al.,	  2006)
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a	  A	  location	  is	  given	  when	  the	  5ʹ′	  and	  3ʹ′	  ends	  can	  be	  deduced	  with	  reasonable	  certainty	  from	  available	  data.
b	  Experimentally	  found	  values.
c	  The	  middle	  arrow	  indicates	  the	  orientation	  of	  the	  sRNA,	  while	  the	  flanking	  arrows	  indicate	  the	  orientation	  of	  the	  adjacent	  genes.	  Unknown	  orientation	  of	  sRNAs	  is	  indicated	  by	  a	  question	  mark.
d	  A	  +	  indicates	  that	  the	  sRNA	  is	  differentially	  expressed	  in	  the	  conditions	  tested	  in	  this	  work.
e	  The	  fold	  change	  is	  calculated	  as	  the	  ratio	  of	  the	  intensities	  of	  the	  sRNA	  between	  the	  early-­‐stationary	  and	  exponential	  conditions.	  Thus,	  a	  fold	  change	  >	  1	  means	  that	  the	  sRNA	  is	  more	  expressed	  in	  the	  early-­‐stationary	  than	  the	  exponential	  phase.
f	  Mature	  tmRNA	  according	  to	  sequence	  homologies	  (Williams	  and	  Bartel,	  1996).
g	  The	  mature	  form	  was	  reported	  with	  a	  length	  of	  113	  nt	  (Toschka	  et	  al.,	  1989).	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Supplementary	  Table	  4.	  Intergenic	  sRNAs	  candidates	  in	  Pseudomonas	  aeruginosa.
Name Starta Enda
Intergenic	  
region	  start
Intergenic	  
region	  end Length
b
5'	  flanking	  
gene
3'	  flanking	  
gene Direction
c
Distance	  to	  5'	  
flanking	  gene	  
(nt)
Distance	  to	  3'	  
flanking	  gene	  
(nt)
Detection	  in	  
Library	  A
Detection	  in	  
Library	  B
Detection	  in	  
Library	  C
Differential	  
expressiond
Fold	  changee Rfamf blastng
pant1 46 293 1 482 248 PA5570 PA0001 <>> 45 189 + + -­‐ -­‐ -­‐ -­‐ -­‐
pant2 8453 8654 8340 8670 202 PA0006 PA0007 <>> 113 16 -­‐ + + + 4.9 -­‐ -­‐
pant3 40967 41110 40817 41112 144 PA0039 PA0040 >>> 150 2 -­‐ -­‐ + -­‐ -­‐ -­‐ -­‐
pant4 53658 54002 53522 56545 345 PA0041 PA0042 >?> 136 2543 -­‐ + + -­‐ -­‐ -­‐ -­‐
pant5 54656 54806 53522 56545 151 PA0041 PA0042 >>> 1134 1739 -­‐ + -­‐ + 8.5 -­‐ -­‐
pant6 55066 56182 53522 56545 1117 PA0041 PA0042 >?> 1544 363 + + -­‐ -­‐ -­‐ -­‐ -­‐
pant7 60222 60564 60160 60655 343 PA0044 PA0045 >?> 62 91 -­‐ + + -­‐ -­‐ -­‐ -­‐
pant8 62798 63023 62787 63067 226 PA0048 PA0049 <<< 11 44 -­‐ -­‐ + + 13.2 -­‐ -­‐
pant9 64880 65034 64730 65338 155 PA0049 PA0050 <<> 150 304 -­‐ + + + 10.3 -­‐ -­‐
pant10 65587 66281 65480 66302 695 PA0050 PA0051 >?> 107 21 + + + -­‐ -­‐ -­‐ -­‐
pant11 68822 68972 68617 69271 151 PA0052 PA0053 <?> 205 299 -­‐ -­‐ + -­‐ -­‐ -­‐ -­‐
pant12 123728 123839 123496 123870 112 PA0101 PA0102 >?> 232 31 -­‐ -­‐ + + 4.3 -­‐ -­‐
pant13 124638 124776 124600 124809 139 PA0102 PA0103 >>> 38 33 -­‐ + + + 0.3 -­‐ -­‐
pant14 127119 127375 127115 127377 257 PA0104 PA0105 >>> 4 2 -­‐ + + + 11.9 -­‐ -­‐
pant15 143369 143529 143268 143566 161 PA0123 PA0124 <?< 101 37 -­‐ + + -­‐ -­‐ -­‐ -­‐
pant16 153324 153524 153307 153695 201 PA0134 PA0135 <?> 17 171 -­‐ + + -­‐ -­‐ -­‐ -­‐
pant17 161581 161712 161449 161905 132 PA0141 PA0142 <<> 132 193 -­‐ + + -­‐ -­‐ -­‐ -­‐
pant18 176133 176214 176109 176314 82 PA0154 PA0155 ><> 24 100 -­‐ + -­‐ + 2.7 -­‐ -­‐
pant19 182619 182692 182570 182767 74 PA0158 PA0159 ><> 49 75 -­‐ -­‐ + -­‐ -­‐ -­‐ -­‐
pant20 188728 188861 188449 189119 134 PA0164 PA0165 >>> 279 258 -­‐ + + + 0.3 -­‐ -­‐
pant21 188903 189044 188449 189119 142 PA0164 PA0165 >>> 454 75 -­‐ + -­‐ + 0.4 -­‐ -­‐
pant22 193682 193797 193673 193798 116 PA0169 PA0170 <<< 9 1 -­‐ + -­‐ -­‐ -­‐ -­‐ -­‐
pant23 196750 196823 196749 197010 74 PA0172 PA0173 <>< 1 187 -­‐ + -­‐ + 0.5 -­‐ -­‐
pant24 213440 213626 213402 213818 187 PA0186 PA0187 >?> 38 192 + + + -­‐ -­‐ -­‐ -­‐
pant25 218894 218999 218823 219171 106 PA0191 PA0192 <>> 71 172 -­‐ + -­‐ -­‐ -­‐ -­‐ -­‐
pant26 223577 223723 223455 224100 147 PA0194 PA0195 >?> 122 377 -­‐ + + -­‐ -­‐ -­‐ -­‐
pant27 223784 224041 223455 224100 258 PA0194 PA0195 >?> 329 59 -­‐ + + + 6.7 -­‐ -­‐
pant28 245760 245915 245620 245947 156 PA0217 PA0218 <?< 140 32 + + + -­‐ -­‐ -­‐ -­‐
pant29 264600 264954 264523 264963 355 PA0234 PA0235 ><< 77 9 -­‐ + + -­‐ -­‐ -­‐ +
pant30 269579 269667 269520 269668 89 PA0238 PA0239 >?> 59 1 -­‐ + + -­‐ -­‐ -­‐ -­‐
pant31 288131 288320 288121 288383 190 PA0256 PA0257 <>< 10 63 -­‐ + + -­‐ -­‐ -­‐ -­‐
pant32 291005 291139 291005 291153 135 PA0259 PA0260 <<< 0 14 -­‐ + + -­‐ -­‐ -­‐ -­‐
pant33 297591 297937 297562 298815 347 PA0263 PA0263.1 <>< 29 878 -­‐ + + -­‐ -­‐ -­‐ -­‐
pant34 298455 298687 297562 298815 233 PA0263 PA0263.1 <?< 893 128 + -­‐ -­‐ -­‐ -­‐ -­‐ -­‐
pant35 301059 301154 300974 301217 96 PA0265 PA0266 >>> 85 63 -­‐ + -­‐ -­‐ -­‐ gabT -­‐
pant36 317834 317961 317790 317965 128 PA0283 PA0284 <?< 44 4 -­‐ -­‐ + -­‐ -­‐ -­‐ -­‐
pant37 326764 327071 326672 327283 308 PA0290 PA0291 >>> 92 212 -­‐ + + -­‐ -­‐ -­‐ -­‐
pant38 327152 327252 326672 327283 101 PA0290 PA0291 >?> 480 31 -­‐ + -­‐ -­‐ -­‐ -­‐ -­‐
pant39 339649 339764 339541 339958 116 PA0300 PA0301 >>> 108 194 -­‐ + + + 3.8 -­‐ -­‐
pant40 347931 348110 347854 349049 180 PA0306 PA0308 ><> 77 939 -­‐ + + -­‐ -­‐ -­‐ -­‐
pant41 348843 349035 347854 349049 193 PA0306 PA0308 ><> 989 14 + + + -­‐ -­‐ -­‐ +
pant42 354489 354679 354462 354753 191 PA0314 PA0315 <?> 27 74 -­‐ -­‐ + + 2.6 -­‐ ++
pant43 356490 356599 356478 356680 110 PA0316 PA0317 <?> 12 81 -­‐ -­‐ + -­‐ -­‐ P2 -­‐
pant44 363032 363166 362858 363277 135 PA0322 PA0323 <<< 174 111 -­‐ + -­‐ + 8.8 -­‐ -­‐
pant45 367249 367433 367130 367456 185 PA0326 PA0327 <<> 119 23 -­‐ + + -­‐ -­‐ -­‐ -­‐
pant46 371843 371948 371834 372090 106 PA0330 PA0331 <?> 9 142 -­‐ + + -­‐ -­‐ -­‐ -­‐
pant47 397937 398067 397896 398223 131 PA0353 PA0354 <>< 41 156 -­‐ -­‐ + + 4.4 -­‐ -­‐
pant48 412084 412328 411872 412328 245 PA0367 PA0368 ><< 212 0 -­‐ + + -­‐ -­‐ -­‐ -­‐
pant49 413655 413808 413655 413932 154 PA0369 PA0370 <<< 0 124 -­‐ -­‐ + -­‐ -­‐ -­‐ -­‐
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pant50 449389 449483 449385 449638 95 PA0407 PA0408 <?> 4 155 -­‐ + -­‐ -­‐ -­‐ -­‐ -­‐
pant51 484173 484273 484116 484403 101 PA0432 PA0433 <?> 57 130 -­‐ -­‐ + -­‐ -­‐ SAH	  riboswitch -­‐
pant52 501123 501317 501121 501375 195 PA0445 PA0446 <?< 2 58 -­‐ + -­‐ + 2.0 -­‐ -­‐
pant53 507452 507589 507252 507630 138 PA0450 PA0451 <>> 200 41 -­‐ + + + 3.2 -­‐ -­‐
pant54 514536 514620 514428 514774 85 PA0455 PA0456 <>> 108 154 -­‐ -­‐ + -­‐ -­‐ -­‐ -­‐
pant55 517652 517740 517463 518082 89 PA0458 PA0459 <>> 189 342 -­‐ -­‐ + + 246.3 -­‐ -­‐
pant56 521517 521870 521316 522464 354 PA0460 PA0462 ><> 201 594 + + -­‐ + 3.1 -­‐ -­‐
pant57 521960 522172 521316 522464 213 PA0460 PA0462 ><> 644 292 + + + -­‐ -­‐ -­‐ ++
pant58 522650 523205 522518 523253 556 PA0461 PA0463 <?> 132 48 + -­‐ -­‐ + 5.3 -­‐ +
pant59 522753 522868 522518 523253 116 PA0461 PA0463 <>> 235 385 -­‐ -­‐ + + 8.4 -­‐ ++
pant60 522900 523037 522518 523253 138 PA0461 PA0463 <>> 382 216 -­‐ + + + 9.9 -­‐ +
pant61 545931 546048 545645 546333 118 PA0484 PA0485 ><< 286 285 -­‐ + -­‐ + 0.4 -­‐ -­‐
pant62 546131 546304 545645 546333 174 PA0484 PA0485 >>< 486 29 + + + -­‐ -­‐ -­‐ -­‐
pant63 559211 559544 559079 559643 334 PA0499 PA0500 <?> 132 99 + + + -­‐ -­‐ -­‐ -­‐
pant64 600177 600277 600177 600425 101 PA0542 PA0543 <<> 0 148 -­‐ + + -­‐ -­‐ -­‐ -­‐
pant65 627957 628275 627766 628334 319 PA0572 PA0573 <>< 191 59 -­‐ + + -­‐ -­‐ -­‐ -­‐
pant66 648698 648847 648653 648930 150 PA0588 PA0589 <<< 45 83 -­‐ + + + 7.0 -­‐ -­‐
pant67 674043 674369 673962 674418 327 PA0611 PA0612 <>> 81 49 -­‐ + + -­‐ -­‐ -­‐ -­‐
pant68 698707 698894 698697 698931 188 PA0641 PA0642 >>> 10 37 -­‐ + + -­‐ -­‐ -­‐ -­‐
pant69 703216 703328 703059 703476 113 PA0648 PA0649 >>> 157 148 -­‐ + -­‐ -­‐ -­‐ -­‐ -­‐
pant70 706691 706815 706673 706943 125 PA0652 PA0653 <<> 18 128 -­‐ -­‐ + -­‐ -­‐ -­‐ -­‐
pant71 707436 707677 707367 707685 242 PA0653 PA0654 >>> 69 8 -­‐ + + + 0.3 -­‐ -­‐
pant72 727470 727602 727256 727607 133 PA0668.5 PA0669 >>< 214 5 -­‐ + + + 0.5 -­‐ -­‐
pant73 773742 773924 773697 774415 183 PA0701 PA0702 >>< 45 491 -­‐ + + -­‐ -­‐ -­‐ -­‐
pant74 781147 781246 780974 781258 100 PA0707 PA0708 <<< 173 12 -­‐ + -­‐ + 2.3 -­‐ -­‐
pant75 783859 784028 783834 784172 170 PA0712 PA0713 <<> 25 144 -­‐ -­‐ + -­‐ -­‐ -­‐ -­‐
pant76 785731 785832 785571 785968 102 PA0714.1 PA0715 ><> 160 136 -­‐ + + -­‐ -­‐ -­‐ -­‐
pant77 788390 789051 788254 789143 662 PA0716 PA0717 >?> 136 92 -­‐ + + -­‐ -­‐ -­‐ +
pant78 791239 791330 791235 791369 92 PA0723 PA0724 >>> 4 39 -­‐ + -­‐ -­‐ -­‐ -­‐ -­‐
pant79 796855 797228 796777 797250 374 PA0728 PA0729 >>> 78 22 -­‐ -­‐ + -­‐ -­‐ -­‐ -­‐
pant80 798893 799149 798828 799278 257 PA0730 PA0731 <<< 65 129 -­‐ + + -­‐ -­‐ -­‐ -­‐
pant81 804295 804574 804149 804655 280 PA0736 PA0737 <>> 146 81 -­‐ + + -­‐ -­‐ -­‐ -­‐
pant82 804581 804652 804149 804655 72 PA0736 PA0737 <?> 432 3 -­‐ + + -­‐ -­‐ -­‐ -­‐
pant83 828360 828477 828345 828616 118 PA0759 PA0760 <>> 15 139 -­‐ + + + 2.8 -­‐ -­‐
pant84 845182 845255 845180 845277 74 PA0777 PA0778 <<< 2 22 -­‐ -­‐ + -­‐ -­‐ -­‐ -­‐
pant85 851613 851745 851320 851782 133 PA0781 PA0782 <>> 293 37 -­‐ -­‐ + + 0.0 -­‐ -­‐
pant86 855071 855234 854966 855276 164 PA0782 PA0783 >>> 105 42 -­‐ + + -­‐ -­‐ -­‐ -­‐
pant87 863428 863611 863301 864094 184 PA0788 PA0789 <>> 127 483 -­‐ + + -­‐ -­‐ -­‐ -­‐
pant88 863878 864029 863301 864094 152 PA0788 PA0789 <>> 577 65 -­‐ + + -­‐ -­‐ -­‐ -­‐
pant89 883433 883594 883217 883776 162 PA0805 PA0806 <?> 216 182 -­‐ -­‐ + -­‐ -­‐ -­‐ -­‐
pant90 884351 884629 884173 884798 279 PA0806 PA0807 >?> 178 169 + -­‐ -­‐ -­‐ -­‐ -­‐ -­‐
pant91 892821 892966 892821 893040 146 PA0814 PA0815 <<> 0 74 -­‐ + + -­‐ -­‐ -­‐ -­‐
pant92 896243 896374 896118 896415 132 PA0819 PA0820 >>> 125 41 -­‐ -­‐ + + 6.1 -­‐ -­‐
pant93 913662 913761 913572 913776 100 PA0837 PA0838 >>> 90 15 -­‐ + -­‐ -­‐ -­‐ -­‐ -­‐
pant94 916156 916300 916156 916345 145 PA0840 PA0841 ><> 0 45 -­‐ + + -­‐ -­‐ -­‐ -­‐
pant95 927232 927551 927215 927879 320 PA0847 PA0849 <?> 17 328 -­‐ -­‐ + + 6.9 -­‐ ++
pant96 927603 927784 927215 927879 182 PA0847 PA0849 <>> 388 95 -­‐ + + -­‐ -­‐ -­‐ ++
pant97 936354 936454 936295 936458 101 PA0857 PA0858 >>> 59 4 -­‐ + + -­‐ -­‐ -­‐ -­‐
pant98 946960 947064 946908 947204 105 PA0865 PA0866 >>> 52 140 -­‐ + -­‐ + 5.2 -­‐ -­‐
pant99 950713 950898 950649 950961 186 PA0869 PA0870 <?< 64 63 -­‐ + + -­‐ -­‐ -­‐ -­‐
pant100 999767 999920 999767 1000012 154 PA0916 PA0917 <?> 0 92 -­‐ + + -­‐ -­‐ -­‐ -­‐
pant101 1006635 1006711 1006612 1006859 77 PA0920 PA0921 <<> 23 148 -­‐ + -­‐ + 7.5 -­‐ -­‐
pant102 1038894 1038971 1038886 1039239 78 PA0951 PA0952 >>< 8 268 -­‐ + -­‐ -­‐ -­‐ -­‐ -­‐
pant103 1045522 1045656 1045315 1045831 135 PA0958 PA0959 <<> 207 175 -­‐ + + + 2.8 -­‐ -­‐
7
74
pant104 1047055 1047183 1046912 1047548 129 PA0961 PA0962 <<< 143 365 + + + -­‐ -­‐ -­‐ -­‐
pant105 1047198 1047439 1046912 1047548 242 PA0961 PA0962 <<< 286 109 + + + -­‐ -­‐ -­‐ -­‐
pant106 1063787 1064073 1063545 1064554 287 PA0981 PA0982 >?< 242 481 -­‐ + -­‐ + 3.0 -­‐ -­‐
pant107 1064226 1064534 1063545 1064554 309 PA0981 PA0982 >?< 681 20 + + + -­‐ -­‐ -­‐ -­‐
pant108 1070187 1070289 1070174 1070293 103 PA0988 PA0989 >>< 13 4 -­‐ + + -­‐ -­‐ -­‐ -­‐
pant109 1078124 1078298 1077905 1078461 175 PA0995 PA0996 <>> 219 163 + + + + 51.5 -­‐ -­‐
pant110 1087101 1087236 1087096 1087842 136 PA1003 PA1004 <>> 5 606 + + + -­‐ -­‐ -­‐ -­‐
pant111 1087260 1087621 1087096 1087842 362 PA1003 PA1004 <<> 164 221 + + + -­‐ -­‐ -­‐ -­‐
pant112 1099180 1099330 1099129 1099668 151 PA1015 PA1016 <>> 51 338 -­‐ + + -­‐ -­‐ -­‐ -­‐
pant113 1105672 1105853 1105365 1105887 182 PA1019 PA1020 >?> 307 34 -­‐ + + + 3.8 -­‐ -­‐
pant114 1116110 1116211 1116061 1116212 102 PA1028 PA1029 >>> 49 1 -­‐ + + -­‐ -­‐ -­‐ -­‐
pant115 1117635 1117968 1117610 1118157 334 PA1030.1 PA1031 >>> 25 189 -­‐ + + + 0.3 -­‐ -­‐
pant116 1135225 1135406 1135203 1135407 182 PA1047 PA1048 >>> 22 1 -­‐ -­‐ + -­‐ -­‐ -­‐ -­‐
pant117 1141746 1142015 1141733 1142060 270 PA1053 PA1054 >?> 13 45 -­‐ + + -­‐ -­‐ -­‐ -­‐
pant118 1163013 1163160 1162978 1163275 148 PA1074 PA1075 <>> 35 115 -­‐ -­‐ + + 3.2 -­‐ -­‐
pant119 1182779 1182921 1182698 1183057 143 PA1091 PA1092 ><> 81 136 -­‐ -­‐ + + 3.5 -­‐ -­‐
pant120 1204789 1205025 1204782 1205030 237 PA1112 PA1112.1 >>< 7 5 + + + + 3.0 -­‐ ++
pant121 1205337 1205617 1205331 1205770 281 PA1112.1 PA1113 <>> 6 153 -­‐ + + -­‐ -­‐ -­‐ -­‐
pant122 1246048 1246223 1245929 1246443 176 PA1151 PA1152 >>> 119 220 -­‐ -­‐ + -­‐ -­‐ -­‐ -­‐
pant123 1248655 1248804 1248487 1249018 150 PA1153 PA1154 <?< 168 214 -­‐ + + + 2.8 -­‐ -­‐
pant124 1248876 1248985 1248487 1249018 110 PA1153 PA1154 <>< 389 33 -­‐ + -­‐ -­‐ -­‐ -­‐ -­‐
pant125 1254329 1254720 1254310 1255041 392 PA1156 PA1157 <<> 19 321 + + + + 0.2 -­‐ -­‐
pant126 1254790 1254903 1254310 1255041 114 PA1156 PA1157 <<> 480 138 + + + + 0.2 -­‐ -­‐
pant127 1255801 1255974 1255753 1256093 174 PA1157 PA1158 >>> 48 119 -­‐ + + -­‐ -­‐ -­‐ +
pant128 1266929 1267100 1266783 1267281 172 PA1167 PA1168 ><> 146 181 -­‐ + -­‐ + 5.3 -­‐ -­‐
pant129 1270848 1270960 1270516 1270971 113 PA1170 PA1171 <>> 332 11 -­‐ + + -­‐ -­‐ -­‐ -­‐
pant130 1284338 1284437 1284178 1284512 100 PA1182 PA1183 <>> 160 75 -­‐ + -­‐ -­‐ -­‐ -­‐ -­‐
pant131 1292441 1292545 1292413 1292570 105 PA1190 PA1191 <?< 28 25 -­‐ + + + 6.4 -­‐ +
pant132 1324155 1324426 1324110 1324792 272 PA1221 PA1222 <<< 45 366 -­‐ + + + 45.4 -­‐ -­‐
pant133 1348429 1348618 1348402 1349415 190 PA1244 PA1245 <<> 27 797 -­‐ -­‐ + -­‐ -­‐ C4 -­‐
pant134 1348836 1349074 1348402 1349415 239 PA1244 PA1245 <<> 434 341 -­‐ + + -­‐ -­‐ -­‐ -­‐
pant135 1349247 1349393 1348402 1349415 147 PA1244 PA1245 <?> 845 22 -­‐ + + + 8.4 -­‐ -­‐
pant136 1355391 1355625 1355273 1355630 235 PA1248 PA1249 >>> 118 5 -­‐ + + + 3.4 -­‐ -­‐
pant137 1357149 1357257 1357071 1357316 109 PA1249 PA1250 >>> 78 59 -­‐ -­‐ + + 10.1 -­‐ -­‐
pant138 1372693 1372804 1372683 1372978 112 PA1263 PA1264 >?< 10 174 -­‐ -­‐ + -­‐ -­‐ -­‐ ++
pant139 1379227 1379357 1379169 1379412 131 PA1269 PA1270 <>> 58 55 -­‐ -­‐ + + 4.3 -­‐ -­‐
pant140 1381509 1381765 1381453 1381803 257 PA1270 PA1271 >>> 56 38 -­‐ -­‐ + -­‐ -­‐ Cobalamin +
pant141 1400537 1400648 1400506 1400710 112 PA1288 PA1289 <>< 31 62 -­‐ -­‐ + -­‐ -­‐ -­‐ -­‐
pant142 1406850 1406989 1406753 1407006 140 PA1295 PA1296 >>> 97 17 -­‐ + + -­‐ -­‐ -­‐ -­‐
pant143 1427465 1428040 1427454 1428079 576 PA1316 PA1317 ><> 11 39 + + + -­‐ -­‐ -­‐ -­‐
pant144 1471942 1472164 1471673 1472546 223 PA1359 PA1361 <>< 269 382 -­‐ + + -­‐ -­‐ -­‐ ++
pant145 1474178 1474389 1473981 1474390 212 PA1361 PA1362 <<> 197 1 -­‐ + + -­‐ -­‐ -­‐ -­‐
pant146 1479852 1480066 1479792 1480214 215 PA1366 PA1367 <<< 60 148 -­‐ + + -­‐ -­‐ -­‐ -­‐
pant147 1482904 1482991 1482759 1483122 88 PA1368 PA1369 <<> 145 131 -­‐ + -­‐ + 10.9 -­‐ -­‐
pant148 1485764 1485865 1485764 1486265 102 PA1370 PA1371 ><< 0 400 -­‐ -­‐ + + 5.6 -­‐ -­‐
pant149 1486012 1486265 1485764 1486265 254 PA1370 PA1371 >?< 248 0 -­‐ -­‐ + -­‐ -­‐ -­‐ -­‐
pant150 1489164 1489362 1489096 1489814 199 PA1372 PA1373 <<< 68 452 -­‐ -­‐ + -­‐ -­‐ -­‐ -­‐
pant151 1489557 1489652 1489096 1489814 96 PA1372 PA1373 <>< 461 162 -­‐ + + -­‐ -­‐ -­‐ -­‐
pant152 1602058 1602160 1601894 1602178 103 PA1474 PA1475 <>> 164 18 -­‐ + + -­‐ -­‐ -­‐ -­‐
pant153 1609295 1609403 1609292 1609737 109 PA1483 PA1484 >>< 3 334 -­‐ + + -­‐ -­‐ -­‐ -­‐
pant154 1617190 1617423 1617086 1617488 234 PA1489 PA1490 <<< 104 65 -­‐ + -­‐ + 2.7 -­‐ -­‐
pant155 1618312 1618442 1618266 1618611 131 PA1490 PA1491 <<> 46 169 -­‐ + + -­‐ -­‐ -­‐ -­‐
pant156 1625863 1625937 1625696 1626061 75 PA1497 PA1498 <<< 167 124 -­‐ + -­‐ -­‐ -­‐ -­‐ -­‐
pant157 1644795 1645115 1644726 1645210 321 PA1512 PA1513 <>< 69 95 -­‐ + + -­‐ -­‐ -­‐ -­‐
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pant158 1681845 1681933 1681806 1682050 89 PA1544 PA1545 <?> 39 117 -­‐ -­‐ + + 8.2 -­‐ -­‐
pant159 1703072 1703249 1703053 1703378 178 PA1562 PA1563 <?> 19 129 -­‐ + + + 4.0 -­‐ -­‐
pant160 1717940 1718216 1717895 1718385 277 PA1578 PA1579 >>> 45 169 + + + + 0.2 -­‐ ++
pant161 1729853 1730100 1729853 1730180 248 PA1587 PA1588 >>> 0 80 -­‐ -­‐ + -­‐ -­‐ -­‐ -­‐
pant162 1732291 1732390 1732235 1732544 100 PA1589 PA1590 >?> 56 154 -­‐ + -­‐ -­‐ -­‐ -­‐ -­‐
pant163 1758602 1758698 1758598 1758747 97 PA1613 PA1614 <?> 4 49 -­‐ + + -­‐ -­‐ -­‐ -­‐
pant164 1773494 1773592 1773441 1773681 99 PA1629 PA1630 <?> 53 89 -­‐ + -­‐ -­‐ -­‐ -­‐ -­‐
pant165 1802487 1802745 1802454 1803625 259 PA1655 PA1656 >?> 33 880 -­‐ + + -­‐ -­‐ -­‐ -­‐
pant166 1802750 1803294 1802454 1803625 545 PA1655 PA1656 >>> 296 331 -­‐ + + + 8.8 -­‐ -­‐
pant167 1803380 1803604 1802454 1803625 225 PA1655 PA1656 >>> 926 21 -­‐ + -­‐ -­‐ -­‐ -­‐ -­‐
pant168 1824753 1824900 1824724 1824968 148 PA1672 PA1673 <<> 29 68 -­‐ -­‐ + -­‐ -­‐ -­‐ -­‐
pant169 1882442 1882555 1882344 1882594 114 PA1737 PA1738 ><< 98 39 -­‐ -­‐ + -­‐ -­‐ -­‐ -­‐
pant170 1886040 1886112 1886034 1886277 73 PA1741 PA1742 <<> 6 165 -­‐ -­‐ + + 4.0 -­‐ -­‐
pant171 1904315 1904419 1904248 1904478 105 PA1760 PA1761 >>> 67 59 -­‐ -­‐ + + 8.0 -­‐ -­‐
pant172 1947992 1948157 1947805 1948501 166 PA1796.4 PA1797 >>< 187 344 -­‐ + + -­‐ -­‐ -­‐ -­‐
pant173 1948239 1948395 1947805 1948501 157 PA1796.4 PA1797 >?< 434 106 -­‐ + -­‐ + 2.2 -­‐ -­‐
pant174 1988953 1989087 1988852 1989108 135 PA1829 PA1830 <>< 101 21 -­‐ + + -­‐ -­‐ -­‐ -­‐
pant175 2005007 2005107 2004893 2005253 101 PA1845 PA1846 <<> 114 146 -­‐ + + + 2.8 -­‐ -­‐
pant176 2012651 2012770 2012531 2012814 120 PA1852 PA1853 <?> 120 44 -­‐ + + -­‐ -­‐ -­‐ -­‐
pant177 2016813 2016924 2016582 2016927 112 PA1856 PA1857 <>< 231 3 -­‐ -­‐ + -­‐ -­‐ -­‐ -­‐
pant178 2028243 2028416 2028014 2028453 174 PA1866 PA1867 >>> 229 37 -­‐ + + -­‐ -­‐ -­‐ -­‐
pant179 2031706 2031839 2031706 2031987 134 PA1869 PA1870 >>> 0 148 -­‐ + -­‐ + 4.2 -­‐ -­‐
pant180 2068748 2068961 2068729 2069489 214 PA1897 PA1898 <?> 19 528 -­‐ + -­‐ + 12.0 -­‐ -­‐
pant181 2068964 2069268 2068729 2069489 305 PA1897 PA1898 <>> 235 221 -­‐ + + -­‐ -­‐ -­‐ -­‐
pant182 2070481 2070599 2070204 2070684 119 PA1898 PA1899 >>> 277 85 -­‐ + + + 62.3 -­‐ -­‐
pant183 2093320 2093418 2093251 2093443 99 PA1918 PA1919 <>< 69 25 -­‐ + -­‐ -­‐ -­‐ -­‐ -­‐
pant184 2104152 2104333 2104097 2104596 182 PA1925 PA1926 >>> 55 263 -­‐ + + -­‐ -­‐ -­‐ ++
pant185 2104397 2104580 2104097 2104596 184 PA1925 PA1926 >>> 300 16 -­‐ + + + 0.3 -­‐ ++
pant186 2118138 2118426 2118098 2118584 289 PA1936 PA1937 ><> 40 158 -­‐ + + + 3.0 -­‐ -­‐
pant187 2119868 2120185 2119748 2120224 318 PA1938 PA1939 ><< 120 39 -­‐ + + + 2.7 -­‐ -­‐
pant188 2130677 2130840 2130636 2130853 164 PA1945 PA1946 ><> 41 13 -­‐ + + -­‐ -­‐ -­‐ -­‐
pant189 2153211 2153381 2153069 2153593 171 PA1971 PA1972 <>> 142 212 -­‐ + + -­‐ -­‐ -­‐ -­‐
pant190 2189965 2190071 2189884 2190083 107 PA2002 PA2003 >>< 81 12 -­‐ + + -­‐ -­‐ -­‐ -­‐
pant191 2230425 2230600 2230184 2230688 176 PA2039 PA2040 <>> 241 88 -­‐ + -­‐ + 3.2 -­‐ -­‐
pant192 2232100 2232186 2232066 2232221 87 PA2040 PA2041 >>> 34 35 -­‐ + + + 4.7 -­‐ -­‐
pant193 2233636 2233805 2233593 2234079 170 PA2041 PA2042 >>> 43 274 -­‐ + + -­‐ -­‐ -­‐ -­‐
pant194 2282233 2282379 2281579 2282479 147 PA2075 PA2076 <?> 654 100 -­‐ + + -­‐ -­‐ -­‐ -­‐
pant195 2291596 2291763 2291590 2291790 168 PA2082 PA2083 >?> 6 27 -­‐ + -­‐ -­‐ -­‐ -­‐ -­‐
pant196 2314392 2314498 2314250 2314511 107 PA2102 PA2103 >>> 142 13 -­‐ + -­‐ + 4.6 -­‐ -­‐
pant197 2330441 2330688 2330425 2330958 248 PA2118 PA2119 >?< 16 270 + + + -­‐ -­‐ -­‐ -­‐
pant198 2330834 2330934 2330425 2330958 101 PA2118 PA2119 >?< 409 24 -­‐ -­‐ + + 4.7 -­‐ -­‐
pant199 2341653 2341988 2341641 2342492 336 PA2127 PA2128 <<> 12 504 -­‐ + + + 3.7 -­‐ -­‐
pant200 2341875 2341978 2341641 2342492 104 PA2127 PA2128 <>> 234 514 -­‐ + -­‐ + 3.4 -­‐ -­‐
pant201 2342040 2342162 2341641 2342492 123 PA2127 PA2128 <<> 399 330 -­‐ + -­‐ -­‐ -­‐ -­‐ -­‐
pant202 2396383 2396488 2396253 2396535 106 PA2174 PA2175 <>< 130 47 -­‐ -­‐ + + 4.2 -­‐ -­‐
pant203 2442721 2443060 2442692 2443160 340 PA2220 PA2221 >?> 29 100 + + + -­‐ -­‐ -­‐ -­‐
pant204 2444367 2444624 2444367 2444885 258 PA2221 PA2222 ><< 0 261 -­‐ + + -­‐ -­‐ -­‐ -­‐
pant205 2447361 2447521 2447326 2447572 161 PA2224 PA2225 <<< 35 51 -­‐ + + + 3.5 -­‐ -­‐
pant206 2450801 2450900 2450766 2451706 100 PA2228 PA2229 <<> 35 806 -­‐ + -­‐ -­‐ -­‐ -­‐ -­‐
pant207 2451228 2451464 2450766 2451706 237 PA2228 PA2229 <?> 462 242 + -­‐ -­‐ + 2.2 -­‐ -­‐
pant208 2453289 2453505 2453141 2453666 217 PA2230 PA2231 ><> 148 161 -­‐ + + -­‐ -­‐ -­‐ -­‐
pant209 2493101 2493210 2493051 2493217 110 PA2263 PA2264 >?> 50 7 -­‐ + + + 9.3 -­‐ -­‐
pant210 2521175 2521247 2521105 2521257 73 PA2290 PA2291 <?< 70 10 -­‐ -­‐ + -­‐ -­‐ -­‐ -­‐
pant211 2522623 2522747 2522617 2522957 125 PA2291 PA2292 <<< 6 210 -­‐ + + -­‐ -­‐ -­‐ -­‐
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pant212 2531867 2531979 2531841 2532058 113 PA2300 PA2301 <<< 26 79 -­‐ + + -­‐ -­‐ -­‐ -­‐
pant213 2557983 2558363 2557965 2558917 381 PA2319 PA2320 >>< 18 554 + + + -­‐ -­‐ -­‐ -­‐
pant214 2559995 2560132 2559950 2560143 138 PA2320 PA2321 <>> 45 11 -­‐ + + -­‐ -­‐ -­‐ -­‐
pant215 2614740 2614850 2614685 2614892 111 PA2364 PA2365 <>> 55 42 -­‐ + + + 3.3 -­‐ -­‐
pant216 2623966 2624200 2623857 2624203 235 PA2372 PA2373 >?> 109 3 -­‐ + -­‐ + 4.1 -­‐ -­‐
pant217 2627303 2627451 2627176 2627451 149 PA2375 PA2376 <>> 127 0 + + + -­‐ -­‐ -­‐ -­‐
pant218 2629644 2629914 2629500 2629915 271 PA2377 PA2378 >>< 144 1 -­‐ + + -­‐ -­‐ -­‐ -­‐
pant219 2687349 2687474 2687179 2687496 126 PA2402 PA2403 <?> 170 22 -­‐ + -­‐ + 5.9 -­‐ -­‐
pant220 2705330 2705770 2705298 2705772 441 PA2421 PA2422 ><> 32 2 + + + -­‐ -­‐ -­‐ -­‐
pant221 2707261 2707595 2707182 2707665 335 PA2423 PA2424 >>< 79 70 + + + -­‐ -­‐ -­‐ -­‐
pant222 2728318 2728427 2728142 2728541 110 PA2431 PA2432 <<> 176 114 -­‐ + + -­‐ -­‐ -­‐ -­‐
pant223 2737455 2737705 2737195 2737881 251 PA2439 PA2440 <<> 260 176 -­‐ + + + 3.4 -­‐ -­‐
pant224 2760623 2760747 2760620 2760871 125 PA2460 PA2461 <?< 3 124 -­‐ + + -­‐ -­‐ -­‐ -­‐
pant225 2761392 2761657 2761352 2761920 266 PA2461 PA2462 <<< 40 263 -­‐ -­‐ + + 0.3 -­‐ -­‐
pant226 2761671 2761919 2761352 2761920 249 PA2461 PA2462 <<< 319 1 -­‐ -­‐ + -­‐ -­‐ -­‐ -­‐
pant227 2822388 2822488 2822323 2822573 101 PA2504 PA2505 <<< 65 85 -­‐ -­‐ + + 24.6 -­‐ -­‐
pant228 2843524 2843740 2843306 2843817 217 PA2522 PA2523 <>> 218 77 -­‐ + + -­‐ -­‐ -­‐ -­‐
pant229 2893863 2894130 2893829 2894451 268 PA2559 PA2560 <?< 34 321 -­‐ + + -­‐ -­‐ -­‐ -­‐
pant230 2916938 2917154 2916749 2917171 217 PA2580 PA2581 <<> 189 17 -­‐ + + + 2.4 -­‐ -­‐
pant231 2943992 2944212 2943916 2944254 221 PA2600 PA2601 <?< 76 42 -­‐ + + -­‐ -­‐ -­‐ -­‐
pant232 2959289 2959461 2959241 2959467 173 PA2615 PA2616 <>> 48 6 -­‐ -­‐ + -­‐ -­‐ -­‐ -­‐
pant233 2964966 2965175 2964844 2965200 210 PA2621 PA2622 <<> 122 25 -­‐ -­‐ + -­‐ -­‐ -­‐ -­‐
pant234 2967068 2967160 2966803 2967160 93 PA2623 PA2624 <>> 265 0 -­‐ + -­‐ + 0.4 -­‐ -­‐
pant235 2977424 2977601 2977162 2977755 178 PA2633 PA2634 >>> 262 154 -­‐ + + + 3.1 -­‐ -­‐
pant236 2982246 2982481 2982182 2982780 236 PA2636 PA2637 ><> 64 299 -­‐ + + + 2.5 -­‐ -­‐
pant237 2982583 2982654 2982182 2982780 72 PA2636 PA2637 ><> 401 126 -­‐ + -­‐ + 2.9 -­‐ -­‐
pant238 3008717 3008809 3008633 3008846 93 PA2659 PA2660 <<> 84 37 -­‐ + + -­‐ -­‐ -­‐ -­‐
pant239 3017012 3017103 3016885 3017233 92 PA2668 PA2669 <<< 127 130 -­‐ + -­‐ -­‐ -­‐ -­‐ -­‐
pant240 3035720 3036327 3035703 3037885 608 PA2684 PA2686 <?> 17 1558 -­‐ + + -­‐ -­‐ -­‐ +
pant241 3036726 3037186 3035703 3037885 461 PA2684 PA2686 <<> 1023 699 -­‐ + + -­‐ -­‐ -­‐ +
pant242 3037237 3037426 3035703 3037885 190 PA2684 PA2686 <<> 1534 459 -­‐ + + -­‐ -­‐ -­‐ ++
pant243 3037611 3037811 3035703 3037885 201 PA2684 PA2686 <?> 1908 74 -­‐ + + -­‐ -­‐ -­‐ -­‐
pant244 3044769 3044839 3044767 3044946 71 PA2690 PA2691 <?< 2 107 -­‐ + -­‐ -­‐ -­‐ -­‐ -­‐
pant245 3050173 3050313 3050162 3050330 141 PA2696 PA2697 <>< 11 17 -­‐ + + -­‐ -­‐ -­‐ -­‐
pant246 3065879 3066090 3065877 3066295 212 PA2711 PA2712 ><> 2 205 -­‐ + + -­‐ -­‐ -­‐ -­‐
pant247 3067747 3067961 3067687 3068039 215 PA2713 PA2714 <<> 60 78 -­‐ + + -­‐ -­‐ -­‐ -­‐
pant248 3087529 3088155 3087492 3088659 627 PA2729 PA2730 ><< 37 504 -­‐ + + -­‐ -­‐ -­‐ -­‐
pant249 3088213 3088434 3087492 3088659 222 PA2729 PA2730 >?< 721 225 -­‐ + + -­‐ -­‐ -­‐ -­‐
pant250 3088452 3088618 3087492 3088659 167 PA2729 PA2730 >>< 960 41 -­‐ + -­‐ -­‐ -­‐ -­‐ -­‐
pant251 3094233 3094534 3094186 3094756 302 PA2733 PA2734 <?< 47 222 -­‐ + + -­‐ -­‐ -­‐ ++
pant252 3098983 3099074 3098980 3099305 92 PA2736 PA2736.1 <?< 3 231 -­‐ + + -­‐ -­‐ -­‐ -­‐
pant253 3108450 3108697 3108384 3108969 248 PA2746 PA2747 >>< 66 272 + + + -­‐ -­‐ -­‐ -­‐
pant254 3108698 3108907 3108384 3108969 210 PA2746 PA2747 ><< 314 62 + + + -­‐ -­‐ -­‐ -­‐
pant255 3109522 3109714 3109258 3109742 193 PA2747 PA2748 <<< 264 28 -­‐ + + -­‐ -­‐ -­‐ -­‐
pant256 3110558 3110777 3110526 3110900 220 PA2748 PA2749 <?> 32 123 + + + -­‐ -­‐ -­‐ -­‐
pant257 3115808 3115984 3115634 3116653 177 PA2754 PA2755 ><> 174 669 -­‐ + -­‐ + 3.4 -­‐ -­‐
pant258 3116209 3116365 3115634 3116653 157 PA2754 PA2755 >?> 575 288 -­‐ + + + 2.6 -­‐ -­‐
pant259 3119820 3119930 3119709 3120072 111 PA2759 PA2760 <<> 111 142 -­‐ + + + 2.7 -­‐ -­‐
pant260 3122766 3122846 3122587 3123598 81 PA2763 PA2764 <<> 179 752 -­‐ -­‐ + + 5.8 -­‐ -­‐
pant261 3123173 3123434 3122587 3123598 262 PA2763 PA2764 <<> 586 164 + + + -­‐ -­‐ -­‐ -­‐
pant262 3129277 3129477 3129072 3129728 201 PA2770 PA2771 <<> 205 251 -­‐ + + -­‐ -­‐ -­‐ -­‐
pant263 3129461 3129635 3129072 3129728 175 PA2770 PA2771 <<> 389 93 -­‐ + + -­‐ -­‐ -­‐ -­‐
pant264 3138591 3138791 3138533 3139010 201 PA2781 PA2782 >>> 58 219 -­‐ + + + 6.0 -­‐ -­‐
pant265 3150508 3150730 3150435 3150885 223 PA2793 PA2794 <<< 73 155 + + + -­‐ -­‐ -­‐ -­‐
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pant266 3193555 3193835 3193520 3193885 281 PA2839 PA2840 >?< 35 50 + + + -­‐ -­‐ -­‐ -­‐
pant267 3195665 3195766 3195590 3195899 102 PA2840 PA2841 <<> 75 133 -­‐ -­‐ + + 0.2 -­‐ -­‐
pant268 3218534 3218648 3218420 3218665 115 PA2865 PA2866 <?> 114 17 -­‐ -­‐ + -­‐ -­‐ -­‐ -­‐
pant269 3249634 3249821 3249632 3249976 188 PA2894 PA2895 <<< 2 155 -­‐ + + -­‐ -­‐ -­‐ -­‐
pant270 3251354 3251454 3251323 3251650 101 PA2896 PA2897 <<< 31 196 -­‐ -­‐ + + 2.3 -­‐ -­‐
pant271 3251355 3251627 3251323 3251650 273 PA2896 PA2897 <<< 32 23 -­‐ + -­‐ -­‐ -­‐ -­‐ -­‐
pant272 3261207 3261426 3261186 3261521 220 PA2906 PA2907 <<> 21 95 -­‐ + + -­‐ -­‐ Cobalamin -­‐
pant273 3265500 3265795 3265212 3265847 296 PA2910 PA2911 <>> 288 52 + + + -­‐ -­‐ Cobalamin +
pant274 3281758 3281897 3281667 3281987 140 PA2926 PA2927 ><> 91 90 -­‐ + -­‐ -­‐ -­‐ -­‐ -­‐
pant275 3284713 3284940 3284599 3285006 228 PA2928 PA2929 <<< 114 66 -­‐ + + -­‐ -­‐ -­‐ -­‐
pant276 3293795 3294072 3293782 3294281 278 PA2938 PA2939 <?> 13 209 + + + -­‐ -­‐ -­‐ -­‐
pant277 3305612 3305787 3305565 3305918 176 PA2945 PA2946 <<> 47 131 -­‐ + + -­‐ -­‐ Cobalamin ++
pant278 3316654 3316731 3316651 3316799 78 PA2956 PA2957 <<< 3 68 -­‐ -­‐ + -­‐ -­‐ -­‐ -­‐
pant279 3346360 3346486 3345797 3346976 127 PA2987 PA2989 <<> 563 490 -­‐ + + -­‐ -­‐ -­‐ +
pant280 3347047 3347276 3347040 3348072 230 PA2988 PA2990 <<> 7 796 -­‐ + + -­‐ -­‐ -­‐ -­‐
pant281 3366842 3366917 3366755 3366969 76 PA3005 PA3006 <<< 87 52 -­‐ -­‐ + + 0.3 -­‐ -­‐
pant282 3376636 3376826 3376608 3377034 191 PA3014 PA3015 <>> 28 208 -­‐ + + -­‐ -­‐ -­‐ +
pant283 3378402 3378478 3378305 3378511 77 PA3016 PA3017 <<> 97 33 -­‐ + -­‐ + 3.8 -­‐ -­‐
pant284 3409983 3410069 3409954 3410263 87 PA3046 PA3047 <<> 29 194 -­‐ + + -­‐ -­‐ -­‐ -­‐
pant285 3414160 3414264 3413941 3414400 105 PA3048 PA3049 <?> 219 136 -­‐ + -­‐ + 0.4 -­‐ -­‐
pant286 3415758 3416030 3415730 3416060 273 PA3050 PA3052 <>> 28 30 -­‐ + + -­‐ -­‐ -­‐ +
pant287 3416582 3416725 3416068 3417112 144 PA3051 PA3053 <>> 514 387 -­‐ + + -­‐ -­‐ -­‐ +
pant288 3441450 3441689 3441441 3441712 240 PA3068 PA3069 <<< 9 23 -­‐ + + + 4.8 -­‐ -­‐
pant289 3442446 3442661 3442331 3442822 216 PA3069 PA3070 <<> 115 161 -­‐ + + + 3.5 -­‐ -­‐
pant290 3459955 3460268 3459934 3460379 314 PA3082 PA3083 <<< 21 111 -­‐ + + -­‐ -­‐ -­‐ -­‐
pant291 3475180 3475456 3475171 3475456 277 PA3094 PA3094.1 >?< 9 0 -­‐ + + -­‐ -­‐ -­‐ -­‐
pant292 3545653 3545831 3545075 3545880 179 PA3159 PA3160 <?< 578 49 -­‐ + -­‐ + 3.1 -­‐ -­‐
pant293 3567471 3567603 3567378 3567605 133 PA3176 PA3177 >?> 93 2 -­‐ + -­‐ -­‐ -­‐ -­‐ -­‐
pant294 3581773 3581852 3581647 3582170 80 PA3190 PA3191 <>< 126 318 -­‐ + + -­‐ -­‐ -­‐ -­‐
pant295 3581900 3582070 3581647 3582170 171 PA3190 PA3191 <<< 253 100 -­‐ + + -­‐ -­‐ -­‐ -­‐
pant296 3588569 3588705 3588438 3588740 137 PA3195 PA3196 >>< 131 35 -­‐ + -­‐ + 2.9 -­‐ -­‐
pant297 3592929 3593104 3592929 3593143 176 PA3200 PA3201 <<> 0 39 -­‐ -­‐ + -­‐ -­‐ -­‐ -­‐
pant298 3612366 3612474 3612360 3612558 109 PA3224 PA3225 <>> 6 84 -­‐ -­‐ + + 4.1 -­‐ -­‐
pant299 3616919 3617018 3616763 3617043 100 PA3228 PA3229 >>> 156 25 -­‐ + + + 2.8 -­‐ -­‐
pant300 3630634 3630737 3630606 3630764 104 PA3242 PA3243 <<> 28 27 -­‐ + + + 5.0 -­‐ -­‐
pant301 3648952 3649078 3648917 3649704 127 PA3261 PA3262 ><< 35 626 -­‐ + + -­‐ -­‐ -­‐ +
pant302 3649100 3649605 3648917 3649704 506 PA3261 PA3262 ><< 183 99 + + + -­‐ -­‐ -­‐ -­‐
pant303 3669652 3669788 3669589 3669820 137 PA3276 PA3277 <?< 63 32 -­‐ + + -­‐ -­‐ -­‐ -­‐
pant304 3677575 3677718 3677082 3677719 144 PA3284 PA3285 <<< 493 1 -­‐ + + -­‐ -­‐ P17 +
pant305 3679417 3679810 3679387 3679945 394 PA3286 PA3287 <<> 30 135 -­‐ + + -­‐ -­‐ -­‐ -­‐
pant306 3706855 3707061 3706855 3707089 207 PA3307 PA3308 <?> 0 28 -­‐ + + -­‐ -­‐ -­‐ -­‐
pant307 3722785 3722865 3722760 3722989 81 PA3319 PA3320 <<< 25 124 -­‐ + + + 3.5 -­‐ -­‐
pant308 3729139 3729327 3729128 3729470 189 PA3325 PA3326 ><< 11 143 -­‐ -­‐ + + 6.2 -­‐ -­‐
pant309 3730189 3730383 3730077 3730556 195 PA3326 PA3327 <<> 112 173 -­‐ + -­‐ + 17.7 -­‐ -­‐
pant310 3730416 3730556 3730077 3730556 141 PA3326 PA3327 <>> 339 0 -­‐ + + + 47.2 -­‐ -­‐
pant311 3751917 3752011 3751768 3752043 95 PA3340 PA3341 <?< 149 32 -­‐ -­‐ + + 4.8 -­‐ -­‐
pant312 3759712 3759942 3759682 3759995 231 PA3347 PA3348 <<< 30 53 -­‐ + + -­‐ -­‐ -­‐ -­‐
pant313 3772588 3772694 3772562 3773028 107 PA3360 PA3361 <<> 26 334 -­‐ + -­‐ -­‐ -­‐ -­‐ -­‐
pant314 3772905 3773012 3772562 3773028 108 PA3360 PA3361 <>> 343 16 -­‐ -­‐ + + 81.9 -­‐ -­‐
pant315 3803431 3803595 3803344 3803616 165 PA3397 PA3398 <>> 87 21 -­‐ + + -­‐ -­‐ -­‐ -­‐
pant316 3819826 3819939 3819797 3820005 114 PA3412 PA3413 <>> 29 66 -­‐ + + + 3.4 -­‐ -­‐
pant317 3841795 3842086 3841738 3842273 292 PA3433 PA3434 ><< 57 187 -­‐ + + -­‐ -­‐ -­‐ -­‐
pant318 3843293 3843364 3843291 3843652 72 PA3434 PA3435 <?< 2 288 -­‐ + -­‐ -­‐ -­‐ -­‐ -­‐
pant319 3843449 3843551 3843291 3843652 103 PA3434 PA3435 <?< 158 101 -­‐ + -­‐ -­‐ -­‐ -­‐ -­‐
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pant320 3865152 3865261 3865127 3865280 110 PA3457 PA3458 >?< 25 19 -­‐ -­‐ + + 2.4 -­‐ -­‐
pant321 3877915 3878018 3877912 3878032 104 PA3465 PA3466 ><< 3 14 -­‐ -­‐ + -­‐ -­‐ -­‐ -­‐
pant322 3885259 3885449 3885255 3885710 191 PA3471 PA3472 <<> 4 261 -­‐ + + -­‐ -­‐ -­‐ -­‐
pant323 3885464 3885686 3885255 3885710 223 PA3471 PA3472 <>> 209 24 -­‐ -­‐ + -­‐ -­‐ -­‐ -­‐
pant324 3893030 3893253 3893009 3893431 224 PA3479 PA3480 <<< 21 178 -­‐ + + + 4.2 -­‐ +
pant325 3900073 3900231 3899939 3900232 159 PA3485 PA3486 >>> 134 1 -­‐ + + -­‐ -­‐ -­‐ -­‐
pant326 3930268 3930716 3930231 3930742 449 PA3514 PA3515 <>< 37 26 -­‐ + + -­‐ -­‐ -­‐ -­‐
pant327 3936883 3937150 3936838 3937237 268 PA3519 PA3520 <<< 45 87 + + -­‐ + 6.5 -­‐ -­‐
pant328 3937547 3937816 3937433 3938019 270 PA3520 PA3521 <>< 114 203 -­‐ + + -­‐ -­‐ -­‐ -­‐
pant329 3949697 3949817 3949594 3949852 121 PA3529 PA3530 <<> 103 35 -­‐ + + -­‐ -­‐ -­‐ -­‐
pant330 3954610 3954687 3954609 3954906 78 PA3534 PA3535 <<> 1 219 -­‐ -­‐ + + 5.9 -­‐ -­‐
pant331 3957895 3957978 3957895 3958287 84 PA3535 PA3536 >>< 0 309 -­‐ + -­‐ -­‐ -­‐ -­‐ -­‐
pant332 3958050 3958149 3957895 3958287 100 PA3535 PA3536 >>< 102 138 -­‐ + + -­‐ -­‐ -­‐ -­‐
pant333 3958814 3959028 3958756 3959032 215 PA3536 PA3537 <<> 58 4 + + + -­‐ -­‐ -­‐ -­‐
pant334 3979483 3979687 3979477 3979859 205 PA3551 PA3552 ><> 6 172 -­‐ + + -­‐ -­‐ -­‐ -­‐
pant335 4009052 4009156 4009052 4009541 105 PA3577 PA3578 <<< 0 385 -­‐ -­‐ + -­‐ -­‐ -­‐ +
pant336 4009456 4009526 4009052 4009541 71 PA3577 PA3578 <?< 404 15 -­‐ + -­‐ -­‐ -­‐ -­‐ -­‐
pant337 4012689 4012804 4012542 4012805 116 PA3580 PA3581 <?> 147 1 -­‐ + -­‐ + 0.1 -­‐ -­‐
pant338 4029599 4029753 4029541 4029758 155 PA3594 PA3595 >>> 58 5 -­‐ + + -­‐ -­‐ -­‐ -­‐
pant339 4064994 4065078 4064988 4065118 85 PA3629 PA3630 <<> 6 40 -­‐ + -­‐ + 3.3 -­‐ -­‐
pant340 4072509 4072650 4072489 4072658 142 PA3637 PA3638 <<< 20 8 -­‐ + + -­‐ -­‐ -­‐ -­‐
pant341 4080262 4080358 4080224 4080439 97 PA3641 PA3642 <?< 38 81 -­‐ + -­‐ + 0.2 -­‐ -­‐
pant342 4092998 4093157 4092969 4093166 160 PA3654 PA3655 <<< 29 9 -­‐ + + + 0.2 -­‐ -­‐
pant343 4094917 4095015 4094908 4095171 99 PA3656 PA3657 <<> 9 156 -­‐ -­‐ + -­‐ -­‐ t44 +
pant344 4133987 4134089 4133759 4134137 103 PA3690 PA3691 >>> 228 48 -­‐ + + -­‐ -­‐ -­‐ -­‐
pant345 4160036 4160301 4160006 4160328 266 PA3713 PA3714 ><> 30 27 -­‐ + + + 2.1 -­‐ -­‐
pant346 4170519 4170697 4170484 4170769 179 PA3724 PA3725 <<< 35 72 -­‐ + + + 16.3 -­‐ -­‐
pant347 4183467 4183589 4183229 4183709 123 PA3732 PA3733 <<> 238 120 -­‐ + + -­‐ -­‐ -­‐ -­‐
pant348 4185172 4185429 4184940 4185521 258 PA3733 PA3734 ><> 232 92 + -­‐ -­‐ + 5.5 -­‐ -­‐
pant349 4189585 4189708 4189548 4189760 124 PA3736 PA3737 <<< 37 52 -­‐ + + -­‐ -­‐ -­‐ -­‐
pant350 4241090 4241338 4240580 4241341 249 PA3781 PA3782 >>< 510 3 -­‐ + + -­‐ -­‐ -­‐ -­‐
pant351 4281929 4282070 4281752 4282077 142 PA3824.1 PA3825 >>< 177 7 -­‐ + + + 0.3 -­‐ -­‐
pant352 4288718 4288937 4288607 4288942 220 PA3830 PA3831 <?> 111 5 -­‐ -­‐ + -­‐ -­‐ -­‐ -­‐
pant353 4295455 4296062 4294606 4297249 608 PA3835 PA3836 <<> 849 1187 + -­‐ -­‐ -­‐ -­‐ -­‐ -­‐
pant354 4296539 4296803 4294606 4297249 265 PA3835 PA3836 <<> 1933 446 -­‐ + -­‐ + 5.3 -­‐ -­‐
pant355 4296877 4296974 4294606 4297249 98 PA3835 PA3836 <<> 2271 275 -­‐ -­‐ + + 9.1 -­‐ -­‐
pant356 4321074 4321255 4320821 4321433 182 PA3860 PA3861 <>> 253 178 -­‐ + + -­‐ -­‐ -­‐ -­‐
pant357 4326945 4327123 4326396 4327696 179 PA3865 PA3866 <>< 549 573 -­‐ -­‐ + + 7.8 -­‐ -­‐
pant358 4344851 4344951 4344836 4345009 101 PA3877 PA3878 <>> 15 58 -­‐ + + -­‐ -­‐ -­‐ -­‐
pant359 4352499 4352599 4352495 4352827 101 PA3886 PA3887 >>< 4 228 -­‐ + + + 5.9 -­‐ +
pant360 4354229 4354375 4354103 4354543 147 PA3887 PA3888 <<> 126 168 -­‐ + + -­‐ -­‐ -­‐ -­‐
pant361 4388737 4388953 4388728 4389230 217 PA3919 PA3920 <<> 9 277 -­‐ + + -­‐ -­‐ -­‐ +
pant362 4403499 4403704 4403427 4403706 206 PA3927 PA3928 >>< 72 2 -­‐ + + -­‐ -­‐ -­‐ -­‐
pant363 4406484 4406652 4406369 4406805 169 PA3930 PA3931 <>> 115 153 -­‐ + + + 7.6 -­‐ -­‐
pant364 4418063 4418200 4417935 4418302 138 PA3939 PA3940 <>> 128 102 -­‐ + + -­‐ -­‐ -­‐ -­‐
pant365 4433194 4433358 4433171 4433410 165 PA3952 PA3953 <<> 23 52 -­‐ + + -­‐ -­‐ -­‐ -­‐
pant366 4472724 4472848 4472199 4473622 125 PA3991 PA3993 <<> 525 774 -­‐ -­‐ + + 5.2 -­‐ ++
pant367 4472877 4473081 4472199 4473622 205 PA3991 PA3993 <>> 678 541 -­‐ + + -­‐ -­‐ -­‐ ++
pant368 4474657 4474804 4474640 4474958 148 PA3993 PA3994 >>< 17 154 -­‐ + + -­‐ -­‐ -­‐ +
pant369 4474837 4474958 4474640 4474958 122 PA3993 PA3994 >>< 197 0 -­‐ + + -­‐ -­‐ -­‐ -­‐
pant370 4514358 4514685 4514349 4514694 328 PA4033 PA4034 >>> 9 9 + + + -­‐ -­‐ -­‐ -­‐
pant371 4518941 4519197 4518871 4519274 257 PA4036 PA4037 ><> 70 77 + + + -­‐ -­‐ -­‐ -­‐
pant372 4523842 4523939 4523754 4523984 98 PA4040 PA4041 >>< 88 45 -­‐ + + -­‐ -­‐ -­‐ -­‐
pant373 4536503 4536632 4536494 4536920 130 PA4055 PA4056 <<< 9 288 -­‐ + + -­‐ -­‐ -­‐ -­‐
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pant374 4545655 4545745 4545306 4545745 91 PA4067 PA4068 ><< 349 0 -­‐ + + -­‐ -­‐ -­‐ -­‐
pant375 4547578 4547720 4547553 4547820 143 PA4069 PA4070 <<< 25 100 -­‐ + -­‐ -­‐ -­‐ -­‐ -­‐
pant376 4559680 4559844 4559651 4560294 165 PA4080 PA4081 <<< 29 450 -­‐ + + -­‐ -­‐ -­‐ -­‐
pant377 4559856 4560204 4559651 4560294 349 PA4080 PA4081 <>< 205 90 + + + -­‐ -­‐ -­‐ -­‐
pant378 4592559 4592662 4592432 4592989 104 PA4108 PA4109 >>< 127 327 -­‐ + + + 4.1 -­‐ -­‐
pant379 4592808 4592973 4592432 4592989 166 PA4108 PA4109 ><< 376 16 -­‐ + + + 3.0 -­‐ -­‐
pant380 4601449 4601564 4601421 4601573 116 PA4113 PA4114 <<< 28 9 -­‐ + + -­‐ -­‐ -­‐ -­‐
pant381 4629195 4629347 4629186 4629943 153 PA4138 PA4139 <<> 9 596 -­‐ + + -­‐ -­‐ -­‐ -­‐
pant382 4632172 4632301 4632169 4632476 130 PA4140 PA4141 ><> 3 175 -­‐ + + + 2.7 -­‐ -­‐
pant383 4639348 4639448 4639292 4639501 101 PA4146 PA4147 ><< 56 53 -­‐ -­‐ + + 5.0 -­‐ -­‐
pant384 4648578 4648773 4648564 4648998 196 PA4154 PA4155 <>< 14 225 -­‐ + + -­‐ -­‐ -­‐ -­‐
pant385 4670823 4671197 4670785 4671318 375 PA4174 PA4175 >?> 38 121 -­‐ + + + 3.9 -­‐ -­‐
pant386 4696088 4696278 4696036 4696280 191 PA4197 PA4198 <>> 52 2 -­‐ + -­‐ -­‐ -­‐ -­‐ -­‐
pant387 4713137 4713370 4713100 4713795 234 PA4209 PA4210 <?> 37 425 -­‐ -­‐ + + 200.7 -­‐ +
pant388 4713459 4713664 4713100 4713795 206 PA4209 PA4210 <>> 359 131 -­‐ + + -­‐ -­‐ -­‐ +
pant389 4783131 4783217 4783112 4783227 87 PA4274 PA4275 <?< 19 10 -­‐ -­‐ + -­‐ -­‐ -­‐ +
pant390 4791760 4791860 4791725 4791950 101 PA4280.2 PA4280.3 <>< 35 90 -­‐ -­‐ + + 68.3 -­‐ ++
pant391 4813801 4813991 4812602 4814212 191 PA4289 PA4291 ><> 1199 221 -­‐ + + -­‐ -­‐ -­‐ +
pant392 4814535 4814996 4814215 4815042 462 PA4290 PA4292 <>> 320 46 + + + -­‐ -­‐ -­‐ -­‐
pant393 4830663 4830846 4830555 4830963 184 PA4305 PA4306 <<> 108 117 -­‐ + + + 10.5 -­‐ -­‐
pant394 4834913 4835263 4834865 4835263 351 PA4308 PA4309 <>> 48 0 -­‐ -­‐ + -­‐ -­‐ -­‐ -­‐
pant395 4854991 4855070 4854979 4855071 80 PA4326 PA4327 <>> 12 1 -­‐ + -­‐ + 14.8 -­‐ -­‐
pant396 4860508 4861088 4860256 4861652 581 PA4331 PA4333 <<> 252 564 -­‐ + + + 2.6 -­‐ +
pant397 4861124 4861399 4860256 4861652 276 PA4331 PA4333 <?> 868 253 + + + -­‐ -­‐ -­‐ -­‐
pant398 4861733 4862026 4861712 4863272 294 PA4332 PA4334 <?< 21 1246 -­‐ + + -­‐ -­‐ -­‐ ++
pant399 4862054 4862348 4861712 4863272 295 PA4332 PA4334 <>< 342 924 -­‐ + + + 0.4 -­‐ ++
pant400 4862626 4863181 4861712 4863272 556 PA4332 PA4334 <>< 914 91 + + + -­‐ -­‐ -­‐ ++
pant401 4878593 4878723 4878588 4878789 131 PA4349 PA4350 <<> 5 66 -­‐ + + + 6.4 -­‐ -­‐
pant402 4888276 4888582 4888196 4889111 307 PA4360 PA4361 <>< 80 529 + + + + 0.4 -­‐ +
pant403 4893521 4893633 4893351 4893696 113 PA4365 PA4366 >?> 170 63 -­‐ -­‐ + -­‐ -­‐ -­‐ -­‐
pant404 4903327 4903450 4903297 4903465 124 PA4373 PA4374 >>> 30 15 -­‐ + -­‐ + 0.4 -­‐ -­‐
pant405 4921096 4921416 4920867 4921980 321 PA4390 PA4392 <<> 229 564 -­‐ + + -­‐ -­‐ -­‐ +
pant406 4956222 4956326 4956030 4956327 105 PA4421 PA4421.1 <<> 192 1 -­‐ + + -­‐ -­‐ -­‐ -­‐
pant407 4989152 4989259 4988892 4989304 108 PA4456 PA4457 <<> 260 45 -­‐ -­‐ + + 5.7 -­‐ -­‐
pant408 5013486 5013605 5013432 5013670 120 PA4481 PA4482 <<> 54 65 -­‐ -­‐ + -­‐ -­‐ -­‐ +
pant409 5030276 5030516 5030249 5030524 241 PA4494 PA4495 <>> 27 8 -­‐ + + -­‐ -­‐ -­‐ -­‐
pant410 5030390 5030516 5030249 5030524 127 PA4494 PA4495 <<> 141 8 -­‐ + + -­‐ -­‐ -­‐ -­‐
pant411 5031356 5031482 5031236 5031487 127 PA4495 PA4496 >>> 120 5 -­‐ + -­‐ -­‐ -­‐ -­‐ -­‐
pant412 5038743 5038856 5038676 5038900 114 PA4500 PA4501 >>> 67 44 -­‐ -­‐ + + 6.6 -­‐ -­‐
pant413 5055878 5056088 5055878 5056094 211 PA4514 PA4515 <<> 0 6 -­‐ + -­‐ -­‐ -­‐ -­‐ -­‐
pant414 5061315 5061556 5061279 5061729 242 PA4519 PA4520 <?< 36 173 -­‐ + + + 0.2 -­‐ -­‐
pant415 5080300 5080649 5080209 5080756 350 PA4539 PA4540 <<> 91 107 -­‐ + + -­‐ -­‐ -­‐ -­‐
pant416 5086761 5086889 5086697 5086924 129 PA4541 PA4541.1 >?< 64 35 -­‐ + -­‐ + 0.3 -­‐ -­‐
pant417 5091879 5091950 5091816 5091960 72 PA4544 PA4545 <>> 63 10 -­‐ + -­‐ -­‐ -­‐ -­‐ -­‐
pant418 5097463 5097563 5097463 5097596 101 PA4548 PA4549 <<> 0 33 -­‐ + + -­‐ -­‐ -­‐ -­‐
pant419 5112382 5112481 5112380 5112662 100 PA4562 PA4563 <>> 2 181 -­‐ + -­‐ -­‐ -­‐ -­‐ -­‐
pant420 5118198 5118323 5118196 5118537 126 PA4570 PA4571 >>> 2 214 -­‐ + + -­‐ -­‐ -­‐ -­‐
pant421 5141281 5141583 5141190 5141785 303 PA4590 PA4591 <<< 91 202 -­‐ + + -­‐ -­‐ -­‐ -­‐
pant422 5146428 5146671 5146404 5146906 244 PA4594 PA4595 <?< 24 235 -­‐ + + + 3.6 -­‐ -­‐
pant423 5166749 5166864 5166698 5166899 116 PA4607 PA4608 <>> 51 35 -­‐ + + + 4.3 -­‐ -­‐
pant424 5171891 5172157 5171727 5172252 267 PA4613 PA4614 <<> 164 95 -­‐ + + + 3.7 -­‐ -­‐
pant425 5174710 5174954 5174653 5174979 245 PA4616 PA4617 <?> 57 25 + -­‐ -­‐ -­‐ -­‐ -­‐ -­‐
pant426 5182285 5182374 5182269 5182578 90 PA4621 PA4622 <?> 16 204 -­‐ -­‐ + -­‐ -­‐ -­‐ -­‐
pant427 5203330 5203607 5203243 5203667 278 PA4634 PA4635 <?> 87 60 + + + + 0.2 -­‐ -­‐
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pant428 5207886 5208410 5207623 5208463 525 PA4639 PA4640 <>> 263 53 + + + -­‐ -­‐ -­‐ -­‐
pant429 5222265 5222539 5222261 5222539 275 PA4654 PA4655 <>< 4 0 -­‐ + + -­‐ -­‐ -­‐ -­‐
pant430 5224560 5224883 5224477 5224889 324 PA4656 PA4657 <?> 83 6 -­‐ + + -­‐ -­‐ -­‐ -­‐
pant431 5242663 5242905 5242560 5243177 243 PA4674 PA4675 <<> 103 272 -­‐ + + -­‐ -­‐ -­‐ -­‐
pant432 5242933 5243127 5242560 5243177 195 PA4674 PA4675 <>> 373 50 -­‐ + + -­‐ -­‐ -­‐ -­‐
pant433 5247427 5247538 5247424 5247621 112 PA4677 PA4678 <<< 3 83 -­‐ + -­‐ -­‐ -­‐ -­‐ -­‐
pant434 5248778 5248977 5248773 5249031 200 PA4679 PA4680 <<< 5 54 -­‐ + + -­‐ -­‐ -­‐ -­‐
pant435 5269263 5269463 5269260 5269802 201 PA4690.5 PA4691 <?< 3 339 -­‐ + + -­‐ -­‐ -­‐ +
pant436 5269486 5269748 5269260 5269802 263 PA4690.5 PA4691 <?< 226 54 -­‐ + + + 0.1 -­‐ -­‐
pant437 5275788 5275989 5275733 5276282 202 PA4696 PA4697 <<> 55 293 -­‐ + -­‐ -­‐ -­‐ -­‐ +
pant438 5297644 5297893 5297484 5297896 250 PA4718 PA4719 <>> 160 3 -­‐ + + -­‐ -­‐ -­‐ -­‐
pant439 5309038 5309310 5308965 5309325 273 PA4726.2 PA4727 <>> 73 15 + + + -­‐ -­‐ -­‐ -­‐
pant440 5323178 5323345 5323102 5323373 168 PA4739 PA4740 <>< 76 28 -­‐ + -­‐ + 0.3 -­‐ -­‐
pant441 5353511 5353695 5353508 5353782 185 PA4767 PA4768 <<> 3 87 -­‐ + + -­‐ -­‐ -­‐ -­‐
pant442 5355250 5355360 5355059 5355386 111 PA4769 PA4770 <>> 191 26 -­‐ + + + 0.3 -­‐ -­‐
pant443 5357104 5357204 5357076 5357229 101 PA4770 PA4771 ><> 28 25 -­‐ -­‐ + -­‐ -­‐ -­‐ -­‐
pant444 5361261 5361475 5361259 5361585 215 PA4772 PA4773 >>> 2 110 -­‐ + + + 0.2 -­‐ +
pant445 5372502 5372590 5372268 5372590 89 PA4784 PA4785 ><< 234 0 -­‐ + + -­‐ -­‐ -­‐ -­‐
pant446 5383814 5383886 5383813 5383946 73 PA4797 PA4798 <?> 1 60 -­‐ + -­‐ -­‐ -­‐ -­‐ -­‐
pant447 5391673 5391785 5391555 5391835 113 PA4805 PA4806 <>> 118 50 -­‐ + + -­‐ -­‐ -­‐ -­‐
pant448 5418130 5418343 5418125 5418350 214 PA4825 PA4826 <<< 5 7 -­‐ + + + 0.2 -­‐ -­‐
pant449 5418593 5418778 5418570 5418898 186 PA4826 PA4827 <<< 23 120 + + -­‐ + 0.3 -­‐ -­‐
pant450 5447495 5447604 5447445 5447647 110 PA4851 PA4852 >?> 50 43 -­‐ + + -­‐ -­‐ -­‐ -­‐
pant451 5472178 5472292 5472043 5472438 115 PA4874 PA4875 <?> 135 146 -­‐ + -­‐ + 3.4 -­‐ -­‐
pant452 5483773 5483927 5483769 5483987 155 PA4887 PA4888 <<< 4 60 -­‐ + + -­‐ -­‐ -­‐ -­‐
pant453 5513435 5513583 5513113 5513731 149 PA4913 PA4914 <>> 322 148 -­‐ + -­‐ + 16.7 -­‐ -­‐
pant454 5522145 5522246 5522111 5522385 102 PA4922 PA4923 <<> 34 139 -­‐ -­‐ + -­‐ -­‐ -­‐ -­‐
pant455 5563373 5563543 5563288 5563964 171 PA4957 PA4958 >?> 85 421 -­‐ + + + 2.5 -­‐ -­‐
pant456 5579547 5579621 5579500 5579652 75 PA4969 PA4970 <?< 47 31 -­‐ + -­‐ -­‐ -­‐ -­‐ -­‐
pant457 5580773 5580854 5580720 5580961 82 PA4971 PA4972 <<> 53 107 -­‐ -­‐ + -­‐ -­‐ -­‐ -­‐
pant458 5583649 5583870 5583646 5584100 222 PA4973 PA4974 <?> 3 230 + + + -­‐ -­‐ TPP -­‐
pant459 5593485 5593669 5593425 5593682 185 PA4980 PA4981 <>< 60 13 + + + -­‐ -­‐ -­‐ -­‐
pant460 5647596 5647784 5647396 5647813 189 PA5020 PA5021 >?> 200 29 -­‐ + + -­‐ -­‐ -­‐ -­‐
pant461 5654418 5654798 5654406 5654810 381 PA5023 PA5024 >?> 12 12 + + + -­‐ -­‐ -­‐ +
pant462 5689838 5689938 5689716 5689963 101 PA5050 PA5051 >?> 122 25 -­‐ + + -­‐ -­‐ -­‐ -­‐
pant463 5695214 5695341 5694948 5695365 128 PA5055 PA5056 >>> 266 24 -­‐ -­‐ + + 14.7 -­‐ -­‐
pant464 5714033 5714242 5714033 5714269 210 PA5076 PA5077 <<< 0 27 -­‐ + -­‐ -­‐ -­‐ -­‐ -­‐
pant465 5718436 5718578 5718426 5718881 143 PA5078 PA5079 <<< 10 303 -­‐ + -­‐ -­‐ -­‐ -­‐ -­‐
pant466 5718584 5718804 5718426 5718881 221 PA5078 PA5079 <?< 158 77 -­‐ + + -­‐ -­‐ -­‐ -­‐
pant467 5766271 5766371 5766148 5766483 101 PA5118 PA5119 <>> 123 112 -­‐ + -­‐ + 2.4 -­‐ -­‐
pant468 5775535 5775702 5774808 5776085 168 PA5125 PA5127 ><> 727 383 -­‐ + + + 3.6 -­‐ -­‐
pant469 5776459 5776595 5776088 5776605 137 PA5126 PA5128 <?< 371 10 -­‐ + + + 0.3 -­‐ +
pant470 5777944 5778124 5777810 5778133 181 PA5130 PA5131 <>> 134 9 -­‐ -­‐ + + 0.2 -­‐ -­‐
pant471 5790193 5790397 5790133 5790444 205 PA5141 PA5142 <?< 60 47 -­‐ + + -­‐ -­‐ -­‐ +
pant472 5803741 5803812 5803514 5803866 72 PA5155 PA5156 >?> 227 54 -­‐ + + -­‐ -­‐ -­‐ -­‐
pant473 5804955 5805202 5804803 5805205 248 PA5156 PA5157 >>> 152 3 -­‐ + + -­‐ -­‐ -­‐ -­‐
pant474 5817046 5817146 5816951 5817190 101 PA5166 PA5167 >>> 95 44 -­‐ -­‐ + + 5.0 -­‐ -­‐
pant475 5820448 5820845 5820115 5820909 398 PA5169 PA5170 >?> 333 64 + + + + 5.9 -­‐ -­‐
pant476 5825725 5826053 5825720 5826134 329 PA5173 PA5174 ><> 5 81 -­‐ -­‐ + -­‐ -­‐ -­‐ -­‐
pant477 5835909 5835984 5835896 5835993 76 PA5182 PA5183 ><> 13 9 -­‐ -­‐ + -­‐ -­‐ -­‐ -­‐
pant478 5836444 5836841 5836402 5836909 398 PA5183 PA5184 ><> 42 68 + + + -­‐ -­‐ -­‐ -­‐
pant479 5843826 5843965 5843801 5844053 140 PA5190 PA5191 <<> 25 88 -­‐ + + -­‐ -­‐ -­‐ -­‐
pant480 5853463 5853562 5853397 5853584 100 PA5200 PA5201 <<> 66 22 -­‐ + -­‐ + 2.2 -­‐ -­‐
pant481 5859468 5859660 5859457 5859792 193 PA5204 PA5205 <<> 11 132 -­‐ + -­‐ -­‐ -­‐ -­‐ -­‐
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pant482 5892668 5892830 5892661 5892909 163 PA5234 PA5235 ><> 7 79 -­‐ + + + 0.2 -­‐ -­‐
pant483 5906521 5906609 5906462 5906625 89 PA5244 PA5245 ><> 59 16 -­‐ + + -­‐ -­‐ -­‐ -­‐
pant484 5914527 5914996 5914522 5915042 470 PA5252 PA5253 <>< 5 46 + + + -­‐ -­‐ -­‐ -­‐
pant485 5924373 5924582 5924372 5924595 210 PA5262 PA5263 <?> 1 13 -­‐ + + -­‐ -­‐ -­‐ -­‐
pant486 5955066 5955166 5955056 5955179 101 PA5290 PA5291 ><> 10 13 -­‐ + -­‐ + 2.3 -­‐ -­‐
pant487 5973554 5973827 5973477 5973832 274 PA5304 PA5305 <<< 77 5 + + + -­‐ -­‐ -­‐ -­‐
pant488 5986290 5986454 5986171 5986474 165 PA5316.1 PA5317 ><> 119 20 -­‐ + + -­‐ -­‐ -­‐ -­‐
pant489 5991138 5991429 5991132 5992382 292 PA5321 PA5322 >>> 6 953 -­‐ + + -­‐ -­‐ -­‐ -­‐
pant490 5991564 5991777 5991132 5992382 214 PA5321 PA5322 >?> 432 605 -­‐ + + -­‐ -­‐ -­‐ +
pant491 5991800 5992035 5991132 5992382 236 PA5321 PA5322 >>> 668 347 -­‐ + + -­‐ -­‐ -­‐ -­‐
pant492 5995818 5995936 5995812 5996035 119 PA5324 PA5325 <?> 6 99 -­‐ + + -­‐ -­‐ -­‐ -­‐
pant493 6032310 6032385 6032269 6032386 76 PA5364 PA5365 <?< 41 1 -­‐ + + -­‐ -­‐ -­‐ -­‐
pant494 6037875 6038041 6037790 6038211 167 PA5368 PA5369 <<< 85 170 -­‐ + + -­‐ -­‐ -­‐ +
pant495 6042772 6042872 6042737 6042962 101 PA5369.2 PA5369.3 <>< 35 90 -­‐ -­‐ + + 35.1 -­‐ ++
pant496 6045008 6045246 6044744 6045309 239 PA5369.5 PA5370 <<< 264 63 -­‐ + + + 0.1 -­‐ -­‐
pant497 6051319 6051484 6051312 6051643 166 PA5374 PA5375 <?> 7 159 -­‐ + -­‐ + 2.0 -­‐ -­‐
pant498 6056431 6056684 6056414 6056876 254 PA5378 PA5379 <<> 17 192 -­‐ + + -­‐ -­‐ -­‐ -­‐
pant499 6058343 6058460 6058254 6058672 118 PA5379 PA5380 >>> 89 212 -­‐ + + -­‐ -­‐ -­‐ -­‐
pant500 6086677 6086895 6086675 6087098 219 PA5410 PA5411 <<> 2 203 -­‐ + + + 57.6 -­‐ -­‐
pant501 6125211 6125386 6125081 6125795 176 PA5440 PA5441 ><< 130 409 -­‐ -­‐ + -­‐ -­‐ -­‐ ++
pant502 6125568 6125748 6125081 6125795 181 PA5440 PA5441 ><< 487 47 -­‐ + -­‐ -­‐ -­‐ -­‐ +
pant503 6162085 6162220 6161868 6162220 136 PA5472 PA5473 <>> 217 0 -­‐ + + -­‐ -­‐ -­‐ -­‐
pant504 6167543 6167752 6167410 6167782 210 PA5476 PA5477 <>> 133 30 -­‐ + + -­‐ -­‐ -­‐ -­‐
pant505 6172877 6172977 6172874 6173347 101 PA5482 PA5483 <?> 3 370 -­‐ + + -­‐ -­‐ -­‐ -­‐
pant506 6173073 6173287 6172874 6173347 215 PA5482 PA5483 <>> 199 60 -­‐ + + -­‐ -­‐ -­‐ -­‐
pant507 6187926 6188150 6187878 6188165 225 PA5495 PA5496 >?< 48 15 -­‐ + + -­‐ -­‐ -­‐ -­‐
pant508 6211770 6212005 6211769 6212146 236 PA5518 PA5519 <<< 1 141 -­‐ + + -­‐ -­‐ -­‐ -­‐
pant509 6220755 6220874 6220740 6221100 120 PA5528 PA5529 <<> 15 226 -­‐ + + -­‐ -­‐ -­‐ -­‐
pant510 6240638 6240792 6240633 6240869 155 PA5546 PA5547 <?> 5 77 -­‐ + -­‐ + 2.9 -­‐ -­‐
pant511 6241760 6241846 6241494 6241850 87 PA5547 PA5548 ><> 266 4 -­‐ + + -­‐ -­‐ -­‐ -­‐
pant512 6259392 6259552 6259198 6259670 161 PA5565 PA5566 <>< 194 118 -­‐ + + -­‐ -­‐ -­‐ -­‐
pant513 6263613 6263715 6263565 6263804 103 PA5568 PA5569 <>< 48 89 -­‐ + + -­‐ -­‐ -­‐ -­‐
a	  The	  coordinates	  of	  the	  transcript	  predicted	  by	  RNA	  sequencing	  data.
b	  Length	  of	  the	  sRNA	  candidate	  predicted	  by	  RNA	  sequencing	  data.
c	  The	  middle	  arrow	  indicates	  the	  orientation	  of	  the	  sRNA,	  while	  the	  flanking	  arrows	  indicate	  the	  orientation	  of	  the	  adjacent	  genes.	  An	  unknown	  sRNA	  orientation	  is	  indicated	  by	  a	  question	  mark.
d	  A	  plus	  symbol	  (+)	  indicates	  that	  the	  sRNA	  is	  differentially	  expressed	  between	  the	  conditions	  tested	  in	  this	  work.
e	  The	  fold	  change	  is	  calculated	  as	  the	  ratio	  of	  the	  intensities	  of	  the	  sRNA	  between	  the	  early-­‐stationary	  and	  exponential	  conditions.	  Thus,	  a	  fold	  change	  >	  1	  indicates	  that	  the	  sRNA	  is	  more	  highly	  expressed	  in	  the	  early-­‐stationary	  than	  the	  exponential	  phase.
f	  Candidate	  sRNAs	  were	  queried	  against	  the	  Rfam	  database	  and	  matches	  to	  known	  sRNAs	  are	  indicated.
g	  The	  sequence	  conservation	  of	  candidate	  sRNAs	  in	  other	  microbial	  organisms	  was	  investigated	  using	  the	  BLASTN	  algorithm.	  (-­‐),	  	  no	  sequence	  conservation	  found;	  (+),	  sequence	  conserved	  primarily	  in	  Pseudomonadaceae;	  (++)	  sequence	  conserved	  in	  bacterial	  species
	  	  outside	  the	  Pseudomonadaceae	  family.
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Supplementary	  Table	  5.	  5´-­‐RACE	  validation	  of	  sRNA	  candidates.	  
	  
	  
Name	  
Start	  predicted	  
by	  RNA	  
sequencinga	  
Start	  
validated	  by	  
5´-­‐RACEb	  
Nt	  difference	  
between	  RNAseq	  
and	  5´-­‐RACEc	  
Directiond	  
pant44	   363166	   363154	   12	   <<<	  
pant66	   648847	   648847	   0	   <<<	  
pant217	   2627303	   2627304	   1	   <>>	  
RgsA	  (forward)	   3318747	   3318737	   10	   >><	  
RgsA	  (reverse)	   3318868	   3318870	   2	   ><<	  
pant381	   4629347	   4629347	   0	   <<>	  
pant441	   5353695	   5353695	   0	   <<>	  
pant503	   6162085	   6162085	   0	   <>>	  
	  
	  
a	  Transcript	  start	  predicted	  by	  our	  script	  based	  on	  the	  RNA	  sequencing	  data.	  
b	  Experimentally	  found	  values	  using	  5´-­‐RACE.	  
c	  Difference	  in	  nucleotides	  between	  the	  start	  of	  transcription	  predicted	  by	  RNA	  sequencing	  and	  that	  determined	  by	  5´-­‐RACE.	  
d	  The	  middle	  arrow	   indicates	   the	  orientation	  of	   the	  sRNA,	  while	   the	   flanking	  arrows	   indicate	   the	  orientation	  of	   the	  adjacent	  
genes.	  	  
	  	  	  	  
	  	  
16
83
Supplementary	  Table	  6.	  Novel	  sRNA	  candidates	  conserved	  in	  organisms	  outside	  the	  Pseudomonadaceae	  family.
Name Starta Enda
Intergenic	  
region	  
start
Intergenic	  
region	  end Length
b 5'	  flanking	  
gene
3'	  flanking	  
gene Direction
c
Detection	  
in	  Library	  
A
Detection	  
in	  Library	  
B
Detection	  
in	  Library	  
C
Differential	  
expressiond
Fold	  
changee
Rfamf Ordersg Classesh
pant42 354489 354679 354462 354753 191 PA0314 PA0315 <?> -­‐ -­‐ + + 2.6 -­‐ Burkholderiales Beta	  Proteobacteria
pant57 521960 522172 521316 522464 213 PA0460 PA0462 ><> + + + -­‐ -­‐ -­‐
Aeromonadales	  /	  Alteromonadales	  /	  Burkholderiales	  /	  unclassified	  Deltaproteobacteria	  
/	  Enterobacteriales	  /	  Oceanospirillales	  /	  Pseudomonadales	  /	  unclassified	  
Gammaproteobacteria	  (gamma	  proteobacterium	  HdN1)	  /	  Xanthomonadales
Beta	  Proteobacteria	  /	  Delta	  
Proteobacteria	  /	  Gamma	  
Proteobacteria
pant59 522753 522868 522518 523253 116 PA0461 PA0463 <>> -­‐ -­‐ + + 8.4 -­‐ Halomonas	  /	  Pseudomonas Gamma	  Proteobacteria
pant95 927232 927551 927215 927879 320 PA0847 PA0849 <?> -­‐ -­‐ + + 6.9 -­‐
Rhizobiales	  /	  Desulfovibrionales	  /	  Rhodocyclales	  /	  Gallionellales	  /	  Nitrosomonadales	  /	  
Neisseriales	  /	  Methylophilales	  /	  Oceanospirillales	  /	  Alteromonadales	  /	  Vibrionales	  /	  
Aeromonadales	  /	  Enterobacteriales	  /	  Methylococcales	  /	  Pseudomonadales
Alpha	  Proteobacteria	  /	  Beta	  
Proteobacteria	  /	  Delta	  Proteobacteria	  
/	  Gamma	  Proteobacteria
pant96 927603 927784 927215 927879 182 PA0847 PA0849 <>> -­‐ + + -­‐ -­‐ -­‐ Aeromonadales	  /	  Enterobacteriales	  /	  Neisseriales	  /	  Rhodocyclales
Beta	  Proteobacteria	  /	  Gamma	  
Proteobacteria
pant120 1204789 1205025 1204782 1205030 237 PA1112 PA1112.1 >>< + + + + 3.0 -­‐ Aeromonadales	  	  /	  Rhodocyclales	  /	  Pseudomonadales	  
	  Beta	  Proteobacteria	  /	  Gamma	  
Proteobacteria
pant138 1372693 1372804 1372683 1372978 112 PA1263 PA1264 >?< -­‐ -­‐ + -­‐ -­‐ -­‐ Aeromonadales	  /	  Burkholderiales	  /	  Xanthomonadales
	  Beta	  Proteobacteria	  /	  Gamma	  
Proteobacteria
pant144 1471942 1472164 1471673 1472546 223 PA1359 PA1361 <>< -­‐ + + -­‐ -­‐ -­‐
Burkholderiales	  /	  Caulobacterales	  /	  Enterobacteriales	  /	  Myxococcales	  /	  
Oceanospirillales	  /	  Pseudomonadales	  /	  Rhizobiales	  /	  Sphingomonadales	  /	  
Xanthomonadales
Alpha	  Proteobacteria	  /	  Beta	  
Proteobacteria	  /	  Delta	  Proteobacteria	  
/	  Gamma	  Proteobacteria
pant160 1717940 1718216 1717895 1718385 277 PA1578 PA1579 >>> + + + + 0.2 -­‐ Burkholderiales	  /	  Pseudomonadales
	  Beta	  Proteobacteria	  /	  Gamma	  
Proteobacteria
pant184 2104152 2104333 2104097 2104596 182 PA1925 PA1926 >>> -­‐ + + -­‐ -­‐ -­‐
Alteromonadales	  /	  Burkholderiales	  /	  Caulobacterales	  /	  Enterobacteriales	  /	  
Methylophilales	  /	  Myxococcales	  /	  Neisseriales	  /	  Nitrosomonadales	  /	  Oceanospirillales	  /	  
Pseudomonadales	  /	  Rhizobiales	  /	  Rhodocyclales	  /	  Sphingomonadales	  /	  
Xanthomonadales
Alpha	  Proteobacteria	  /	  Beta	  
Proteobacteria	  /	  Delta	  Proteobacteria	  
/	  Gamma	  Proteobacteria
pant185 2104397 2104580 2104097 2104596 184 PA1925 PA1926 >>> -­‐ + + + 0.3 -­‐
Alteromonadales	  /	  Burkholderiales	  /	  Methylophilales	  /	  Neisseriales	  /	  Oceanospirillales	  /	  
Pseudomonadales	  /	  Rhodocyclales
Beta	  Proteobacteria	  /	  Gamma	  
Proteobacteria
pant242 3037237 3037426 3035703 3037885 190 PA2684 PA2686 <<> -­‐ + + -­‐ -­‐ -­‐ Burkholderiales	  /	  Pseudomonas	  /	  Rhodocyclales
Beta	  Proteobacteria	  /	  Gamma	  
Proteobacteria
pant251 3094233 3094534 3094186 3094756 302 PA2733 PA2734 <?< -­‐ + + -­‐ -­‐ -­‐
Acidithiobacillales	  /	  Desulfovibrionales	  /	  Nitrosomonas	  /	  Desulfuromonadales	  /	  
Chlorobiales	  /	  Pseudomonadales	  /	  unclassified	  Gammaproteobacteria	  (gamma	  
proteobacterium	  HdN1)	  /	  Synergistales
Chlorobea	  /	  Synergistia	  /	  Beta	  
Proteobacteria	  /	  Delta	  Proteobacteria	  
/	  Gamma	  Proteobacteria
pant277 3305612 3305787 3305565 3305918 176 PA2945 PA2946 <<> -­‐ + + -­‐ -­‐ Cobalamin Rhodobacterales	  /	  Pseudomonas	  /	  Rhizobiales
Alpha	  Proteobacteria	  /	  Gamma	  
Proteobacteria
pant366 4472724 4472848 4472199 4473622 125 PA3991 PA3993 <<> -­‐ -­‐ + + 5.2 -­‐
Burkholderiales	  /	  Caulobacterales	  /	  Pseudomonadales	  /	  Rhizobiales	  /	  Rhodobacterales	  
/	  Rhodospirillales	  /	  unclassified	  Alphaproteobacteria	  (Polymorphum	  gilvum)	  /	  
Xanthomonadales
Alpha	  Proteobacteria	  /	  Beta	  
Proteobacteria	  /	  Gamma	  
Proteobacteria
pant367 4472877 4473081 4472199 4473622 205 PA3991 PA3993 <>> -­‐ + + -­‐ -­‐ -­‐
Pseudomonadaceae	  	  /	  Burkholderiales	  /	  Rhodospirillales	  	  /	  unclassified	  
Alphaproteobacteria	  (Polymorphum	  gilvum)
Alpha	  Proteobacteria	  /	  Beta	  
Proteobacteria	  /	  Gamma	  
Proteobacteria
pant390 4791760 4791860 4791725 4791950 101 PA4280.2 PA4280.3 <>< -­‐ -­‐ + + 68.3 -­‐
unclassified	  Bacteria	  (toluene-­‐degrading	  bacterium	  UCR	  026m;	  chlamydia-­‐associated	  
clinical	  samples)	  /	  Pseudomonadales	  /	  Myxococcales
Delta	  Proteobacteria	  /	  Gamma	  
Proteobacteria
pant398 4861733 4862026 4861712 4863272 294 PA4332 PA4334 <?< -­‐ + + -­‐ -­‐ -­‐
Alteromonadales	  /	  Burkholderiales	  /	  Acidobacteriales	  /	  Chromatiales	  /	  Gallionellales	  /	  
Oceanospirillales	  /	  Pseudomonadales	  /	  Rhodocyclales	  /	  Xanthomonadales
Acidobacteria	  /	  Beta	  Proteobacteria	  /	  
Gamma	  Proteobacteria
pant399 4862054 4862348 4861712 4863272 295 PA4332 PA4334 <>< -­‐ + + + 0.4 -­‐
Aeromonadales	  	  /	  Burkholderiales	  	  /	  Chromatiales	  	  /	  Neisseriales	  	  /	  Pseudomonadales	  	  /	  
Rhizobiales	  	  /	  Rhodocyclales	  	  /	  Sphingomonadales	  	  /	  unclassified	  Betaproteobacteria	  
(Candidatus	  Accumulibacter)	  /	  Xanthomonadales	  
Alpha	  Proteobacteria	  /	  Beta	  
Proteobacteria	  /	  Gamma	  
Proteobacteria
pant400 4862626 4863181 4861712 4863272 556 PA4332 PA4334 <>< + + + -­‐ -­‐ -­‐
Burkholderiales	  /	  Chromatiales	  /	  Neisseriales	  /	  Oceanospirillales	  /	  Pseudomonadales	  /	  
Rhodocyclales	  /	  Sphingomonadales	  /	  Xanthomonadales
Alpha	  Proteobacteria	  /	  Beta	  
Proteobacteria	  /	  Gamma	  
Proteobacteria
pant495 6042772 6042872 6042737 6042962 101 PA5369.2 PA5369.3 <>< -­‐ -­‐ + + 35.1 -­‐
unclassified	  Bacteria	  (toluene-­‐degrading	  bacterium	  UCR	  026m	  /	  chlamydia-­‐associated	  
clinical	  samples)	  /	  Pseudomonadales	  /	  Myxococcales
Delta	  Proteobacteria	  /	  Gamma	  
Proteobacteria
pant501 6125211 6125386 6125081 6125795 176 PA5440 PA5441 ><< -­‐ -­‐ + -­‐ -­‐ -­‐ Burkholderia	  /	  Aeromonadales	  	  /	  Pseudomonas
Delta	  Proteobacteria	  /	  Gamma	  
Proteobacteria
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a	  Transcript's	  coordinates	  predicted	  by	  the	  RNA	  sequencing	  data.
b	  	  Length	  of	  the	  sRNA	  candidate	  	  predicted	  by	  the	  RNA	  sequencing	  data.
c	  The	  middle	  arrow	  indicates	  the	  orientation	  of	  the	  sRNA,	  while	  the	  flanking	  arrows	  indicate	  the	  orientation	  of	  the	  adjacent	  genes.	  Unknown	  orientation	  of	  sRNAs	  is	  indicated	  by	  a	  question	  mark.
d	  A	  +	  indicates	  that	  the	  sRNA	  is	  differentially	  expressed	  between	  the	  conditions	  tested	  in	  this	  work.
e	  The	  fold	  change	  indicates	  the	  ratio	  of	  the	  intensities	  of	  the	  sRNA	  between	  the	  early-­‐stationary	  and	  exponential	  conditions.	  Thus,	  a	  number	  higher	  than	  1	  indicates	  that	  the	  sRNA	  is	  more	  expressed	  in	  the	  early-­‐stationary	  than	  the	  exponential	  phase.
f	  Candidate	  sRNAs	  was	  queried	  against	  the	  Rfam	  database;	  matches	  to	  known	  sRNAs	  are	  indicated.
g	  Orders	  of	  the	  bacteria	  in	  which	  the	  sequence	  of	  the	  sRNA	  candidate	  was	  found	  to	  be	  conserved.
h	  Classes	  of	  the	  bacteria	  in	  which	  the	  sequence	  of	  the	  sRNA	  candidate	  was	  found	  to	  be	  conserved.
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Supplementary	  Table	  7.	  Cut-­‐offs	  used	  for	  the	  detection	  of	  novel	  transcripts.	  	  
Library	   Coverage	  at	  each	  base	   Average	  expression	  
LIB>100	   >20	   >40	  
LIB<500	   >35	   >70	  
LIB<200	   >50	   >100	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Supplementary	   Figure	   1.	  Agilent	  Bioanalyzer	   analysis	   of	   total	   and	   rRNA-­‐depleted	  
RNA.	  
	  
The	   23S,	   16S	   and	   5S	   rRNAs	   were	   removed	   from	   the	   total	   RNA	   (A)	   by	   subtractive	  
hybridization	   as	   described	   in	   the	   Experimental	   Procedures.	   Note	   that	   the	   peaks	  
corresponding	   to	   23S,	   16S	   and	   5S	   rRNAs	   are	   not	   present	   in	   the	   rRNA-­‐depleted	  
sample	  (B).	  The	  peaks	  marked	  with	  asterisks	  (*)	  probably	  correspond	  to	  tRNAs	  and	  
sRNA	  species	  shorter	  than	  120	  nt.	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ABSTRACT  
 
Small regulatory RNAs (sRNAs) in bacteria are known to modulate gene expression and 
control a variety of processes including metabolic reactions, stress responses and 
pathogenesis in response to environmental signals. A method to identify bacterial sRNAs 
on a genome-wide scale based on RNA sequencing (RNA-seq) is described that involves 
the preparation and analysis of three different sequencing libraries. As a significant number 
of unique sRNAs are identified in each library, the libraries can either be used alone or in 
combination to increase the number of sRNAs identified.  The approach may be applied to 
identify sRNAs in any bacterium under different growth and stress conditions. 
 
 
1. INTRODUCTION 
 
Small RNAs (sRNAs) in bacteria play important regulatory roles in controlling various 
physiological processes such as carbon metabolism, iron homeostasis, and virulence in 
response to environmental cues. Bacteria contain hundreds of sRNAs that exist as a 
heterogeneous group of transcripts with a typical size range of 70 to 500 nucleotides (nt) 
(1,2). Many sRNAs function by affecting the expression of mRNA targets via base-pairing, 
while others act by binding to proteins and altering their activity. The base-pairing sRNAs 
fall into two broad classes: cis-encoded antisense sRNAs and trans-encoded sRNAs. The 
former are encoded on the DNA strand opposite the target RNA and therefore have perfect 
complementarity with their targets. Trans-encoded sRNAs are encoded in intergenic 
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 regions and often have multiple targets with which there is only limited complementarity.  
Despite the fact that some bacterial sRNAs have been known for some time, earlier studies 
to identify these RNAs have often depended on serendipity, direct detection due to high 
abundance, protein copurification, and computational predictions based on sequence 
conservation (3). Recent efforts to identify sRNAs on a genome-wide scale have been 
based mainly on the extremely sensitive, probe-independent RNA sequencing approach 
(RNA-seq) that has revolutionized the field and led to the discovery of hundreds of novel 
sRNAs in diverse bacteria (4,5).  
 
We have recently developed a robust RNA-seq method and used it to identify over 500 
novel sRNAs in P. aeruginosa (6).  The approach is based on three different sequencing 
libraries prepared from different RNA populations that can either be used alone or in 
combination to increase the number of identified sRNAs. In order to enrich the RNA 
samples for sRNA detection, ribosomal RNAs (23S, 16S and 5S rRNAs) are depleted from 
the total RNA. One of the libraries (LIB>100) is prepared using a standard RNA-seq 
protocol for full transcriptomes and contains information on all mRNAs transcribed by the 
bacteria. The other two libraries (LIB<500 and LIB<200) are prepared from size-selected 
RNA containing transcripts shorter than 500 and 200 nt, respectively. A significant number 
of unique sRNAs are detected in each library, suggesting that the set of identified RNAs 
obtained depends strongly on the specific library preparation strategy used (6).  The 
detailed experimental procedures to prepare the three sequencing libraries are described in 
the first sections of the chapter. 
 
Using RNA-seq allows counting the number of reads that align to specific parts of a 
genome, producing results similar to those of gene expression microarrays. While the end 
results are similar, the informatic challenges of analyzing RNA-seq data are fundamentally 
different than those of analyzing microarrays. Although there are several ways in which 
RNA-seq data can be analyzed, our analysis pipeline to find novel P. aeruginosa intergenic 
and antisense sRNAs is detailed in the latter sections of this chapter.   
 
 
2. MATERIALS (see Note 1) 
 
2.1 General materials and equipment 
 
1. Disposable, nuclease-free pipette tips with filter, 1.5-mL microcentrifuge tubes, 15-
mL conical tubes. 
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 2. RNase-ZAP (Ambion) to remove ribonuclease (RNase) contamination from glass 
and plastic (see Note 1). 
3. Glycogen (5 mg/mL) (Ambion). 
4. Nuclease-free water (not DEPC-treated water). 
5. TE buffer (10 mM Tris-HCl, pH 7, 1 mM EDTA). 
6. 100% and 70% Ethanol. 
7. Phase-Lock Gel tubes, Heavy, 2 mL (5 PRIME). 
8. 3 M Sodium acetate (NaOAc), pH 5.5 (Ambion). 
9. PCI (Phenol:Chloroform:Isoamyl Alcohol) solution (25:24:1, v/v). 
10. RiboLock RNase inhibitor (40 U/µL) (Thermo Scientific). 
11. Microcentrifuges (room temperature and 4ºC), centrifuge (4ºC). 
12. Vortexer. 
13. Heat block. 
14. Bioanalyzer (Agilent). 
15. RNA 6000 Nano Kit (Agilent).  
16. Qubit® Fluorometer (Invitrogen). 
17. Qubit® dsDNA HS or BR Assay Kit.  
18. Qubit® RNA Assay Kit. 
19. Low-volume spectrophotometer, for example the Nanodrop (Thermo Fisher 
Scientific). 
 
2.2 Preparation of total RNA 
 
1. Isopropanol. 
2. Trizol (Invitrogen). 
3. Chloroform. 
4. Phenol. 
5. Deoxyribonuclease (DNase) I, nuclease-free (1 U/µL) (Thermo Scientific). 
 
2.3 Depletion of ribosomal RNAs (rRNAs) 
 
1. MICROBExpress™  Bacterial mRNA Enrichment Kit (Ambion).  
2. DynaMag-2 Magnet (Invitrogen). 
3. HPLC-purified 5S oligo:  
5’-AAAAAAAAAAAAAAAAAAGCGTTTCACTTCTGAGTTCGGCA-3’ 
 
2.4 Size selection of transcripts shorter than 500 nt (for LIB<500 library) 
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1. Mini-PROTEAN Electrophoresis System for vertical gel electrophoresis (Bio-Rad). 
2. 10% Mini-PROTEAN TBE-Urea Gel (Bio-Rad, cat no. 456-6033). This is a precast 
10% polyacrylamide gel (10-well, 30 µL well capacity) for use with the Mini-
PROTEAN system (see Note 2). 
3. Gel Loading Buffer II: 95% Formamide, 18mM EDTA, 0.025% SDS, 0.025% Xylene 
Cyanol, 0.025% Bromophenol Blue (Ambion). 
4. Nuclease-free, sterile 10X TBE solution: 890 mM Tris base, 890 mM boric acid, 20 
mM EDTA, pH 8.0. From this stock prepare 1xTBE solution. 
5. 0.4 M sodium chloride (NaCl) solution. 
6. Low range ssRNA ladder (New England Biolabs). 
7. 5 µm filter tube (IST Engineering). 
8. Gel Breaker tube (IST Engineering). 
9. Sterile scalpel blade. 
10. SYBR Gold Nucleic Acid Gel Stain (Invitrogen). 
11. Tube shaker or rotator. 
12. Safe Imager 2.0 Blue Light Transilluminator (Invitrogen) or similar 
 
2.5 Library-specific RNA preparation steps  
 
1. mirVana™ miRNA Isolation Kit (Ambion) (for LIB<200 library). 
2. Tobacco Acid Pyrophosphatase (Epicentre) (for LIB<500 and LIB<200 libraries). 
3. RNase III (Invitrogen) (for LIB<500 library). 
 
2.6 Library preparation 
 
2.6.1 Library preparation (all libraries)  
 
1. Magnetic Stand-96 (Ambion). 
2. 96-well thermal cycler. 
3. 10-µL, 200-µL, and 1000-µL multichannel pipettes. 
4. Agencourt AMPure XP 60 mL kit (Beckman Coulter Genomics). 
5. 96-well 250-µL PCR plates and caps for PCR strips compatible with the plates. 
6. 8-well PCR strip tubes and caps. 
7. SuperScript II Reverse Transcriptase (Invitrogen). 
8. 10 mM Tris-Cl, pH 8.5, solution containing 0.1% Tween 20. 
9. Microplate centrifuge. 
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2.6.2 Library preparation (for LIB>100 library) 
 
1. TruSeq™  RNA Sample Preparation Kit v2 (Illumina) (see Notes 3 and 4). 
2. DNA 1000 kit (Agilent). 
 
2.6.3 Library preparation (for LIB<500 and LIB<200 libraries) 
 
1. TruSeq™  Small RNA Sample Preparation Kit (Illumina) (see Notes 3 and 5). 
2. T4 RNA Ligase 2, truncated (New England Biolabs). 
3. High Sensitivity DNA kit (Agilent). 
 
2.7 List of programs used 
 
The programs referred to in the data analysis pipeline are listed below with name, version, 
and URL: 
1. Flexbar v2.2, http://sourceforge.net/projects/theflexibleadap/ 
2. Bowtie 2, http://bowtie-bio.sourceforge.net/bowtie2/index.shtml 
3. SAMtools v1.4, http://samtools.sourceforge.net/ 
4. Tablet v1.12.08.29, http://bioinf.scri.ac.uk/tablet/ 
 
3. METHODS 
 
A general scheme of the method is illustrated in Figure 1, and the library characteristics are 
summarized in Table 1. The libraries prepared in this protocol are compatible with the 
Illumina technology (see Note 6). The sequencing libraries are called LIB>100, LIB<500, 
and LIB<200 to indicate the transcript sizes in nucleotides that are not excluded from each, 
but all transcripts in these size ranges are not necessarily detected in the corresponding 
library.  
 
Table 1. Library characteristics. 
 
 
 
 
Library LIB>100 Library LIB<500 Library <200
>100 nt <500 nt <200 nt
Divalent cations RNase III No
No Yes Yes
Length of transcripts sequenced
Fragmentation
Strand specificity 
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The three libraries were prepared with different RNA populations isolated from bacterial 
total RNA. Library LIB>100 contains information corresponding to all transcripts in the cell, 
with the exception of rRNAs and transcripts shorter than 100 nt. This library was prepared 
using a standard RNA-seq protocol and is suitable for analyzing full transcriptomes. 
Although many known sRNAs are roughly 100 nt in length, transcripts shorter than 100 nt 
are not represented in this library because the corresponding cDNA fragments are not 
retained during the protocol. Size-selected RNA shorter than 500 and 200 nt and depleted 
of 5S rRNA was used to prepare the LIB<500 and LIB<200 libraries, respectively. As these 
libraries were prepared from RNA that does not include longer transcripts, they are 
enriched for information on sRNAs and thus more sensitive for sRNA detection compared 
to the LIB>100 library that contains information on the full transcriptome (6). Fragments 
corresponding to transcripts shorter than 100 nt are retained in the LIB<500 and LIB<200 
libraries because specific adapters are ligated to the 5´- and 3´-ends of RNAs prior to cDNA 
synthesis. In addition, they are strand-specific, which means that the information about the 
strand from which the transcripts are transcribed is retained. Furthermore, treatment of 
RNA used to prepare the LIB<500 and LIB<200 libraries ensures the inclusion of primary 
transcripts containing a 5´-triphosphate (see Note 7).  
 
The library preparation protocols also differ in terms of whether they include fragmentation 
steps. In order to be compatible with the relatively short read-lengths of the Illumina 
sequencing technology, long RNA molecules must be cleaved into shorter fragments. 
Therefore, the protocols for preparation of the LIB>100 and LIB<500 libraries include 
fragmentation steps using divalent cations and RNase III, respectively. Library LIB<200 
does not have any fragmentation-associated biases because the short RNAs used to 
prepare the library obviate the need for a fragmentation step. 
  
In sections 3.12 to 3.17, we describe a high-throughput bioinformatics pipeline for the 
analysis of RNA-Seq. The objectives of the pipeline are to detect transcripts and to quantify 
their relative abundance between different samples. Our pipeline is designed for use on 
organisms where an annotated reference genome exists, and as input uses the quality-
filtered and de-multiplexed sequencing reads obtained as output from sequencing centers 
(i.e. reads that are already in or can be converted to the FASTQ-format). Specifically, the 
pipeline was tested on 100-bp paired-end Illumina HiSeq2000 reads obtained from cDNA-
libraries prepared from cultures of Pseudomonas aeruginosa PAO1 (6).  
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Figure 1. Library preparation scheme. Steps involved in the preparation of the different 
sequencing libraries (LIB>100, LIB<500 and LIB<200). 
 
3.1 Cell Growth and Harvest 
 
1. Prepare a 15-mL conical tube with 2 mL of the STOP solution (95% ethanol, 5% 
phenol). Pre-chill on ice. 
2. Dilute an overnight bacterial culture in 50-100 volumes of growth medium. 
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 3. When the desired OD600 is reached, transfer 10 mL of culture into the 15-mL conical 
tube with the STOP solution. 
4. Vortex thoroughly for 15 s. Incubate at room temperature for 5 min. 
5. Pellet the bacteria by centrifugation (3,500 x g, 10 min, 4ºC). Remove the supernatant. 
6. Dissolve the pellet in 1 mL Trizol by pipetting (see Notes 8 and 9). Incubate at room 
temperature for 5 min. 
7. Proceed to RNA extraction (section 3.2) or store at -80ºC. The homogenized samples 
can be stored at -80ºC for at least one month.  
 
3.2 RNA extraction 
 
1. Spin down the Phase-Lock Gel (PLG) at 12,000-16,000 x g for 30 s. 
2. Transfer the homogenized sample to the PLG tube. 
3. Add 200 µL of chloroform (work inside a fume hood). Shake vigorously for 30 s (do not 
vortex). 
4. Incubate at room temperature for 2 min. 
5. Centrifuge at 12,000-16,000 x g for 5 min at room temperature. The PLG will form a 
barrier between the aqueous and organic phases. 
6. Transfer 500 µL of the aqueous phase to a clean 1.5-mL tube. 
7. Add 400 µL isopropanol, mix and incubate for 10 min at room temperature. 
8. Pellet the RNA by centrifugation (14,500 x g, 10 min, 4ºC). Remove the supernatant.  
9. Wash the RNA pellet by adding 500 µL ice-cold 75% ethanol and vortex briefly. 
10. Pellet the RNA by centrifugation (14,500 x g, 5 min, 4ºC). Remove the supernatant 
(see Note 10). 
11. Repeat the last two steps for a total of two washes with ethanol. It is important to 
remove the ethanol completely at the end of the second wash. 
12. Air-dry the pellet at room temperature for 5 min by leaving the tube lid open.  
13. Dissolve the RNA pellet in 100 µL of nuclease-free water. 
14. Incubate at 65ºC with shaking for 5 min. 
15. Proceed to DNase I treatment (section 3.3) immediately or store at -80ºC. 
 
3.3 Treatment with DNase I 
 
1. Add to RNA sample (100 µL): 
 1 µL RiboLock RNase inhibitor (40 U/µL) 
 40 µL 10X DNase I reaction buffer with MgCl2 
 219 µL nuclease-free water 
97
  40 µL DNase I 1U/µL                         
 400 µL total volume 
2. Mix by gently pipetting the entire volume ten times.  
3. Incubate at 37ºC for 30 min. 
4. Spin down the Phase-Lock Gel (PLG) at 12,000-16,000 x g for 30 s. 
5. Transfer the reaction mixture to the PLG tube. 
6. Add 400 µL PCI solution. 
7. Shake vigorously for 30 s (do not vortex). 
8. Centrifuge at 12,000-16,000 x g for 5 min at room temperature. 
9. Transfer the aqueous phase to a clean 1.5-mL tube (volume should be approximately 
400 µL). 
10. Precipitate the RNA by adding 0.02 volume glycogen (5 mg/mL), 0.1 volume 3 M 
NaOAc pH 5.5, and 2.5 volumes of 100% ethanol (ice-cold). Precipitate at -20ºC for at 
least one hour. At this point, the RNA can be stored at -20ºC or -80ºC (see Note 10). 
Pellet the RNA by centrifugation (14,500 x g, 30 min, 4ºC) and remove the supernatant. 
Recover the RNA as described in steps 9-12 of section 3.2. 
11. Resuspend in 50 µL TE buffer. 
12. Check the concentration and purity of the RNA sample using a low volume 
spectrophotometer (see Note 11). Check the quality of the RNA with a RNA 6000 Nano 
chip on the Bioanalyzer (see Note 12). The RNA profile should appear similar to that in 
Figure 2A. Proceed to the next step immediately (see Figure 1) or store at -80ºC. 
 
3.4 Size selection of transcripts shorter than 500 nt (LIB<500 library) 
 
Denaturing polyacrylamide-urea gels are used in order to size-select transcripts shorter 
than 500 nt (see Note 2). 
 
1. Prior to sample loading the gels are pre-run in 1X TBE at 300V for 30 minutes. 
2. Combine on ice total RNA (up to 150 µg) in a maximum volume of 30 µL with one 
volume of Gel Loading Buffer II. Each sample is loaded onto two lanes of the gel. 
3. For each lane containing the marker, combine on ice: 
 6 µL of Low Range ssRNA Ladder (3 µg) 
 4 µL nuclease-free water 
 10 µL Gel Loading Buffer II 
 20 µL total volume 
4. Incubate the RNA and marker at 65ºC for 5 minutes just prior to loading them onto the 
gel. 
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 5. Clean the wells of the gel with a syringe containing 1X TBE buffer. 
6. For each RNA sample load equal volumes into two adjacent wells on the gel. Leave an 
empty lane next to the RNA ladder and also between different samples. 
7. Run the gel at 200 V for 35 minutes. 
8. Stain the gel by soaking it in 50 mL 1X TBE with 5 µL of SYBR Gold Nucleic Acid Gel 
Stain at room temperature for 30 min. Use a nuclease-free container that is protected 
from light. 
9. Place the 0.5-mL Gel Breaker tube into a 2-mL microcentrifuge tube. 
10. Visualize the RNA and cut out the gel containing RNA between 50 and 500 nt by 
comparison with the bands of the RNA ladder. 
11. Place the gel pieces corresponding to the same sample into the 0.5-mL Gel Breaker 
tube. 
12. Centrifuge the stacked tubes (20,000 x g, 2 min, room temperature) to move the gel 
through the holes and into the 2-mL tube. Ensure that all of the gel has moved into the 
bottom tube. 
13. Add 400 µL 0.4 M NaCl solution to the gel debris. 
14. Elute the RNA by rotating or shaking the tube overnight at room temperature. 
15. Transfer the eluate and the gel debris to the top of a 5-µm filter tube. 
16. Centrifuge the filter at 600 x g for 10 s. Discard the filter and retain the eluate which 
contains the RNA. 
17. Precipitate the RNA by following step 10 under section 3.3 Treatment with DNase I. 
18. Resuspend in 20 µL TE buffer. 
19. Quantitate the yield of the rRNA-depleted RNA using the Qubit® RNA Assay Kit on the 
Qubit® Fluorometer (Invitrogen), or a low-volume spectrophotometer (see Note 11). 
Check the quality of the RNA with a RNA 6000 Nano chip on the Bioanalyzer (see Note 
12). The profile of the RNA obtained should be similar to that depicted in Figure 2C.  
20. Proceed to the 5S rRNA depletion (section 3.7) immediately or store at -80ºC. 
 
3.5 Size selection of transcripts shorter than 200 nt (LIB<200 library) 
 
The mirVana™ miRNA Isolation Kit.from Ambion (Part Number 1560M Rev. C January 
2011 / http://tools.invitrogen.com/content/sfs/manuals/fm_1560.pdf) can be used to select 
for sRNAs shorter than 200 nt (see Note 13).  
1. Follow the protocol described in section IV. Additional Procedures. A. Isolation of Small 
RNAs from Total RNA Samples of the kit manual to obtain a 100 µL solution containing 
the sRNAs ≤ 200 nt. 
2. Precipitate the RNA by following step 10 from section 3.3 Treatment with DNase I. 
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 3. Resuspend the RNA in 20 µL TE buffer. 
4. Quantitate the yield of the rRNA-depleted RNA using the Qubit® RNA Assay Kit on the 
Qubit® Fluorometer (Invitrogen), or a low-volume spectrophotometer (see Note 11). 
Check the quality of the RNA with a RNA 6000 Nano chip on the Bioanalyzer (see Note 
12). The profile of the RNA obtained should be similar to that depicted in Figure 2C.  
5. Proceed to the 5S rRNA depletion (section 3.7) immediately or store at -80ºC. 
 
3.6 Depletion of 23S, 16S and 5S rRNAs (LIB>100 library) 
 
After obtaining total RNA, the next step is to deplete abundant rRNAs from the sample. 
Bacterial total RNA consists of approximately 86% rRNA (7). Removal of rRNA significantly 
increases the fraction of mRNAs and sRNAs in the sample, allowing higher sequencing 
coverage and more sensitive detection of novel transcripts. Although the 
MICROBExpress™ Bacterial mRNA Enrichment Kit from Ambion is used here (Part 
Number 1905M Rev. C January 2011 / 
http://tools.invitrogen.com/content/sfs/manuals/fm_1905.pdf), there are other commercially 
available kits to deplete rRNA (see Note 14). The MICROBExpress™  Kit is designed to 
enrich bacterial mRNA (including sRNAs) from purified total RNA by removing the 16S and 
23S rRNAs via a subtractive hybridization approach.  
 
The MICROBExpress™  Kit is followed with the following two modifications: an additional 
oligo is employed to remove 5S rRNA and 25% more magnetic beads are used. The 
modifications needed to remove the 23S, 16S and 5S rRNAs in a single step are described 
below. 
 
1. Using the concentration obtained by the spectrophotometer, calculate the volume of 
sample that contains 2-10 µg of RNA (see Note 15). The recommended maximum 
amount of RNA per reaction is 10 µg and the recommended maximum volume is 15 
µL. If the recommended maximum amount of total bacterial RNA is exceeded, then 
rRNA removal will be incomplete. 
2. Follow the protocol detailed in Section B Anneal RNA and Capture Oligonucleotide Mix 
of the kit manual.  
3. After step B.2, add 1 µL of the HPLC-purified 5S oligo (20 µM). Continue the protocol 
from step B.3. 
4. In step C.1, remove 62.5 µL of Oligo MagBeads for each RNA sample, corresponding 
to 25% more beads per sample. The reason for this is that adding the HPLC-purified 
5S oligo results in a 25% increase in capture oligos. We have successfully processed 
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 Oligo MagBeads for up to 10 samples (625 µL) in a single 1.5-mL tube. Continue the 
protocol from step C.2. 
5. In step D.2, add 62.5 µL of the prepared Oligo MagBeads to the RNA/Capture Oligo 
Mix and incubate at 37ºC for 15 min. Continue the protocol from step D.3. 
6. In step E.2, resuspend the RNA pellet in 25 µL of nuclease-free water. Do not 
resuspend in TE buffer. Continue the protocol from step E.3 (but do not perform step 
E.4, as this removes sRNAs). 
7. Quantitate the yield of the rRNA-depleted RNA using the Qubit® RNA Assay Kit on the 
Qubit® Fluorometer (Invitrogen). Check the quality of the RNA with a RNA 6000 Nano 
chip on the Bioanalyzer. The profile of the RNA obtained should be similar to that 
depicted in Figure 2D.  
8. Proceed to the LIB>100 library preparation immediately (section 3.10) or store at -
80ºC. 
 
3.7 Depletion of 5S rRNA after size selection (LIB<500 and LIB<200 libraries) 
 
Although the 23S and 16S rRNAs are depleted from the samples after the size selection 
step, a significant fraction of the sample now consists of 5S rRNA. In order to deplete 5S 
rRNA, the MICROBExpress™  Kit manual (Part Number 1905M Rev. C January 2011 / 
http://tools.invitrogen.com/content/sfs/manuals/fm_1905.pdf) is followed with the 
modification that the HPLC-purified 5S oligo is added as the only Capture Oligo as 
described below. 
 
1. Using the concentration obtained by the spectrophotometer, calculate the volume 
of sample that contains 2-10 µg of RNA (see Note 15). The recommended 
maximum amount of RNA per reaction is 10 µg and the recommended maximum 
volume is 15 µL. If the recommended maximum amount of total bacterial RNA is 
exceeded, then rRNA removal will be incomplete. 
2. Follow the protocol detailed in Section B Anneal RNA and Capture Oligonucleotide 
Mix of the kit manual. In step B.2, add 4 µL of the HPLC-purified 5S oligo (20 µM), 
but do not add 4 µl of Capture Oligo Mix. Continue the protocol from step B.3. Do 
not add the Capture Oligo Mix included in the kit, as this contains oligos 
complementary to 23S and 16S rRNAs. 
3. In step E.2, resuspend the RNA pellet in 25 µL of nuclease-free water. Do not 
resuspend in TE buffer. Continue the protocol from step E.3 (but do not perform 
step E.4, as this removes sRNAs). 
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 4. Quantitate the yield of the rRNA-depleted RNA using the Qubit® RNA Assay Kit on 
the Qubit® Fluorometer (Invitrogen). Check the quality of the RNA with a RNA 6000 
Nano chip on the Bioanalyzer. The profile of the RNA obtained should be similar to 
that depicted in Figure 2D.  
5. Proceed to the Tobacco Acid Pyrophosphatase treatment (section 3.8) immediately 
or store at -80ºC. 
 
 
Figure 2. Typical size profiles of RNA samples. All profiles correspond to RNA extracted from P. 
aeruginosa PAO1 cells analyzed with the RNA 6000 Nano chip on the Bioanalyzer (Agilent). A. Total 
RNA extracted with Trizol and treated with DNase I. B. Total RNA extracted with the NucleoSpin 
RNA II kit (Macherey Nagel) and treated with DNase I. C. Size-selected RNA (<500 nt) purified on a 
denaturing polyacrylamide-urea gel. D. An rRNA-depleted sample. The 23S (2891 nt), 16S (1536 nt) 
and 5S (120 nt) rRNAs were removed from the total RNA by subtractive hybridization as described in 
the Materials and Methods sections. The peaks marked with asterisks (*) correspond to tRNAs and 
sRNA species shorter than 120 nt. 
 
 
3.8 Treatment with Tobacco Acid Pyrophosphatase (LIB<500 and LIB<200 libraries) 
 
After size-selection of RNA (used to prepare LIB<500 or LIB<200 libraries), the RNA is 
treated with Tobacco Acid Pyrophosphatase (TAP). TAP is used to convert 5′-triphosphate 
RNA into 5′-monophosphate RNA. This step is necessary to ensure that primary transcripts 
(containing a 5′-triphosphate) are ligated to adapters during the library preparation.  
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 1. Assemble the reaction in a PCR tube on ice in the order given: 
17 µL Size-selected RNA (up to 10 µg) diluted in nuclease-free water 
2 µL 10X TAP Reaction Buffer 
1 µL TAP (10 U/ µL)  
20 µL total volume 
2. Pipet up and down a few times to mix. Incubate at 37ºC for one hour. 
3. Spin down the Phase-Lock Gel (PLG) at 12,000-16,000 x g for 30 s. 
4. Transfer the sample to the PLG tube. 
5. Add 130 µL nuclease-free water. 
6. Add 150 µL PCI solution. 
7. Shake vigorously for 30 s (do not vortex). 
8. Centrifuge at 12,000-16,000 x g at room temperature for 5 min. 
9. Transfer the aqueous phase to a clean 1.5-mL tube (the volume should be 
approximately 150 µL). 
10. Precipitate the RNA by following step 10 from section 3.3 Treatment with DNase I. 
11. Resuspend in 15 µL nuclease-free water. 
12. Quantitate the yield of the RNA using the Qubit® RNA Assay Kit on the Qubit® 
Fluorometer (Invitrogen). Check the quality of the RNA with a RNA 6000 Nano chip on 
the Bioanalyzer. The profile of the RNA obtained should be similar to that depicted in 
Figure 2D. 
13. Proceed to the next step immediately (see Figure 1) or store at -80ºC.  
 
3.9 Fragmentation with RNase III (LIB<500 library) 
 
During preparation of the LIB<500 library, the size-selected RNA needs to be fragmented 
after the TAP treatment. The fragmentation is performed with RNase III, which cleaves long 
double-stranded RNA (dsRNA) into shorter dsRNAs containing 5'-PO4, and 3'-OH termini, 
and a 3' dinucleotide overhang. The fragmentation procedure should produce a distribution 
of RNA fragment sizes from 35 nt to several hundred nucleotides, where the average size is 
100–200 nt. 
 
1. Assemble the reaction in a microcentrifuge tube on ice in the order given: 
32 µL RNA (2 µg, from step 13, section 3.8) diluted in nuclease-free water 
4 µL 10X RNase III Buffer 
4 µL RNase III  
40 µL total volume 
2. Pipet up and down a few times to mix. Incubate at 37ºC for 10 min. 
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 3. Immediately after the incubation, add 110 µL of nuclease-free water and place the 
fragmented RNA on ice.  
4. Spin down the Phase-Lock Gel (PLG) at 12,000-16,000 x g for 30 s. 
5. Transfer the sample to a PLG tube. 
6. Add 150 µL PCI solution. 
7. Shake vigorously for 30 s (do not vortex). 
8. Centrifuge at 12,000-16,000 x g for 5 min at room temperature. 
9. Transfer the aqueous phase to a clean 1.5-mL tube (the volume should be 
approximately 150 µL). 
10. Precipitate the RNA by following step 10 from section 3.3 Treatment with DNase I. 
11. Resuspend in 15 µL nuclease-free water. 
12. Quantitate the yield of the fragmented RNA using the Qubit® RNA Assay Kit on the 
Qubit® Fluorometer (Invitrogen). Check the quality of the RNA with a RNA 6000 Nano 
chip on the Bioanalyzer. The profile of the RNA obtained should be similar to that 
depicted in Figure 2D. Proceed to the LIB<500 library preparation (section 3.11) 
immediately, or store at -80ºC. 
 
3.10 Library Preparation for full transcriptome sequencing (LIB<100 library) 
 
The LIB>100 library has been prepared with the Illumina TruSeq™ RNA Sample 
Preparation Kit v2 (Part Number 15026495 Rev. D September 2012 / 
http://support.illumina.com/documents/MyIllumina/b386d5c9-c919-48db-bdc1-
8a687ba2a101/TruSeq_RNA_SamplePrep_v2_Guide_15026495_D.pdf) (see Notes 3 and 
4) with some modifications that are explained below. Read the Best Practices section of the 
manual carefully. We perform the Low Sample (LS) protocol. If only 2-4 samples are to be 
pooled, read the Pooling Guidelines section of the manual. 
 
1. Start the protocol with 100-400 ng of rRNA-depleted RNA, diluted in a maximum 
volume of 5 µL nuclease-free water (see Note 15).  
2. Add 13 µL Elute, Prime, Fragment Mix to the sample. 
3. Continue the protocol from step Incubate RFP (included in section Purify and Fragment 
RNA). Perform all the steps included in sections Incubate RFP, Synthesize First Strand 
cDNA, Synthesize Second Strand cDNA, Perform End Repair, Adenylate 3’ Ends, 
Ligate Adapters and Enrich DNA Fragments (see Note 16). At this point the amplified 
libraries are in a 30 µL volume. 
4. Quantify the libraries using the Qubit® dsDNA HS or BR Assay Kit on the Qubit® 
Fluorometer (Invitrogen) (see Note 17). 
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 5. Check the size and purity of the sample by running a DNA 1000 chip on the 
Bioanalyzer. The final product should be a broad band with an average size of 
approximately 260 bp (see Figure 3A).  
6. Adjust the concentration of the libraries to 10 nM using a 10 mM Tris-Cl  (pH 8.5) 
solution containing 0.1% Tween 20. 
7. Combine 10 µL of each normalized sample library to be pooled in a 1.5-mL 
microcentrifuge tube (see Note 3). Each library in the pooled mixture must have a 
different index or barcode. 
8. Send an aliquot of the pooled libraries to be sequenced (see Note 6) or store at -20ºC. 
It is recommended that the libraries are shipped on dry ice. 
 
3.11 Library Preparation for sRNA sequencing (LIB<500 and LIB<200 libraries) 
 
The LIB<500 and LIB<200 libraries are prepared with the Illumina TruSeq™ Small RNA 
Sample Preparation Kit (Part Number 15004197 Rev. D May 2012 / 
http://support.illumina.com/documents/MyIllumina/b76a55b0-4ac7-4ee7-aa23-
0e993cf7f467/TruSeq_SmallRNA_SamplePrep_Guide_15004197_D.pdf) (see Notes 3 and 
5) with some modifications that are explained below. Read the Best Practices section from 
the manual carefully. If more than 8 samples are to be prepared, then we recommend using 
250-µL PCR plates and caps for PCR strips that are compatible with the plates to perform 
the protocol. 
 
1. Start the protocol at the section Ligate 3’ and 5’ Adapters with 100-400 ng of size-
selected RNA, diluted in a maximum volume of 5 µL nuclease-free water (see Note 15).  
2. Perform all steps from sections Ligate 3’ and 5’ Adapters and Reverse Transcribe and 
Amplify. At this point the amplified libraries are in a 50 µL volume.  
3. Allow the AMPure XP Beads to come to room temperature prior to use. Vortex the 
beads until they are well dispersed, and then add 50 µL of the mixed AMPure XP 
Beads to each PCR amplified library. Gently pipette the entire volume up and down ten 
times to mix thoroughly. 
4. Incubate the PCR tubes or plate at room temperature for 15 min. 
5. Place the PCR tubes or plate on the magnetic stand at room temperature for 5 min or 
until the liquid appears clear. 
6. Remove and discard 95 µL of the supernatant from each PCR tube or plate well. 
7. With the PCR tubes or plate remaining on the magnetic stand, add 200 µL of freshly 
prepared 80% EtOH to each tube or well without disturbing the beads. 
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 8. Incubate at room temperature for 30 s, then remove and discard all of the supernatant 
from each tube or well. 
9. Repeat the last two steps once for a total of two 80% EtOH washes. 
10. While keeping the PCR tubes or plate on the magnetic stand, let the samples air dry at 
room temperature for 15 min and then remove the tubes or plate from the magnetic 
stand. 
11. Resuspend the dried pellet with 22.5 µL TE buffer. Gently pipette the entire volume up 
and down ten times to mix thoroughly. 
12. Incubate at room temperature for 2 min. 
13. Place the PCR tubes or plate on the magnetic stand at room temperature for 5 min or 
until the liquid appears clear. 
14. Transfer 20 µL of the clear supernatant to a clean PCR tube or plate well. 
15. Quantify the libraries using the Qubit® dsDNA HS BR Assay Kit on the Qubit® 
Fluorometer (Invitrogen) (see Note 17). 
16. Check the size and purity of the sample by running a High Sensitivity DNA chip on the 
Bioanalyzer. The final product should be a broad band with an average size of 
approximately of 200 bp (see Figure 3B).  
17. Adjust the concentration of the libraries to 10 nM using a 10 mM Tris-Cl  (pH 8.5) 
solution containing 0.1% Tween 20. 
18. Combine 10 µL of each normalized sample library to be pooled in a 1.5-mL 
microcentrifuge tube (see Note 3). Each library in the pooled mixture must have a 
different index or barcode. 
19. Send an aliquot of the pooled libraries to be sequenced (see Notes 5 and 6) or store at 
-20ºC. It is recommended that the libraries are shipped on dry ice. 
 
 
Figure 3. Typical size profiles of amplified libraries. A. The LIB>100 library analyzed with a DNA 
1000 chip on the Bioanalyzer (Agilent). B. The LIB<500 library analyzed with a High Sensitivity DNA 
chip on the  Bioanalyzer (Agilent). Libraries prepared using the LIB<200 protocol will have a very 
similar profile. 
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 3.12 Read mapping 
 
The first step of the data analysis pipeline is to map the reads against the reference 
genome. Note that cDNA libraries sequenced using a paired-end protocol will yield two 
FASTQ files per library, one containing the forward reads, and the other the reverse reads. 
In the LIB<500 and LIB<200 libraries, information corresponding to short transcripts (<100 
nucleotides) is retained in the library construction. If the native read lengths are longer than 
the shortest cDNA fragments, then the read sequence will run through the cDNA fragment 
and extend into the adapter sequence. The 3’-end adapter sequences should therefore be 
trimmed away before mapping. There are several tools to trim reads, including the Flexbar 
tool that allows for flexible barcode detection and adapter removal. We map the adapter-
trimmed reads onto the reference genome using Bowtie 2, which is a fast and memory-
efficient tool for aligning short sequence reads onto reference genomes. The output of 
Bowtie 2 is the alignment of all the reads onto the reference genome in the generic 
Sequence Alignment/Map (SAM) format. The SAM format is a tab-delimited text format 
containing generic alignment information. For faster processing the SAM format can be 
converted into the equivalent binary format BAM. 
 
3.13 Read coverage quantification 
 
In order to calculate the transcription level across the genome at a single base resolution, 
the number of aligned reads for each position in the genome is counted. Thus, the global 
alignment stored in the SAM format needs to be converted into a list of the genomic 
positions together with the number of covering bases. 
We use SAMtools for manipulating alignments in the SAM format. The SAM-formatted 
alignments are then converted into the BAM format, which is sorted to create a pileup file. 
Pileup format is a text-based format for summarizing the base calls of aligned reads at each 
covered position in the reference sequence. In the pileup file the information about the 
genomic location (chromosome and position) and the count of covering reads is stored in 
columns one, two and eight, respectively. Note that the pileup format only contains 
information about genomic positions that are covered by reads. It is therefore 
recommended to amend the pileup file to include uncovered positions designating the 
number of covering reads to be 0. If there is only one chromosome, the information about 
coverage depth along the genome can be stored in two columns, with the genomic position 
specified in the first column, and the number of covering reads given in the second column. 
This type of file will now be referred to as the coverage file. 
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 3.14 Normalization and replicate merging 
 
After determining the read coverage across the genome, the read counts in the coverage 
file are then normalized according to the total number of reads in the cDNA library. This is 
done in order to compare the level of transcription across different libraries. After 
normalization the normalized coverage files from replicate samples are merged by 
calculating the average read count at each position. 
 
3.15 Full transcriptome analysis (library LIB>100) 
 
If the library LIB>100 protocol has been followed, it is now possible to calculate the 
transcription levels of all already-annotated genes.  
 
1. Using your normalized coverage files (not merged), calculate the average expression 
of each gene by dividing the normalized read coverage depth (the sum of coverage at 
each base of the gene) by the length of the transcript. It is necessary to have an 
annotation file containing all the annotated genes of your organism, their coordinates 
and length. 
2. Analyze differential gene expression between the different samples, using ANOVA for 
example. 
 
3.16 Identification of trans-encoded sRNAs (all libraries) 
 
Most sRNAs characterized to date regulate gene expression by base pairing with mRNAs. 
These sRNAs fall into two broad classes: those encoded in cis on the DNA strand opposite 
the target RNA that share extended regions of perfect complementarity (cis-encoded 
antisense sRNAs), and those encoded in intergenic regions that share limited 
complementarity with their targets (trans-encoded sRNAs). In this section, we explain how 
to identify trans-encoded sRNAs. Although this type of analysis can be performed using all 
three types of libraries described here, a larger number of sRNAs will be detected in the 
LIB<500 and LIB<200 libraries because they are prepared from RNA that is size-selected 
and enriched for sRNAs (6). For the purpose of our analysis we define trans-encoded 
sRNAs as transcripts encoded entirely in the intergenic regions. Nonetheless, some trans-
encoded sRNAs might extend into their neighboring genes. Also, some of the identified 
sRNAs might represent 5’-UTRs truncated before the start codon of their respective genes. 
In order to detect trans-encoded sRNAs in a high-throughput manner, we have employed 
an automated algorithm that detects transcripts starting and ending in intergenic regions. 
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 The algorithm detects the sudden increases in read coverage depths in the intergenic 
regions by the following criteria: (a) A transcript is detected if the coverage depth increases 
above a cut-off that is set to discriminate noise caused by sequenced mRNA. Our cut-off 
was set based on the average expression intensities of forty-four previously validated 
sRNAs in P. aeruginosa (6). (b) The average transcriptional level (calculated as the 
normalized read coverage depth divided by the length of the transcript) of the detected 
transcript must be twice the previously defined cut-off to be considered further as an sRNA 
candidate. The two cut-off values are necessary and used together to identify sRNAs in that 
the second cut-off (b) ensures detection of very abrupt increases in read coverage depths 
whereas the first cut-off (a) enables the length of the transcripts to be defined more 
accurately. 
 
After detecting transcripts, their transcriptional levels can be compared between samples as 
described in the previous section. The detected trans-encoded sRNAs can be visualized 
using a global alignment viewer such as Tablet (8) that may be helpful in more accurately 
defining the lengths of the sRNAs. Tablet visualizes the alignment using the sorted BAM 
format described in section 3.13. Tablet also requires an indexed BAM formatted alignment 
to be indexed. Indexing enables a more rapid alignment retrieval, and can be performed 
with SAMtools. 
 
3.17 Identification of cis-encoded sRNAs (LIB<500 and LIB<200 libraries) 
 
The next objective is detection of cis-encoded sRNAs. As these sRNAs are transcribed 
from the DNA strand opposite the target RNA, they can only be directly identified in strand-
specific libraries like LIB<500 or LIB<200. The cis-encoded sRNAs are detected using an 
algorithm similar to the one used for detection of trans-encoded sRNAs. As the cis-encoded 
sRNAs are transcribed opposite to their respective genes, the analysis shoud be 
constrained to reads being in the opposite direction to the genes onto which they align.  
Information on the direction of the aligned reads is contained in the second column of the 
SAM format. A number of different flags are used to describe the orientation of the single 
read and its corresponding mate, and flags “99”, “147”, “83” and “163” designate the read 
and its mate to be properly aligned within a distance as defined by the insert size. Read 
pairs with flags 99 or 147 originate from transcripts encoded on the plus strand, while read 
pairs with flags 163 or 83 originate from transcripts encoded on the minus strand. This 
allows us to only extract reads that map to a known gene, but have the opposite direction of 
the gene. The reads that originate from a gene encoded on the plus strand will have the 
flags 99 or 147. Thus, the reads that map to this gene and have the flags 163 or 83 need to 
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 be extracted. The procedure is likewise for genes encoded on the minus strand, where the 
reads with flags 99 or 147 need to be extracted.  
 
The extracted reads are placed into SAM formatted files that are processed into new pileup 
format files which can then be normalized and merged as previously described in sections 
3.13 and 3.14. The algorithm described in section 3.16 is used in order to detect transcripts 
with sudden increases in read coverage depths. The difference in this case is that only 
transcripts that overlap genes are evaluated. The ends of mRNA molecules that do not 
encode proteins are termed untranslated regions (UTRs). These regions can contain 
regulatory elements for controlling gene expression and extend into the neighboring genes. 
Be aware of the fact that some cis-encoded sRNAs detected in your libraries might be 
UTRs from neighboring genes. Calculations of transcriptional levels, comparisons between 
samples, and visualization of cis-encoded sRNAs can be performed as previously 
described in sections 3.13 to 3.16.  
 
4. NOTES 
 
1. RNA is highly susceptible to degradation by ribonucleases. These enzymes are 
present on skin, laboratory equipment, and in dust. They are very stable and difficult to 
inactivate. For these reasons, it is important to follow best laboratory practices while 
preparing and handling RNA samples. Wear gloves and use sterile technique at all 
times. Reserve a set of pipettes for RNA work. Use sterile RNase-free filter pipette tips 
to prevent cross-contamination. Use RNase-free disposable plasticware. All reagents 
and solutions should be sterile and RNase-free where possible. Use RNase 
decontamination solution (such as RNase-ZAP) to decontaminate work surfaces and 
equipment prior to starting this protocol. 
2. Although we have used precast gels to size-select transcripts shorter than 500 nt, 1-
mm thick, 10% polyacrylamide TBE-Urea minigels can also be prepared. For each gel, 
mix 1 mL 10X TBE with 3.33 mL acrylamide: bis-acrylamide (37.5:1), 2.14 mL water, 
4.2 g urea, 330 mL 1.6% ammonium persulfate, and 5 mL tetramethylethylenediamine 
(TEMED). The glass plates, combs, and chambers used should be compatible with the 
Mini-PROTEAN or other suitable electrophoresis system. 
3. It is highly recommended to work with at least two biological replicates of every sample 
to be sequenced. This will enable a better comparison of the transcript expression 
levels between different samples. Thus, if there are twelve samples or conditions, and 
there are two replicates per sample, then there are twenty-four libraries to be 
sequenced. If multiplexed sequencing (sequencing different samples in the same lane) 
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 is to be performed, then each library needs to be prepared using a different index or 
barcode. This will allow the different libraries to be pooled together and sequenced in 
one lane. Therefore, the number of indexes or barcodes needed is the same as the 
total number of libraries to be sequenced in the same lane. We have successfully 
sequenced up to twenty-four different RNA libraries in the same lane. 
4. There are two different versions of the TruSeq™  RNA Sample Prep Kit v2 (Illumina), 
where each contains twelve different indexes or barcodes (twenty-four unique indexes 
or barcodes in total).  
5. There are four different versions of the TruSeq™  Small RNA Sample Preparation Kit 
(Illumina), where each contains twelve different indexes or barcodes (forty-eight unique 
indexes or barcodes in total). This kit is designed for sequencing of eukaryotic 
microRNAs (miRNAs), which are around 22 nt in length. The libraries obtained 
following the kit manual will contain DNA fragments of around 150 bp, including the 
adapters. We describe modifications that allow using the TruSeq™  Small RNA Sample 
Preparation Kit for preparing libraries that enable sequencing of bacterial small RNAs, 
which normally range between 70 and 500 nt in length. The libraries prepared following 
our protocol will contain fragments that range from 100 to 400 bp, including the 
adapters. Make sure to inform your sequencing provider about these modifications. 
6. The libraries described here were sequenced using the Illumina HiSeq2000 platform 
with a paired-end protocol and read lengths of 100 nt. On average, 16.7 million 
sequence reads were generated from each library, and of these 12.3 million were of 
sufficient quality to be mapped onto our reference genome (6). However, as 
sequencing technologies are rapidly evolving, sequencing using the latest available 
technology as well as the longest possible read length is recommended. 
7. The RNA used to prepare the LIB<500 and LIB<200 libraries was treated with Tobacco 
Acid Pyrophosphatase (TAP) to ensure the inclusion of primary transcripts containing a 
5´-triphosphate. Although primary and processed transcripts are not distinguishable in 
these libraries, it is possible to modify the approach with additional libraries to obtain 
this information. One approach is to discriminate primary from processed 5’ ends by 
preparing two libraries from the same RNA sample. One library is prepared with 
untreated RNA and the other library is enriched for primary transcripts by treatment 
with Terminator 5´-Phosphate-Dependent Exonuclease (Epicentre), which degrades 
RNA with 5´-monophosphate but not 5´-triphosphate ends (9). 
8. There are a number of protocols and kits for RNA isolation, but many of them do not 
quantitatively retain the smaller RNAs that are of interest here. This is the case for 
most of the kits that use spin columns. We use Trizol (Invitrogen) to isolate RNA 
because it is a quick method that allows retention of all RNA species. The protocol 
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 described here can also be used to extract RNA from mucoid cells. If another method 
is used to extract RNA, it is important to ensure that small RNA species are retained by 
checking the sample with a Bioanalyzer. The RNA profile obtained after extraction with 
Trizol is shown in Figure 2A, and that obtained with a spin column kit (in this example 
the NucleoSpin RNA II kit from Macherey Nagel) is shown in Figure 2B.  
9. One milliliter of Trizol is sufficient to extract RNA from 10 mL of P. aeruginosa culture 
harvested at OD600 of 0.5 to 3, where the typical yields of total RNA obtained are 40 to 
150 µg. For other growth/harvest conditions or for bacteria other than P. aeruginosa, 
optimization of the RNA extraction method may be necessary.  
10. The RNA can be stored as pellets in 75% ethanol at -20ºC or -80ºC for at least one 
year, or at 4ºC for at least one week. RNA storage in ethanol is highly recommended 
for long-term storage (weeks or months). 
11. It is important that both the A260/A280 and the A260/A230 ratios of RNA solutions are close 
to 2.0. RNA has its absorbance maximum at 260 nm and this absorbance is not 
dependent on the pH of the solution. However, the absorbance of some contaminants 
(like proteins) is pH-dependent. This means that although the A260 reading of the RNA 
solution will remain the same at different pH values, the A280 reading will differ in a pH-
dependent manner. Adjusting the pH of the RNA solution from approximately 5.5 to a 
slightly alkaline pH of 7.5-8.5 significantly increases RNA A260/A280 ratios from 
approximately 1.5 to 2.0 (10). This should be taken into account when measuring the 
absorbance ratio of RNA dissolved in nuclease-free water. When isolating low amounts 
of RNA the A260/A230 ratio tends to be lower. This indicates contamination of the RNA 
solution with chaotropic salts, phenol or protein. 
12. The Bioanalyzer (Agilent) is a microfluidics-based platform for sizing, quantification and 
quality control of DNA, RNA, proteins and cells. Here it is used for checking the quality 
of RNA, and the size of DNA libraries. We recommend quantifying RNA and DNA using 
other technologies such as a low-volume spectrophotometer or Qubit® Fluorometer 
(Invitrogen). The Bioanalyzer allows for rapid analysis of RNA and DNA samples (30-
40 minutes) with minimal sample consumption (1µL). The higher sensitivity afforded by 
the Bioanalyzer is the main advantage over gel analysis, where larger sample amounts 
are required. 
13. Denaturing polyacrylamide-urea gels can also be used to size-select RNAs shorter 
than 200 nt (see Note 2). However, we find it easier and faster to use the mirVana™ 
miRNA Isolation Kit for this purpose. 
14. The MICROBExpress™  Bacterial mRNA Enrichment Kit (Ambion) has been used 
because it employs subtractive hybridization to specifically deplete rRNAs from total 
RNA. In our libraries, the average percentage of read coverage corresponding to 23S, 
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 16S and 5S rRNAs was 7.1%, 3.8%, and 0.15%, respectively (6). For bacteria other 
than P. aeruginosa and E. coli the oligos used to deplete rRNAs may need to be re-
designed. There are also other commercially available kits to deplete rRNA. One of 
them uses exonuclease to preferentially degrade processed RNAs with 5′ 
monophosphate ends (mRNA-ONLY Prokaryotic mRNA Isolation kit, from Epicentre). 
Exonuclease degrades all processed RNAs and, although the majority of the 
processed RNAs are believed to be rRNAs and tRNAs, there may be other transcripts 
including sRNAs that are also processed. He et al (2010) compared the performance of 
the MICROBExpress™ and mRNA-ONLY kits and found that only the former based on 
subtractive hybridization adequately preserved relative transcript abundance for 
quantitative analyses, whereas the latter based on exonuclease treatment greatly 
compromised mRNA abundance fidelity (11). Another commercially available kit based 
on subtractive hybridization contains capture oligonucleotides to remove 23S, 16S and 
5S rRNAs (Ribo-Zero rRNA Removal Kit, Epicentre).  
15. Concentration of RNA samples can be achieved via an ethanol precipitation. Follow 
step 10 from section 3.3 Treatment with DNase I and resuspend in the appropriate 
volume of TE buffer or nuclease-free water. 
16. Illumina recommends using Microseal ‘B’ adhesive seals (BioRad) to seal the PCR 
plates. However, we find that sealing the PCR plates using caps for compatible PCR 
strips is easier and safer. 
17. In our experience the Qubit® Flurometer (Invitrogen) is a fast and easy alternative for 
library quantification relative to qPCR, which is recommended by Illumina. 
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ABSTRACT 
 
The use of RNA-Seq technologies is revealing that bacterial RNA molecules are more than mRNAs, 
rRNAs or tRNAs. During the last years bacterial transcriptomes have been shown to contain 
intergenic RNAs, antisense RNAs, and untranslated regions, all capable of performing diverse 
regulatory functions. In this study we identified 249 antisense RNAs (asRNAs) in the opportunistic 
pathogen Pseudomonas aeruginosa. A considerable number of asRNAs were transcribed opposite to 
genes encoding membrane proteins and genes involved in the transport of small molecules, cell wall, 
lipopolysaccharide (LPS), and capsule biosynthesis. A substantial number of asRNAs significantly 
changed their expression under osmotic, oxidative and antibiotic stress, suggesting that asRNAs play 
a regulatory role during these conditions. In addition we have validated the existence of two antisense 
RNAs, opposite to the dnaA and ponA genes, which encode the chromosomal replication initiator 
protein DnaA and the penicillin-binding protein 1A, respectively.  
 
INTRODUCTION 
 
During the last years an increasing number of 
bacterial transcriptomes have been examined 
with tiling arrays and RNA sequencing (RNA-
Seq) technologies, revealing that a significant 
number of protein-coding genes are also 
transcribed from the reverse complementary 
strand in a wide range of bacterial species (1-8). 
In general, overlapping transcription results in 
the generation of an antisense RNA (asRNA) 
whose size usually varies between various tens 
to hundreds of nucleotides (nt). The regulatory 
role of asRNAs was first reported more than 30 
years ago in Escherichia coli, when the plasmid- 
and transposon-encoded asRNAs RNAI and 
CopA were found to negatively regulate plasmid 
copy number (9,10). However, until very 
recently, bacterial asRNAs were infrequently 
detected and therefore considered to be rare. By 
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  2007, only about thirty bacterial asRNAs had 
been identified (reviewed in (11)). The number of 
reported asRNAs has lately exploded due to the 
use of tiling array and especially RNA 
sequencing (RNA-Seq) to study microbial 
transcriptomes. While the number of asRNAs 
detected in bacterial transcriptomes is rapidly 
growing, characterization of the physiological 
function of individual asRNAs is growing much 
slower. AsRNAs are known to affect the 
expression of the target gene by different 
mechanisms (reviewed in (12)). These include: 
(i) transcription interference, in which 
transcription from one promoter is suppressed 
by a second promoter located in the opposite 
strand, (ii) transcription attenuation, in which 
base pairing of the asRNA to the target mRNA 
causes premature transcription termination, (iii) 
changes in the target RNA stability, where the 
asRNA either promotes or blocks degradation or 
cleavage of the mRNA by ribonucleases, (iv) 
asRNAs can directly block ribosome binding, 
and (v) might indirectly impact ribosome binding 
(either positively or negatively) by affecting the 
target RNA structure. In addition, regulating the 
expression of the opposite gene is not the only 
function of certain asRNAs. Some asRNAs 
encode small proteins (13), and some have the 
potential to act on multiple targets in trans (14-
18). 
 
In this work, we used RNA sequencing to identify 
asRNAs in the human pathogen Pseudomonas 
aeruginosa. P. aeruginosa can cause severe 
infections, particularly in immuno-compromised 
and cystic fibrosis (CF) patients. Recently two 
independent studies identified antisense 
transcription in P. aeruginosa. One of the studies 
investigated strains PAO1 and PA14 at early 
stationary phase and found 60 asRNAs (19). 
Interestingly, a number of these asRNAs were 
strain-specific or showed strain-specific 
expression (19). The other study identified 384 
antisense transcriptional start sites, but not full 
length asRNAs, in P. aeruginosa PA14 grown at 
28ºC and at 37ºC (20). However, it is evident 
that, due to their regulatory functions, the 
expression of asRNAs occurs mostly in a 
transient manner and is dependent on specific 
environmental cues. Therefore, we have aimed 
to identify asRNAs in P. aeruginosa PAO1 grown 
in a range of 13 different conditions to ensure a 
comprehensive characterization of the P. 
aeruginosa asRNA-ome. The conditions studied 
include exponential and early-stationary phase, 
osmotic, oxidative and antibiotic stress. 
Exponentially growing cultures of P. aeruginosa 
PAO1 were exposed to sodium chloride (NaCl) 
and hydrogen peroxide (H2O2) during osmotic 
and oxidative stress conditions, respectively. 
The antibiotics used were four different ß-
lactams, tobramycin, azithromycin, ciprofloxacin, 
colistin and tetracycline.  
 
Recently, we showed that library preparation for 
RNA-Seq plays a fundamental role when aiming 
at identifying novel transcripts. Using three RNA-
Seq library protocols with different sRNA 
abundance, we identified over 500 novel 
intergenic sRNAs in P. aeruginosa PAO1 
(21,22). Although the use of three different 
libraries increased the number of novel 
transcripts identified, there were significant 
differences in the subset of transcripts detected 
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  in each library (21). Libraries that were prepared 
with a size-selected fraction of RNA were more 
sensitive in the detection of intergenic sRNAs. In 
this study we identified 249 asRNAs using 
strand-specific libraries that contain transcripts 
shorter than 500 nt. 
 
MATERIALS AND METHODS 
Primers and adapters  
 
Supplementary Table 1 lists all primers and adapters 
used in this study. 
 
Plasmid construction 
 
The plasmids used in this study are listed in Table 1. 
Plasmids for L-arabinose-inducible expression of 
asRNAs were constructed by amplification of plasmid 
pBAD33 (23) with primers F1-SacI and R1 producing 
a PCR product of 1250 bp (F1-SacI introduces a SacI 
restriction site). For amplification of the asRNA insert, 
genomic DNA from strain PAO1 was amplified with 
primers F2 and R2-XhoI (F2 starts with the sRNA +1 
site and R2-XhoI introduces an XhoI restriction site). 
The 5´ends of primers F2 and R1 are complementary 
to each other. PCR synthesis by overlap extension 
(PCR-SOE) was carried out by combining the 2 
previously amplified products and running PCR for 10 
cycles, after which primers F1-SacI and R2-XhoI are 
added and the reaction continues for another 30 
cycles. The obtained product was digested with SacI 
and XhoI and cloned into the MCS of plasmid mini-
CTX2 (24). 
 
Bacterial strains 
 
The bacterial strains used in this study are listed in 
Table 1. The Pseudomonas aeruginosa PAO1 strain 
was used as wild-type strain. The E. coli CC118λpir 
strain was used as cloning host (25). Strains pBAD-
asdnaA, pBAD-asponA and pBAD-control were 
created by integration of plasmids pBAD-asdnaA, 
pBAD-asponA and pBAD-control, respectively, at the 
attB site of strain PAO1, followed by Flp-mediated 
excision of the plasmid backbone, as described in 
(24). The first nucleotide of the transcribed products 
is the +1 of the sRNAs. This is an important 
consideration when cloning noncoding RNAs under 
the control of heterologous promoters, since altering 
the natural RNA start site may have unintended 
consequences for its function. The attB region was 
sequenced using primers Pser-up and Pser-down to 
make sure that the integration was successful and the 
plasmid backbone excised. 
Table 1. Strains and plasmids used in this study. 
 
 
 
Growth conditions 
 
Growth in Luria–Bertani (LB) broth (250 rpm, 37°C) or 
on LB plates at 37°C was used throughout this study. 
Stress exposure experiments. Overnight cultures of 
Pseudomonas aeruginosa PAO1 were diluted to a 
starting OD600 of 0.01 and grown to an OD600 of 0.5, 
at which an antibiotic, 0.5 M NaCl or 1mM hydrogen 
peroxide was added. The final concentrations of 
antibiotics are shown in Table 2. Concentrated stock 
solutions of H2O2 and all antibiotics were prepared 
fresh daily. Cells were harvested 1 hour after the 
addition of antibiotics, NaCl and H2O2. Early-
stationary phase cells were harvested from cultures 
grown to an OD600 of 3. RNA was extracted and used 
to make RNA-Seq libraries LIB>100 and LIB<500. 
Experiments were performed in duplicates. 
Pulse-expression experiments.	   Overnight cultures of 
strains pBAD-asdnaA and pBAD-asponA were diluted 
to a starting OD600 of 0.01 and grown to an OD600 of 
0.5, at which sRNA expression was induced with 1% 
L-arabinose. Cells were harvested after 30 min of the 
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  induction. RNA was extracted and used to make 
RNA-Seq libraries LIB>100, which contain the full 
transcriptome. Two sets of negative-control 
conditions were used for comparison. In one, the 
control strain pBAD-control was induced with 
arabinose; in the second, cells containing the pBAD-
asdnaA and pBAD-asponA constructs were grown 
without arabinose induction. Experiments were 
performed in duplicates. The samples were analyzed 
by RNA-seq using a strand-specific library that 
contains transcripts longer than 100 nt. These 
libraries were prepared using the ScriptSeq v2 RNA-
Seq Library Preparation Kit (Epicentre) following the 
manufacturer´s instructions. Briefly, rRNA-depleted 
RNA was fragmented and reverse transcribed using 
random primers containing a 5’-tagging sequence. 
The 5’-tagged cDNA was then tagged at its 3’ end by 
the terminal-tagging reaction to yield di-tagged, 
single-stranded cDNA. Following purification, the di-
tagged cDNA was amplified by PCR, which 
completes the addition of the Illumina adaptor 
sequences, amplifies the library for subsequent 
cluster generation and adds a barcode. The amplified 
RNA-seq library was purified with the Agencourt 
AMPure XP beads (Beckman Coulter Genomics). 
 
MIC value calculation 
 
MIC values of P. aeruginosa PAO1 were assessed 
using both the broth microdilution procedure and E-
test strips. 
Broth Microdilution. LB medium was added to all 
wells of a 96-well microtiter plate loaded with serially 
diluted antibiotics. Each well was inoculated with P. 
aeruginosa PAO1 at a final concentration of 5 x 105 
cfu/ml. The plates were incubated for 24 hours (250 
rpm, 37°C). Following incubation, the optical density 
of all wells was measured and the lowest 
concentration showing complete inhibition of growth 
was recorded as the MIC for that antibiotic. The 
experiments were performed in triplicates. 
Concentrated stock solutions of all antibiotics were 
prepared fresh daily. 
E-Test. E-test (bioMérieux AB BIODISK) strips were 
used according to the manufacturer’s instructions. LB 
plates were inoculated equal amount of P. aeruginosa 
PAO1 cells. After drying, the E-test strips were placed 
on the top of the plates. The MIC values were read 
after 16 h of incubation at 37ºC. The experiments 
were performed in triplicates. 
 
RNA isolation 
 
Harvested cells were mixed immediately with 0.2 
volumes of STOP solution (95% ethanol, 5% phenol) 
and pelleted by centrifugation. Total RNA was 
extracted with Trizol (Invitrogen). Removal of DNA 
was carried out by treatment with DNase I 
(Fermentas) in combination with the RNase inhibitor 
RiboLock (Fermentas). The integrity of total RNA and 
DNA contamination were assessed with an Agilent 
2100 Bioanalyzer (Agilent Technologies). 
 
Removal of 23S, 16S and 5S rRNAs 
 
The 23S, 16S and 5S rRNAs were removed by 
subtractive hybridization using the MICROBExpress 
kit (Ambion) with modifications as previously 
described (21) (22). Capture oligonucleotides 
complementary to the rRNAs of P.aeruginosa PAO1 
were used (Supplementary Table S1). For 
preparation of library LIB>100 (described below), 5 
µM of each capture oligonucleotide was used, for a 
total capture oligonucleotide concentration of 25 µM. 
Compared with the standard protocol, 25% more 
capture oligonucleotides and magnetic beads were 
used. For preparation of libraries LIB<500 (described 
below), 5 µM of the 5S rRNA capture oligonucleotide 
and 50% less magnetic beads were used relative to 
the standard protocol. Removal of rRNAs was 
confirmed with an Agilent 2100 Bioanalyzer (Agilent 
Technologies). 
 
Library preparation and RNA sequencing 
 
Two different sequencing libraries (LIB>100 and 
LIB<500) were constructed as previously described 
(21,22). Each library type was prepared with RNA 
isolated from cells grown in duplicate for each 
condition studied. After each step the samples were 
validated using an Agilent 2100 Bioanalyzer (Agilent 
Technologies), and the final concentration was 
measured using a Qubit 2.0 Fluorometer (Invitrogen). 
The libraries were sequenced using the Illumina 
HiSeq2000 platform with a paired-end protocol and 
read lengths of 100 nt.	  
LIB>100 library. This type of library contains 
transcripts longer than 100 nt and was prepared 
using the TruSeq RNA Sample Preparation kit 
(Illumina) as previously described (21,22). Briefly, the 
rRNA-depleted RNA is fragmented using divalent 
cations under elevated temperature. The cleaved 
RNA fragments are copied into cDNA using reverse 
transcriptase and random primers, followed by 
second-strand cDNA synthesis using DNA 
polymerase I and RNase H. After this step, transcripts 
shorter than 100 nt are not retained due to the 
purification performed with the Agencourt AMPure XP 
beads (Beckman Coulter Genomics). The cDNA 
fragments then go through an end repair process, 3’-
addition of single ‘A’ bases and adapter ligation. This 
is followed by product purification and PCR 
amplification to generate the final cDNA library.	  
LIB<500 library. This type of library is strand-specific 
and contains transcripts shorter than 500 nt. RNA 
size selection was performed by running total RNA on 
10% polyacrylamide gels containing 10 M urea. Gel 
slices corresponding to RNAs up to 500 nt were 
excised, followed by elution of RNA in 0.4 M NaCl 
and precipitation with ethanol. The 5S rRNA was 
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  depleted as previously described, followed by 
treatment with Tobacco Acid Pyrophosphatase 
(Epicentre Technologies) at 37°C for 90 min. Tobacco 
Acid Pyrophosphatase (TAP) is used to convert 5′-
triphosphate RNA into 5′-monophosphate RNA, which 
is important for correct adapter ligation. This was 
followed by treatment with RNase III (Ambion) for 10 
min at 37°C to fragment the RNA. RNase III 
fragments RNA into smaller pieces containing a 5′-
phosphoryl group and a 3′-hydroxyl group, which is 
important for specific adapter ligation in the next step. 
Sequential ligation of RNA 3′ and 5′ adapters was 
performed using the adapters and enzymes from the 
TruSeq Small RNA Sample Preparation kit (Illumina). 
Next, reverse transcription followed by PCR 
amplification was performed to form cDNA constructs 
based on the RNA fragments ligated with 3′ and 
5′ adapters, selectively enriching fragments with 
adapter molecules on both ends. The reverse 
transcription and subsequent PCR amplification were 
performed using the enzymes and reagents from the 
TruSeq Small RNA Sample Preparation kit (Illumina). 
Agencourt AMPure XP beads (Beckman Coulter 
Genomics) were used for the post-PCR clean-up. In 
this type of library the fragments corresponding to 
transcripts shorter than 100 nt are retained due to 
ligated RNA adapters that increase the length of the 
fragments by 125 nt. 
 
Data analysis 
 
Our analysis pipeline is described in detail in Gómez-
Lozano et al (2013) (22). Briefly, reads were mapped 
onto the P. aeruginosa PAO1 genome using the 
Bowtie 2 short read aligner (26). Read alignments 
from Bowtie 2 were handled using SAMtools (27). In 
order to obtain normalized expression intensities of 
the read coverage depth at each position in the 
genome, the number of reads in each replicate was 
normalized according to the total number of reads in 
the library, and expression intensities from replicate 
samples were averaged. A custom-made script was 
designed to detect novel transcripts antisense to 
annotated genes. Only transcripts of at least 70 nt 
were considered further. The resulting transcripts 
from automatic classification were re-evaluated by 
visual inspection. The asRNAs were categorized 
depending on their position with respect to the 
opposite gene as “start-span” (the asRNA spans over 
the start of the antisense gene), “internal” (the asRNA 
start and end within the antisense gene), or “end-
span” (the asRNA spans over the end of the gene).	  A 
two-sample Student’s t-test was performed on the 
average expression of the transcripts to determine 
those with differential expression between the 
conditions tested (P-value <0.05 and fold change >2).  
 
Rapid Amplification of cDNA Ends (RACE) 
 
Schematic representations of the 5´ and 3´ RACE 
protocols can be seen in Supplementary Figures 1 
and 2. Supplementary Table 1 lists primers and 
adapters used. 
5´ RACE. 2 µg rRNA-depleted RNA was incubated 
with 10 U of Tobacco Acid Pyrophosphatase 
(Epicentre Technologies) at 37ºC for 1 h to convert 
RNA 5´ triphosphates in 5´ monophosphates. The 
same amount of control RNA was incubated under 
the same conditions in the absence of the enzyme. 
Reactions were stopped by phenol-chloroform 
extraction, followed by etanol-sodium acetate 
precipitation. Precipitated RNAs were redissolved in 
water, mixed with 500 pmol of 5´ RNA adapter, heat-
denatured at 95ºC for 5 min, then quick-chilled on ice. 
A short RNA adapter was ligated was ligated with 50 
U of T4 RNA ligase (Thermo Scientific) at 37ºC for 1 
h. Reactions were stopped by phenol-chloroform 
extraction, followed by ethanol-sodium acetate 
precipitation. Precipitated RNAs were re-dissolved in 
20 µl water. Then 10 µl of 5´adapter-ligated RNA was 
reverse-transcribed using 2 pmol of primer 
complementary to the sRNA (5´-GSP1) and the 
Thermoscript RT-PCR system (Invitrogen) according 
to the manufacturer’s instructions. Reverse 
transcription (RT) was performed in three subsequent 
20 min steps at 55ºC, 60ºC, and 65ºC, followed by 
treatment with RNase H. Primers were removed 
using the NucleoSpin Gel and PCR Clean-up kit 
(Macherey-Nagel). The products of RT were amplified 
using 10 pmol of another primer complementary to 
the sRNA (5´-GSP2) and 10 pmol the 5´ adapter-
specific primer, together with the Maxima Hot Start 
PCR Master Mix (Thermo Scientific) according to the 
manufacturer’s instructions. Negative controls were 
performed using the 5´ adapter-ligated RNA as 
template. The PCR products were resolved and 
purified using E-Gel SizeSelect 2% Agarose gels 
(Invitrogen). Products were sequenced with 5´-GSP2 
and 5´ adapter-specific primers by LGC Genomics 
GmbH (Germany). 
3´ RACE. 2 µg rRNA-depleted RNA was 
dephosphorylated with calf intestinal alkaline 
phosphatase (New England Biolabs) at 37ºC for 1 h. 
Reactions were stopped by phenol-chloroform 
extraction, followed by etanol-sodium acetate 
precipitation. Ligation was done as above with a 3´ 
RNA adapter with a 3´-inverted deoxythymidine (3´-
idT). RT was carried out as described, but with 10 
pmol of a single primer complementary to the 3´ RNA 
adapter. PCR amplification, band purification and 
sequence analysis was done as described above. All 
enzymatic treatments of RNA were performed in the 
presence of 20 units of RiboLock RNase Inhibitor 
(Thermo Scientific). 
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  RESULTS AND DISCUSSION 
 
Identification of antisense sRNAs. 
 
Recently, we identified over 500 novel intergenic 
sRNAs (21) using three different RNA-Seq 
library preparations (22). Although the use of 
three different libraries increased the number of 
novel transcripts identified, there were significant 
differences in the subset of transcripts detected 
in each library, underscoring the importance of 
library preparation strategy and relative sRNA 
abundance for successful sRNA detection (21). 
In this study we identified 249 asRNAs using the 
library type LIB<500 under different stress 
conditions, including stationary phase, osmotic, 
oxidative and antibiotic stress. Libraries 
prepared using the LIB<500 protocol are strand-
specific and contain transcripts shorter than 500 
nt (21,22). Exponentially growing cultures of P. 
aeruginosa PAO1 were exposed to sodium 
chloride (NaCl) and hydrogen peroxide (H2O2) 
during osmotic and oxidative stress conditions, 
respectively. The antibiotics used were four 
different ß-lactams (piperacillin, ceftazidime, 
aztreonam, meropenem), the aminoglycoside 
tobramycin, the macrolide azithromycin, the 
fluoroquinolone ciprofloxacin, the polymyxin 
antibiotic colistin, and the polyketide tetracycline. 
All antibiotics used in this study, with the 
exception of tetracycline, are routinely used 
against P. aeruginosa infections (28-32). The 
concentrations of antibiotics, NaCl and H2O2 
used in this study are shown in Table 2. The 
conditions were chosen due to their clinical 
relevance during P. aeruginosa infection in CF 
patients, in which the bacteria are exposed to 
high salt concentrations, reactive oxygen 
species (ROS) secreted by the host immune 
response, and aggressive antibiotic treatments. 
The CF lung is an osmotically stressful 
environment, due to the viscous, dehydrated 
mucus, cellular debris and electrolytes 
competing for a limited supply of water (33,34). 
A variety of studies have shown that P. 
aeruginosa encounters ROS in the lungs of CF 
patients due to the exaggerated, sustained and 
extended inflammatory response, characterized 
by influx of neutrophils and high concentrations 
of interleukin-8 (35-37). In addition, P. 
aeruginosa-infected CF patients are routinely 
treated with several types of antibiotics, because 
early and aggressive antipseudomonal treatment 
regimens are correlated with improved lung 
function and survival of CF patients (38).  	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  Table 2. Concentration of antibiotics, NaCl and H2O2 used in the stress exposure experiments. 
 
 
The analysis of the data generated revealed the 
existence of 249 novel asRNAs. Supplementary 
Table 2 lists the coordinates of the asRNAs 
identified in this study, as well as the annotation 
of the opposite genes. Antisense transcripts can 
overlap with the 5’ end, the 3’ end, an internal 
part of the opposite gene, the whole gene, or 
even various contiguous genes that have the 
same direction. The asRNAs were categorized 
depending on their position with respect to the 
opposite gene as “start-span” (the asRNA spans 
over the start of the antisense gene), “internal” 
(the asRNA start and end within the antisense 
gene), or “end-span” (the asRNA spans over the 
end of the gene). Only asRNAs longer than 50 nt 
were taken into consideration. The longest 
detected asRNA is 581-nt long.  Eighteen 
asRNAs overlapped with two contiguous genes 
transcribed from the opposite strand. 
Alternatively, antisense transcription can also be 
due to the overlap between 5’ and 3’ 
untranslated regions of genes encoded in the 
opposite direction. UTRs can contain regulatory 
elements for controlling gene expression and 
extend into the neighboring genes. Some 
asRNAs detected in RNA-Seq libraries might 
actually be UTRs from neighboring genes. To 
prevent the mis-annotation of UTRs as asRNAs, 
in this study we have not considered as asRNAs 
antisense transcription that finished close (less 
than 100 bp) to the start of a flanking gene 
having the same direction as the asRNA. We 
cannot rule out though that some of the novel 
asRNAs identified in this study might be novel 
coding genes encoded opposite to already-
annotated coding regions. It is also possible that 
some of the asRNAs identified are the result of 
non-specific transcription and thus do not have 
physiological functions. 
 
We next examined the distribution of antisense 
sRNAs and found that they appear to be 
homogenously distributed in the genome of P. 
aeruginosa PAO1 (Figure 1A). A recent study 
made by Wurtzel et al (2012) found that 
antisense sRNAs are more often found in some 
parts of the accessory genome of P. aeruginosa 
PA14 (20). Specifically, the authors identified 
384 sites with overlapping transcription on the 
reverse strand, and found that the pathogenicity 
Condition Abbreviation MIC value (!g/ml) 
Concentration 
added at OD=0.5 
Control - - - 
Aztreonam AZT 4 3xMIC 
Ceftazidime CEF 2 3xMIC 
Ciprofloxacin CIP 0.125 3xMIC 
Meropenem MER 1 3xMIC 
Tetracyclin TET 8 3xMIC 
Tobramycin TOB 1 3xMIC 
Azithromycin AZI 1.5 10xMIC 
Colistin CO 4 3xMIC 
Piperacillin PP 4 3xMIC 
Hydrogen peroxyde H2O2 - 1 mM 
Sodium chloride NaCl - 0.5 M !
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  island PAPI-1 is enriched in these kind of sites 
by 5-fold compared to the core genome (20). In 
this study we do not observe more concentration 
of antisense transcripts in the accessory than in 
the core genome. There are three reasons that 
might explain these differences between this 
study and the one from Wurtzel et al (2012). (i) 
The strain used in this study is P. aeruginosa 
PAO1, while Wurtzel et al (2012) used strain 
PA14 (20). Another study investigated the 
expression of sRNAs of strains PAO1 and PA14 
at early stationary phase, and found 60 asRNAs 
(19). Interestingly, a number of these asRNAs 
were strain-specific or showed strain-specific 
expression (19). This also seems to be the case 
for intergenic sRNAs, whose sequences are 
sometimes not conserved between different P. 
aeruginosa strains (21). In addition, the PAPI-1 
island is found in strain PA14 but not in PAO1, 
though it can be transferred by a type IV pilus 
(39). (ii) Wurtzel et al (2012) studied two 
conditions, growth at 28ºC and at 37ºC (20). In 
this study we sequenced samples from P. 
aeruginosa in 12 different conditions. Studying 
more conditions might lead to finding antisense 
transcription sites in more genomic locations. (iii) 
Due to their library preparation protocol, Wurtzel 
et al (2012) identified antisense transcription 
start sites, but the authors could not determined 
the length of the asRNAs (20). In this study, we 
identified 249 asRNAs with lengths ranging from 
50 to 581 nt in length. We did not take into 
consideration neither asRNAs shorter than 50 nt, 
nor asRNAs that might be suspected to be UTRs 
from flanking genes. This might explain why in 
this study we identify considerably less asRNAs 
than in Wurtzel et al (2012). 
 
 
 
 
 
 
Figure 1. Distribution and targets of asRNAs. A. Distribution of asRNAs in the genome of P. aeruginosa 
PAO1. Each asRNA is marked by a black line. B.  Categories of genes with asRNAs transcribed from the 
reverse strand.  
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Intergenic and antisense sRNAs respond to 
stress. 
 
Figure 1B shows the classification of genes with 
asRNAs transcribed from the reverse strand in 
our experiments. A considerable number of 
asRNAs are transcribed opposite to genes 
encoding membrane proteins, genes involved in 
the transport of small molecules, cell wall, 
lipopolysaccharide (LPS), and capsule 
biosynthesis. This most likely reflects the 
conditions used in this study: stationary phase, 
oxidative, osmotic and antibiotic stress. In these 
conditions, fast and fine-tuned regulation of the 
membrane proteins and transport is essential. 
We hypothesize that the regulatory effects of 
asRNAs are important in probably all cellular 
processes, and that the categories of genes with 
antisense transcription regulation mainly depend 
on the conditions studied. 
 
In addition to the 249 asRNAs identified, we 
recently identified over 500 intergenic sRNAs in 
P. aeruginosa PAO1 (21). Figure 2 represents 
the number of intergenic (left) and asRNAs 
(right) whose expression is significantly changed 
during the conditions tested. A substantial 
number of both intergenic and asRNAs 
significantly change their expression, suggesting 
that their regulatory effects are important during 
antibiotic, H2O2, NaCl treatment, and stationary 
phase. About half of the asRNAs detected in this 
study were differentially expressed during 
stationary phase. Supplementary Table 3 lists 
the asRNAs differentially transcribed in our 
conditions, as well as their fold-change in 
expression. We anticipate that these data will be 
important to understand the regulation of genes 
that show antisense transcription on the reverse 
strand. However, the level of transcription alone 
cannot explain the mechanism of action of 
asRNAs, and more experiments will be needed 
in order to determine how asRNAs regulate the 
opposite genes.  
 
 
 
Figure 2. Differential expression of sRNAs. Number of intergenic (left) and asRNAs (right) whose expression 
is significantly changed during antibiotic, H2O2 or NaCl treatment. 
 
 
!" #!" $!" %!" &!" '!!" '#!" '$!" '%!" '&!"
()*+,-./01*2"3'!45678"
7*9-.:.4;1*2"3<45678"
7.=*>?2"3<45678"
7@A;)*B*/@"3<45678"
5@-.9@2@/"3<45678"
()+-@.2;/"3<45678"
C*9@-;1*==*2"3<45678"
D@+-;101=*2"3<45678"
D.E-;/01*2"3<45678"
F;7="3!GH"58"
I0B-.J@2"9@-.4*B@"3'"/58"
K+;?.2;-0"9,;>@"
!"#$%&'()'*+,%&-%+*.'/0!1/'
L9"
M.N2"
!" #!" $!" %!" &!" '!" (!" )!" *!" +!" #!!" ##!"
,-./012345.6"7#!89:;<"
;.=12>28?5.6"7%89:;<"
;2@.AB6"7%89:;<"
;CD?-.E.3C"7%89:;<"
9C12=C6C3"7%89:;<"
,-/1C26?3"7%89:;<"
F.=C1?5.@@.6"7%89:;<"
GC/1?545@.6"7%89:;<"
G2H1?345.6"7%89:;<"
I?;@"7!J'"9<"
K4E12LC6"=C128.EC"7#"39<"
M/?B26?14"=0?AC"
!"#$%&'()'*+,-%+-%'.!/-'
N="
O2P6"
125
	  Antisense sRNAs targeting dnaA and ponA 
 
Two novel asRNAs were validated using 5´and 
3´-RACE. The coordinates of both asRNAs were 
very similar between the RNA-Seq data and the 
RACE experiments, with differences of up to 19 
nt between the two techniques. One asRNA, 
called from now on AsdnaA, is transcribed from 
the reverse strand of the dnaA gene, which 
encodes the chromosomal replication initiator 
protein DnaA (Figure 3). AsdnaA is highly 
expressed during stationary phase (8.7-fold) and 
upon ciprofloxacin (4.6-fold), aztreonam (2.9-
fold) and H2O2 (2.1-fold) exposure. The other 
asRNA is called AsponA and its transcription is 
antisense to the ponA gene, encoding the 
penicillin-binding protein 1A (Figure 3). AsponA 
is upregulated upon aztreonam (2.9-fold), 
piperacillin (2.8-fold), and ciprofloxacin (2-fold) 
exposure, and downregulated during 
meropenem (2-fold), colistin (3-fold), tobramycin 
(5.4-fold), and tetracycline (5.6-fold) exposure.  
 
To determine the effect of these two asRNAs on 
their opposite genes, pulse-expression 
experiments were carried out, in which the 
asRNAs are pulse-expressed with an inducible 
promoter and its immediate effects studied by 
RNA-Seq. Cells carrying the pBAD-asdnaA or 
the pBAD-asponA construct were grown to mid-
log phase in LB and treated with 1% arabinose 
for 30 min. Two sets of negative-control 
conditions were used for comparison. In one, the 
control construct, pBAD-control was induced 
with arabinose; in the second, cells containing 
either the pBAD-asdnaA or pBAD-asponA 
construct were grown without arabinose 
induction. Total RNA was extracted from all 
cultures and processed for RNA-Seq analysis 
(see Materials and Methods). The gene 
expression profiles were compared in two ways: 
(i) induced pBAD-asdnaA or pBAD-asponA-
containing cells were compared to induced 
pBAD-control-containing cells, and (ii) uninduced 
pBAD-asdnaA or pBAD-asponA-containing cells 
were compared to induced pBAD-asdnaA or 
pBAD-asponA-containing cells. The results for 
the two types of comparisons showed consistent 
results, with the exception of the expected 
differences for arabinose-inducible genes. It is 
worth mentioning that while pulse-expression 
experiments of asRNAs can provide important 
insights about their role, they can also cause 
artifactual effects that are not observed during 
endogenous expression of asRNAs. 
 
AsdnaA base is encoded opposite to the second 
half of gene dnaA (Figure 3). Due to its location, 
we initially hypothesize that AsdnaA might (i) 
attenuate the transcription of dnaA, by 
prematurely terminating the transcription on the 
opposite strand, (ii) impact the stability of dnaA 
by either promoting or blocking cleavage by 
ribonucleases, or (iii) indirectly impact (either 
positively or negatively) ribosome binding by 
affecting the target mRNA structure. When 
pulse-expressing AsdnaA, the transcription of 
AsdnaA was increased by 130-fold after 30 min 
of induction. However the levels of the opposite 
gene dnaA were barely affected (1.4-fold more 
when pulse-expressing AsdnaA). This suggest 
that, if any, the physiological role of AsdnaA 
probably is to affect the level of translation of 
dnaA, but further investigations are needed to 
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  prove it.  
 
AsponA spans into the intergenic region 
overlapping with the predicted -10 and -35 σ-70 
promoter elements (Figure 3). Due to the 
location of AsponA, we hypothesized that it 
probably belongs to the class of asRNAs that 
prevent the transcription or translation of the 
opposite gene, either by transcription 
interference or by directly blocking ribosome 
binding. Wurtzel et al (2012) reported the start of 
antisense transcription at the same coordinates 
of the ponA gene (20). The conservation across 
strains together with the condition-dependent 
expression of the AsponA gives weight to the 
conclusion that this asRNA has a physiological 
role. Unfortunately, we did not observe any 
increase in the levels of asRNA AsponA after 
arabinose induction, suggesting that in the 
conditions tested AsponA is not stable. There 
are several possible reasons for this. (i) We are 
not over-expressing the primary transcript of 
AsponA, as we could not determine it by 5´-
RACE. In pulse-expression analysis, the first 
nucleotide of the transcribed product should be 
the +1 of the primary transcript to be pulse-
expressed. This is an important consideration 
when cloning sRNAs under the control of 
heterologous promoters, since altering the 
natural RNA start site may have unintended 
consequences for its function. We were able to 
identify the primary transcript of AsdnaA by 5´-
RACE. However we did not detect the primary 
transcript of AsponA, and this might also explain 
why we did not obtain stable AsponA 
transcription in the pulse-expression experiment. 
(ii) AsponA might only be stable in conditions in 
which is needed, such as aztreonam, 
piperacillin, ciprofloxacin and H2O2 exposure. In 
conditions where the expression of AsponA is 
deleterious it might rapidly get degraded. (iii) 
Some asRNAs interfere with the transcription of 
opposite gene. In this mechanism transcription 
from the antisense promoter blocks transcription 
from the gene promoter by preventing RNA 
polymerase from either binding or extending the 
mRNA encoded on the opposite strand. 
Transcription interference does not require base 
pairing between the asRNA and the mRNA, and 
it does not occur when the asRNA is provided in 
trans. If this is the case of AsponA, then ectopic 
expression of the asRNA in trans will not affect 
the expression of the opposite gene and it might 
also promote the rapid degradation of the 
asRNA. In conclusion, more experiments are 
required to conclude whether AsponA plays a 
physiological role in P. aeruginosa. 
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Figure 3. Antisense sRNAs AsdnaA and AsponaA. Antisense RNA AsdnaA (above) is encoded opposite of 
gene dnaA, which encodes the chromosomal replication initiator protein DnaA. Antisense RNA AsponA (below) 
is encoded opposite the beginning of gene ponA,	  encoding the penicillin-binding protein 1A, and spans into the 
intergenic region overlapping with the predicted -10 and -35 σ-70 promoter elements. 
 
 
CONCLUDING REMARKS 
 
In this work RNA-Seq was used to identify 249 
asRNAs in the opportunistic pathogen P. 
aeruginosa under up to a total of 13 different 
conditions, including stationary phase, osmotic, 
oxidative and antibiotic stress. We provide the 
fold-change in expression of the asRNAs 
differentially transcribed in our conditions. A 
considerable number of asRNAs were 
transcribed opposite to genes encoding 
membrane proteins and genes involved in the 
transport of small molecules, cell wall, LPS, and 
capsule biosynthesis. A substantial number of 
asRNAs significantly changed their expression 
under the conditions tested, suggesting that 
asRNAs play a regulatory role during these 
conditions. Due to our library preparation 
protocol, only asRNAs ranging approximately 
from 50 to 500 nt were detected. Thus the 
number of asRNAs provided in this study is most 
likely an underestimate. Selected asRNAs could 
potentially be exploited as novel drug targets, 
and we anticipate that the data presented here 
will be important to understand the regulation of 
genes that show antisense transcription on the 
reverse strand. Riboswitches have already 
begun to be validated as anti-bacterial drug 
targets. For instance, a pyrimidine compound 
acting as a guanine riboswitch antagonist was 
shown to reduce S. aureus infection rates in 
mice (40). It might be possible to exploit similar 
strategies to target individual sRNAs by small 
compounds, or target mRNAs with synthetic 
antisense sRNAs, in order to combat bacterial 
infections in a species-specific manner. 
 
Two asRNAs have been independently validated 
in this study, and their roles investigated by 
pulse-expression experiments. High expression 
levels of the asRNA asdnaA, which overlaps the 
dnaA gene, had no effect on the dnaA mRNA, 
and we hypothesize that either this asRNA has 
no physiological function or it affects the 
translation of the DnaA protein, by indirectly 
impacting (either positively or negatively) 
ribosome binding by affecting the target mRNA 
structure. The levels of the other asRNA, which 
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  overlaps the ponA gene, were not increased 
after pulse-expression. We could not detect the 
primary transcript of AsponA, and this might be 
the reason for the failure of the pulse-
expression. Alternatively this asRNA might not 
be stable under the conditions tested, or the 
transcription needs to be in cis to have an effect 
on the ponA mRNA. In conclusion, more 
experiments are required to rule out whether 
these two asRNAs play a physiological role in P. 
aeruginosa. 
 
There are many questions that remain to be 
answered regarding the physiological roles of 
bacterial asRNAs. With the recent advances in 
transcriptomics, the hundreds of asRNAs now 
being reported in all bacteria studied need to be 
further validated and functionally characterized. 
We anticipate that understanding the molecular 
mechanisms of action of individual novel RNAs 
will be one of the biggest challenges of current 
RNA research. 
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Supplementary Table 2. Annotation of antisense sRNAs.
Name Start* End* Length* Type of sRNA**
Antisense 
gene***
Direction 
gene
Gene 
name Gene function Gene pathway
asdnaA**** 1320 1784 465 internal PA0001 > dnaA chromosomal replication initiator protein DnaA DNA replication, recombination, modification and repair
as3 15121 15215 95 end-span PA0011 > probable 2-OH-lauroyltransferase Cell wall / LPS / capsule
as3 15121 15215 95 start-span PA0012 > hypothetical protein Hypothetical, unclassified, unknown
as4 35866 35974 109 end-span PA0033 < hptC Histidine phosphotransfer protein HptC
as5 40775 40925 151 end-span PA0039 > hypothetical protein Hypothetical, unclassified, unknown
as6 182516 182617 102 end-span PA0158 > triC Resistance-Nodulation-Cell Division (RND) triclosan efflux transporter, TriC
Antibiotic resistance and susceptibility; Transport of small 
molecules
as7 184720 184861 142 internal PA0162 > opdC histidine porin OpdC Membrane proteins; Transport of small molecules
as8 226915 226976 62 internal PA0196 > pntB pyridine nucleotide transhydrogenase, beta subunit Transport of small molecules; Energy metabolism
as9 263722 263909 188 internal PA0234 > hypothetical protein Hypothetical, unclassified, unknown
as10 288493 288639 147 internal PA0257 < hypothetical protein Related to phage, transposon, or plasmid
as11 290529 290665 137 internal PA0259 < hypothetical protein Hypothetical, unclassified, unknown
as12 291428 291543 116 internal PA0260 < hypothetical protein Hypothetical, unclassified, unknown; Membrane proteins
as13 299094 299181 88 internal PA0264 < hypothetical protein Hypothetical, unclassified, unknown
as14 334305 334355 51 internal PA0296 < spuI Glutamylpolyamine synthetase Putative enzymes; Carbon compound catabolism
as15 338651 338736 86 internal PA0300 > spuD polyamine transport protein Transport of small molecules
as16 353325 353458 134 internal PA0313 < L-cysteine transporter of ABC system YecS Membrane proteins; Transport of small molecules
as17 368517 368669 153 internal PA0328 < hypothetical protein Hypothetical, unclassified, unknown
as18 379215 379350 136 internal PA0337 > ptsP phosphoenolpyruvate-protein phosphotransferase PtsP Transport of small molecules
as19 448929 449284 356 internal PA0407 < gshB glutathione synthetase Amino acid biosynthesis and metabolism; Biosynthesis of cofactors, prosthetic groups and carriers
as20 521726 521838 113 internal PA0461 < conserved hypothetical protein Hypothetical, unclassified, unknown
as21 544658 544778 121 internal PA0483 > probable acetyltransferase Putative enzymes
as22 554963 555078 116 internal PA0495 > hypothetical protein Hypothetical, unclassified, unknown
as23 557312 557569 258 end-span PA0498 < hypothetical protein Hypothetical, unclassified, unknown
as24 646779 646892 114 internal PA0588 < conserved hypothetical protein Hypothetical, unclassified, unknown
as25 654775 654912 138 internal PA0595 < ostA organic solvent tolerance protein OstA precursor Adaptation, Protection
as26 659114 659270 157 internal PA0599 < hypothetical protein Hypothetical, unclassified, unknown
as27 680736 680853 118 internal PA0620 > probable bacteriophage protein Related to phage, transposon, or plasmid
as28 697609 697703 95 internal PA0641 > probable bacteriophage protein Related to phage, transposon, or plasmid
as29 701233 701489 257 end-span PA0645 > hypothetical protein Related to phage, transposon, or plasmid
as29 701233 701489 257 start-span PA0646 > hypothetical protein Related to phage, transposon, or plasmid
as30 718785 718934 150 internal PA0667 < conserved hypothetical protein Hypothetical, unclassified, unknown
as31 748895 749047 153 internal PA0689 > hypothetical protein Hypothetical, unclassified, unknown; Transport of small molecules
as32 749460 749562 103 internal PA0689 > hypothetical protein Hypothetical, unclassified, unknown; Transport of small molecules
as33 761761 761823 63 internal PA0690 > hypothetical protein Hypothetical, unclassified, unknown
as34 784213 784303 91 internal PA0713 > hypothetical protein Hypothetical, unclassified, unknown
as35 795503 795648 146 internal PA0727 > hypothetical protein from bacteriophage Pf1 Hypothetical, unclassified, unknown; Related to phage, transposon, or plasmid
as36 798624 798854 231 start-span PA0730 < probable transferase Putative enzymes
as37 817964 818095 132 start-span PA0750 > ung uracil-DNA glycosylase DNA replication, recombination, modification and repair
as38 898637 898918 282 end-span PA0823 < hypothetical protein Hypothetical, unclassified, unknown
as38 898637 898918 282 start-span PA0822 < hypothetical protein Hypothetical, unclassified, unknown
as39 921673 921840 168 end-span PA0845 < conserved hypothetical protein Hypothetical, unclassified, unknown
as40 967079 967178 100 internal PA0884 > probable C4-dicarboxylate-binding periplasmic protein Transport of small molecules
as41 967184 967283 100 internal PA0884 > probable C4-dicarboxylate-binding periplasmic protein Transport of small molecules
as42 977508 977658 151 internal PA0894 < hypothetical protein Hypothetical, unclassified, unknown
as43 990194 990309 116 internal PA0904 > lysC aspartate kinase alpha and beta chain Amino acid biosynthesis and metabolism
as44 1026460 1026563 104 internal PA0936 < lpxO2 lipopolysaccharide biosynthetic protein LpxO2 Putative enzymes; Cell wall / LPS / capsule
as45 1027896 1028083 188 end-span PA0937 > conserved hypothetical protein Hypothetical, unclassified, unknown
as46 1039125 1039255 131 end-span PA0952 < hypothetical protein Hypothetical, unclassified, unknown
as47 1056103 1056248 146 internal PA0972 > tolB TolB protein Transport of small molecules
as48 1060351 1060676 326 end-span PA0977 < hypothetical protein Hypothetical, unclassified, unknown
as49 1066483 1066610 128 internal PA0985 < pyoS5 pyocin S5 Membrane proteins; Secreted Factors (toxins, enzymes, alginate)
as50 1073865 1074007 143 end-span PA0992 > cupC1 fimbrial subunit CupC1 Motility & Attachment
as50 1073865 1074007 143 start-span PA0993 > cupC2 chaperone CupC2 Motility & Attachment; Chaperones & heat shock proteins
as51 1087094 1087222 129 start-span PA1003 < mvfR Transcriptional regulator MvfR Biosynthesis of cofactors, prosthetic groups and carriers; Transcriptional regulators
as52 1098349 1098557 209 internal PA1015 < probable transcriptional regulator Transcriptional regulators
as53 1119615 1119886 272 end-span PA1032 < quiP QuiP Carbon compound catabolism; Putative enzymes; Antibiotic resistance and susceptibility
as54 1135102 1135286 185 end-span PA1047 > probable esterase Putative enzymes
as55 1135776 1135875 100 internal PA1048 > probable outer membrane protein precursor Membrane proteins; Transport of small molecules
as56 1141250 1141364 115 start-span PA1053 > conserved hypothetical protein Membrane proteins
as57 1207482 1207531 50 internal PA1113 > probable ATP-binding/permease fusion ABC transporter Membrane proteins; Transport of small molecules
as58 1232028 1232169 142 start-span PA1140 < conserved hypothetical protein Hypothetical, unclassified, unknown
as59 1323807 1323918 112 internal PA1221 < hypothetical protein Hypothetical, unclassified, unknown
as60 1394817 1395002 186 internal PA1284 < probable acyl-CoA dehydrogenase Putative enzymes
as61 1400645 1400720 76 end-span PA1289 < hypothetical protein Hypothetical, unclassified, unknown
as62 1455941 1456046 106 internal PA1342 < probable binding protein component of ABC transporter Transport of small molecules
as63 1474290 1474393 104 start-span PA1362 > hypothetical protein Hypothetical, unclassified, unknown
as64 1484863 1485037 175 internal PA1370 > hypothetical protein Hypothetical, unclassified, unknown
as65 1485541 1485595 55 internal PA1370 > hypothetical protein Hypothetical, unclassified, unknown
as66 1499584 1499684 101 internal PA1382 > probable type II secretion system protein Protein secretion/export apparatus
as67 1499690 1499742 53 internal PA1382 > probable type II secretion system protein Protein secretion/export apparatus
as68 1502841 1502987 147 internal PA1383 > hypothetical protein Hypothetical, unclassified, unknown
as69 1503570 1503696 127 internal PA1384 > galE UDP-glucose 4-epimerase Nucleotide biosynthesis and metabolism; Carbon compound catabolism; Central intermediary metabolism
as70 1503843 1503937 95 internal PA1384 > galE UDP-glucose 4-epimerase Nucleotide biosynthesis and metabolism; Carbon compound catabolism; Central intermediary metabolism
as71 1504553 1504676 124 end-span PA1384 > galE UDP-glucose 4-epimerase Nucleotide biosynthesis and metabolism; Carbon compound catabolism; Central intermediary metabolism
as71 1504553 1504676 124 start-span PA1385 > probable glycosyl transferase Cell wall / LPS / capsule
as72 1504788 1504927 140 internal PA1385 > probable glycosyl transferase Cell wall / LPS / capsule
as73 1506107 1506208 102 internal PA1386 > probable ATP-binding component of ABC transporter Transport of small molecules
as74 1558500 1558752 253 internal PA1430 > lasR transcriptional regulator LasR Adaptation, Protection; Transcriptional regulators
as75 1588434 1588549 116 internal PA1458 > probable two-component sensor Chemotaxis; Two-component regulatory systems
as76 1639661 1639805 145 end-span PA1510 < hypothetical protein Hypothetical, unclassified, unknown
as76 1639661 1639805 145 start-span PA1509 < hypothetical protein Hypothetical, unclassified, unknown
as77 1640773 1640948 176 internal PA1510 < hypothetical protein Hypothetical, unclassified, unknown
as78 1698424 1698534 111 internal PA1561 < aer aerotaxis receptor Aer Adaptation, Protection; Chemotaxis
as79 1717815 1717930 116 end-span PA1578 > hypothetical protein Hypothetical, unclassified, unknown
as80 1732127 1732265 139 end-span PA1589 > sucD succinyl-CoA synthetase alpha chain Energy metabolism
as81 1785747 1785881 135 internal PA1640 < conserved hypothetical protein Hypothetical, unclassified, unknown
as82 1790530 1790650 121 internal PA1645 < hypothetical protein Hypothetical, unclassified, unknown
as83 1838134 1838246 113 internal PA1688 > hypothetical protein Hypothetical, unclassified, unknown
as84 1911985 1912118 134 internal PA1767 < hypothetical protein Membrane proteins
as85 1912994 1913099 106 end-span PA1769 < conserved hypothetical protein Hypothetical, unclassified, unknown
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as86 1913728 1913919 192 start-span PA1769 < conserved hypothetical protein Hypothetical, unclassified, unknown
as87 1916046 1916172 127 internal PA1770 > ppsA phosphoenolpyruvate synthase Energy metabolism; Carbon compound catabolism; Central intermediary metabolism
as88 1949036 1949142 107 internal PA1797 < hypothetical protein Hypothetical, unclassified, unknown
as89 1953270 1953371 102 internal PA1800 > tig trigger factor Cell division; Chaperones & heat shock proteins
as90 1954335 1954415 81 internal PA1801 > clpP ClpP Chaperones & heat shock proteins; Cell wall / LPS / capsule
as91 1954420 1954469 50 internal PA1801 > clpP ClpP Chaperones & heat shock proteins; Cell wall / LPS / capsule
as92 2012282 2012454 173 internal PA1852 < hypothetical protein Hypothetical, unclassified, unknown
as93 2027111 2027193 83 internal PA1866 > hypothetical protein Hypothetical, unclassified, unknown
as94 2027457 2027571 115 internal PA1866 > hypothetical protein Hypothetical, unclassified, unknown
as95 2113335 2113442 108 internal PA1933 > probable hydroxylase large subunit Carbon compound catabolism
as96 2113618 2113734 117 internal PA1933 > probable hydroxylase large subunit Carbon compound catabolism
as97 2113817 2113927 111 internal PA1933 > probable hydroxylase large subunit Carbon compound catabolism
as98 2120607 2120921 315 internal PA1939 < hypothetical protein Hypothetical, unclassified, unknown
as99 2121071 2121240 170 internal PA1939 < hypothetical protein Hypothetical, unclassified, unknown
as100 2128729 2128826 98 internal PA1944 > hypothetical protein Hypothetical, unclassified, unknown
as101 2314771 2314932 162 internal PA2103 > probable molybdopterin biosynthesis protein MoeB Biosynthesis of cofactors, prosthetic groups and carriers
as102 2342397 2342560 164 start-span PA2128 > cupA1 fimbrial subunit CupA1 Motility & Attachment
as103 2400697 2400826 130 internal PA2179 < hypothetical protein Hypothetical, unclassified, unknown
as104 2445134 2445251 118 internal PA2222 < hypothetical protein Hypothetical, unclassified, unknown
as105 2550592 2550780 189 start-span PA2313 > hypothetical protein Membrane proteins
as106 2616944 2617020 77 end-span PA2366 > uricase PuuD Hypothetical, unclassified, unknown
as106 2616944 2617020 77 start-span PA2367 > hypothetical protein Hypothetical, unclassified, unknown
as107 2623295 2623503 209 internal PA2372 > hypothetical protein Hypothetical, unclassified, unknown
as108 2701170 2701296 127 start-span PA2418 > hypothetical protein Hypothetical, unclassified, unknown
as109 2705716 2705781 66 start-span PA2422 > hypothetical protein Hypothetical, unclassified, unknown
as110 2756154 2756267 114 end-span PA2455 > hypothetical protein Hypothetical, unclassified, unknown
as111 2756364 2756944 581 end-span PA2456 > hypothetical protein Hypothetical, unclassified, unknown
as111 2756364 2756944 581 start-span PA2457 > hypothetical protein Hypothetical, unclassified, unknown
as112 2759171 2759360 190 end-span PA2458 > hypothetical protein Hypothetical, unclassified, unknown
as113 2802778 2802933 156 internal PA2484 < conserved hypothetical protein Hypothetical, unclassified, unknown
as114 2818927 2819159 233 end-span PA2502 < hypothetical protein Hypothetical, unclassified, unknown
as115 2902292 2902391 100 internal PA2567 > hypothetical protein Hypothetical, unclassified, unknown
as116 2905849 2905976 128 end-span PA2570.1 < tRNA-Leu Non-coding RNA gene
as117 2946138 2946205 68 internal PA2603 > tRNA-Ser Putative enzymes
as118 2959226 2959347 122 start-span PA2615 < ftsK cell division protein FtsK Cell division
as119 2959629 2959767 139 internal PA2616 > trxB1 thioredoxin reductase 1 Nucleotide biosynthesis and metabolism
as120 2982707 2982848 142 start-span PA2637 > nuoA NADH dehydrogenase I chain A Energy metabolism
as121 3005381 3005497 117 internal PA2654 > probable chemotaxis transducer Adaptation, Protection; Chemotaxis
as122 3013744 3013890 147 start-span PA2664 < fhp flavohemoprotein Energy metabolism
as123 3015850 3015969 120 end-span PA2666 > probable 6-pyruvoyl tetrahydrobiopterin synthase Biosynthesis of cofactors, prosthetic groups and carriers
as124 3016813 3016931 119 start-span PA2668 < hypothetical protein Hypothetical, unclassified, unknown
as125 3060103 3060257 155 start-span PA2705 < hypothetical protein Hypothetical, unclassified, unknown
as126 3110332 3110396 65 internal PA2748 < probable methionine aminopeptidase Translation, post-translational modification, degradation
as127 3110413 3110473 61 internal PA2748 < probable methionine aminopeptidase Translation, post-translational modification, degradation
as128 3119347 3119453 107 end-span PA2759 < hypothetical protein Hypothetical, unclassified, unknown
as129 3120806 3120915 110 internal PA2760 > OprQ oprQ
as130 3167934 3168030 97 start-span PA2814 < hypothetical protein Hypothetical, unclassified, unknown
as131 3173549 3173835 287 end-span PA2819 > tRNA-Glu Hypothetical, unclassified, unknown
as132 3312901 3313118 218 internal PA2953 > electron transfer flavoprotein-ubiquinone oxidoreductase Energy metabolism
as133 3357890 3357996 107 internal PA3000 < aroP1 aromatic amino acid transport protein AroP1 Transport of small molecules
as134 3395484 3395684 201 internal PA3032 < snr1 cytochrome c Snr1 Energy metabolism
as135 3414435 3414491 57 internal PA3049 > rmf ribosome modulation factor Translation, post-translational modification, degradation
as136 3508613 3508673 61 internal PA3125 > hypothetical protein Hypothetical, unclassified, unknown
as137 3517655 3517722 68 internal PA3135 < probable transcriptional regulator Transcriptional regulators
as138 3530607 3530794 188 internal PA3147 < wbpJ probable glycosyl transferase WbpJ Putative enzymes; Cell wall / LPS / capsule
as139 3534247 3534324 78 internal PA3150 < wbpG LPS biosynthesis protein WbpG Cell wall / LPS / capsule
as140 3539090 3539161 72 end-span PA3155 < wbpE UDP-2-acetamido-2-dideoxy-d-ribo-hex-3-uluronic acid transaminase, wbpE Putative enzymes; Cell wall / LPS / capsule
as140 3539090 3539161 72 start-span PA3154 < wzy B-band O-antigen polymerase Membrane proteins; Cell wall / LPS / capsule
as141 3540497 3540593 97 internal PA3156 < wbpD UDP-2-acetamido-3-amino-2,3-dideoxy-d-glucuronic acid N-acetyltransferase, WbpD Putative enzymes; Cell wall / LPS / capsule
as142 3540908 3541027 120 internal PA3157 < probable acetyltransferase Putative enzymes; Cell wall / LPS / capsule
as143 3542803 3542997 195 internal PA3158 < wbpB UDP-2-acetamido-2-deoxy-d-glucuronic acid 3-dehydrogenase, WbpB Putative enzymes; Cell wall / LPS / capsule
as144 3592018 3592128 111 end-span PA3200 < conserved hypothetical protein Hypothetical, unclassified, unknown
as144 3592018 3592128 111 start-span PA3199 < conserved hypothetical protein Hypothetical, unclassified, unknown
as145 3593054 3593188 135 start-span PA3201 > conserved hypothetical protein Membrane proteins
as146 3612043 3612282 240 internal PA3224 < hypothetical protein Hypothetical, unclassified, unknown
as147 3625886 3625995 110 internal PA3238 > hypothetical protein Hypothetical, unclassified, unknown
as148 3626660 3626776 117 internal PA3239 > conserved hypothetical protein Hypothetical, unclassified, unknown
as149 3631510 3631629 120 end-span PA3243 > minC cell division inhibitor MinC Cell division
as149 3631510 3631629 120 start-span PA3244 > minD cell division inhibitor MinD Cell division
as150 3697506 3697616 111 internal PA3300 < fadD2 long-chain-fatty-acid--CoA ligase Fatty acid and phospholipid metabolism
as151 3752069 3752155 87 internal PA3341 < probable transcriptional regulator Transcriptional regulators
as152 3866017 3866206 190 internal PA3459 > probable glutamine amidotransferase Amino acid biosynthesis and metabolism
as153 3889807 3889926 120 end-span PA3477 < rhlR transcriptional regulator RhlR Adaptation, Protection; Transcriptional regulators
as154 3944227 3944342 116 internal PA3524 > gloA1 lactoylglutathione lyase Central intermediary metabolism
as155 3999082 3999164 83 end-span PA3567 > probable oxidoreductase Putative enzymes
as156 4014211 4014326 116 internal PA3582 > glpK glycerol kinase Central intermediary metabolism
as157 4048252 4048377 126 start-span PA3613 < hypothetical protein Hypothetical, unclassified, unknown
as158 4070600 4070735 136 internal PA3636 < kdsA 2-dehydro-3-deoxyphosphooctonate aldolase Carbon compound catabolism; Cell wall / LPS / capsule
as159 4087208 4087269 62 internal PA3648 < opr86 outer membrane protein Opr86 Membrane proteins; Transport of small molecules
as160 4092478 4092590 113 internal PA3654 < pyrH uridylate kinase Nucleotide biosynthesis and metabolism
as161 4110202 4110321 120 internal PA3670 < hypothetical protein Hypothetical, unclassified, unknown
as162 4156819 4156946 128 internal PA3711 > probable transcriptional regulator Transcriptional regulators
as163 4166790 4167046 257 internal PA3721 > nalC NalC Transcriptional regulators; Antibiotic resistance and susceptibility
as164 4185534 4185601 68 internal PA3734 > hypothetical protein Hypothetical, unclassified, unknown
as165 4242856 4242966 111 internal PA3783 > hypothetical protein Hypothetical, unclassified, unknown
as166 4311907 4312074 168 end-span PA3851 < hypothetical protein Hypothetical, unclassified, unknown
as167 4327946 4328181 236 internal PA3866 < pyocin protein Adaptation, Protection; Secreted Factors (toxins, enzymes, alginate)
as168 4328357 4328518 162 internal PA3866 < pyocin protein Adaptation, Protection; Secreted Factors (toxins, enzymes, alginate)
as169 4329401 4329645 245 internal PA3866 < pyocin protein Adaptation, Protection; Secreted Factors (toxins, enzymes, alginate)
as170 4330879 4330989 111 end-span PA3867 > probable DNA invertase DNA replication, recombination, modification and repair
as171 4471922 4472053 132 internal PA3991 < hypothetical protein Hypothetical, unclassified, unknown
as172 4616918 4616968 51 internal PA4128 > conserved hypothetical protein Putative enzymes
as173 4619821 4619903 83 internal PA4131 > probable iron-sulfur protein Putative enzymes
as174 4666087 4666202 116 internal PA4168 > fpvB second ferric pyoverdine receptor FpvB Transport of small molecules
as175 4711769 4711861 93 internal PA4208 > opmD probable outer membrane protein precursor Membrane proteins; Transport of small molecules
as176 4759525 4759686 162 end-span PA4247 < rplR 50S ribosomal protein L18 Translation, post-translational modification, degradation
as176 4759525 4759686 162 start-span PA4246 < rpsE 30S ribosomal protein S5 Translation, post-translational modification, degradation
as177 4760853 4760902 50 start-span PA4249 < rpsH 30S ribosomal protein S8 Translation, post-translational modification, degradation
as178 4761521 4761592 72 internal PA4251 < rplE 50S ribosomal protein L5 Translation, post-translational modification, degradation
as179 4763739 4763790 52 internal PA4257 < rpsC 30S ribosomal protein S3 Translation, post-translational modification, degradation
as180 4764919 4765009 91 internal PA4260 < rplB 50S ribosomal protein L2 Translation, post-translational modification, degradation
as181 4773392 4773503 112 internal PA4269 < rpoC DNA-directed RNA polymerase beta* chain Transcription, RNA processing and degradation
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as182 4780416 4780494 79 internal PA4270 < rpoB P26 Transcription, RNA processing and degradation
as183 4781848 4781947 100 internal PA4272.1 > P27 P27 Non-coding RNA gene
as184 4842427 4842583 157 end-span PA4313 > hypothetical protein Hypothetical, unclassified, unknown
as185 4919101 4919236 136 internal PA4389 > probable short-chain dehydrogenase Putative enzymes; Amino acid biosynthesis and metabolism
as186 4925623 4925733 111 internal PA4395 < conserved hypothetical protein Hypothetical, unclassified, unknown
as187 4982939 4983086 148 internal PA4448 < hisD histidinol dehydrogenase Amino acid biosynthesis and metabolism
as188 4991277 4991330 54 internal PA4459 > conserved hypothetical protein Hypothetical, unclassified, unknown
as189 5002347 5002404 58 internal PA4473 > hypothetical protein Hypothetical, unclassified, unknown
as190 5018832 5019000 169 internal PA4488 < conserved hypothetical protein Hypothetical, unclassified, unknown
as191 5037299 5037430 132 internal PA4500 > probable binding protein component of ABC transporter Transport of small molecules
as192 5049739 5049879 141 start-span PA4512 > lpxO1 lipopolysaccharide biosynthetic protein LpxO1 Putative enzymes; Cell wall / LPS / capsule
as193 5055080 5055129 50 internal PA4514 < probable outer membrane receptor for iron transport Transport of small molecules
as194 5055132 5055185 54 internal PA4514 < probable outer membrane receptor for iron transport Transport of small molecules
as195 5071575 5071963 389 internal PA4527 > pilC still frameshift type 4 fimbrial biogenesis protein PilC Motility & Attachment
as196 5071970 5072154 185 internal PA4527 > pilC still frameshift type 4 fimbrial biogenesis protein PilC Motility & Attachment
as197 5101107 5101200 94 internal PA4554 > pilY1 type 4 fimbrial biogenesis protein PilY1 Motility & Attachment
as198 5101511 5101611 101 internal PA4554 > pilY1 type 4 fimbrial biogenesis protein PilY1 Motility & Attachment
as199 5141781 5141969 189 end-span PA4591 < hypothetical protein Hypothetical, unclassified, unknown
as200 5148538 5148668 131 start-span PA4595 < probable ATP-binding component of ABC transporter Transport of small molecules
as201 5274032 5274193 162 internal PA4696 < ilvI acetolactate synthase large subunit Biosynthesis of cofactors, prosthetic groups and carriers; Amino acid biosynthesis and metabolism
as202 5296232 5296293 62 internal PA4717 > conserved hypothetical protein Hypothetical, unclassified, unknown
as203 5296311 5296538 228 internal PA4717 > conserved hypothetical protein Hypothetical, unclassified, unknown
as204 5301771 5301838 68 internal PA4722 < probable aminotransferase Putative enzymes
as205 5356355 5356495 141 internal PA4770 > lldP L-lactate permease Transport of small molecules
as206 5375454 5375529 76 end-span PA4786 > probable short-chain dehydrogenase Putative enzymes
as207 5380813 5380919 107 internal PA4793 > hypothetical protein Hypothetical, unclassified, unknown
as208 5382370 5382497 128 end-span PA4796 > hypothetical protein Hypothetical, unclassified, unknown
as209 5408036 5408137 102 internal PA4818 < conserved hypothetical protein Membrane proteins
as210 5473394 5473504 111 internal PA4877 < hypothetical protein Hypothetical, unclassified, unknown
as211 5522339 5522410 72 start-span PA4923 > conserved hypothetical protein Hypothetical, unclassified, unknown
as212 5532791 5532916 126 internal PA4929 > hypothetical protein Membrane proteins
as213 5541691 5541800 110 end-span PA4937.1 > tRNA-Leu Non-coding RNA gene
as214 5545002 5545131 130 internal PA4941 < hflC protease subunit HflC Translation, post-translational modification, degradation; Cell division
as215 5559871 5559952 82 start-span PA4954 < motA chemotaxis protein MotA Adaptation, Protection; Chemotaxis
as216 5580862 5581109 248 start-span PA4972 > hypothetical protein Hypothetical, unclassified, unknown
as217 5584935 5585163 229 internal PA4974 > probable outer membrane protein precursor Protein secretion/export apparatus
as218 5585580 5585652 73 end-span PA4975 < NAD(P)H quinone oxidoreductase Energy metabolism
as219 5602759 5602870 112 internal PA4986 > probable oxidoreductase Putative enzymes
as220 5617657 5617793 137 internal PA5000 < wapR alpha-1,3-rhamnosyltransferase WapR Putative enzymes; Cell wall / LPS / capsule
as221 5618584 5618634 51 internal PA5001 < hypothetical protein Hypothetical, unclassified, unknown
as222 5655041 5655112 72 internal PA5024 > conserved hypothetical protein Hypothetical, unclassified, unknown
as223 5678557 5678652 96 internal PA5042 < pilO type 4 fimbrial biogenesis protein PilO Motility & Attachment
asponA**** 5680819 5681167 349 start-span PA5045 > ponA penicillin-binding protein 1A Cell wall / LPS / capsule
as225 5684803 5684910 108 end-span PA5047 < hypothetical protein Hypothetical, unclassified, unknown
as226 5699012 5699062 51 internal PA5058 > phaC2 poly(3-hydroxyalkanoic acid) synthase 2 Central intermediary metabolism
as227 5720268 5720351 84 start-span PA5080 < prolyl aminopeptidase Translation, post-translational modification, degradation
as228 5725557 5725795 239 internal PA5087 < hypothetical protein Hypothetical, unclassified, unknown
as229 5739066 5739203 138 internal PA5097 < probable amino acid permease Membrane proteins; Transport of small molecules
as230 5785777 5785905 129 internal PA5136 > hypothetical protein Hypothetical, unclassified, unknown
as231 5799079 5799208 130 internal PA5150 < probable short-chain dehydrogenase Putative enzymes
as232 5817430 5817493 64 internal PA5167 > probable c4-dicarboxylate-binding protein Membrane proteins; Transport of small molecules
as233 5824524 5824599 76 internal PA5172 > arcB ornithine carbamoyltransferase, catabolic Amino acid biosynthesis and metabolism
as234 5844451 5844527 77 end-span PA5192 < pckA phosphoenolpyruvate carboxykinase Carbon compound catabolism; Energy metabolism
as235 5863452 5863719 268 start-span PA5208 < conserved hypothetical protein Hypothetical, unclassified, unknown
as236 5868209 5868408 200 internal PA5213 < gcvP1 glycine cleavage system protein P1 Central intermediary metabolism; Amino acid biosynthesis and metabolism
as237 5896925 5897003 79 internal PA5238 < probable O-antigen acetylase Putative enzymes; Membrane proteins; Cell wall / LPS / capsule
as238 5897008 5897057 50 internal PA5238 < probable O-antigen acetylase Putative enzymes; Membrane proteins; Cell wall / LPS / capsule
as239 5926819 5926963 145 internal PA5264 < hypothetical protein Hypothetical, unclassified, unknown; Membrane proteins
as240 6059529 6059600 72 internal PA5380 > gbdR GbdR Transcriptional regulators
as241 6090655 6090800 146 start-span PA5412 < hypothetical protein Hypothetical, unclassified, unknown
as242 6135711 6135789 79 internal PA5446 > hypothetical protein Hypothetical, unclassified, unknown
as243 6141133 6141239 107 internal PA5451 < wzm membrane subunit of A-band LPS efflux transporter Cell wall / LPS / capsule; Membrane proteins; Transport of small molecules
as244 6157855 6157964 110 internal PA5468 > probable citrate transporter Transport of small molecules
as245 6158032 6158203 172 end-span PA5468 > probable citrate transporter Transport of small molecules
as245 6158032 6158203 172 start-span PA5469 > conserved hypothetical protein Membrane proteins
as246 6171684 6171915 232 start-span PA5480 > hypothetical protein Hypothetical, unclassified, unknown
as247 6183216 6183389 174 internal PA5492 > conserved hypothetical protein Hypothetical, unclassified, unknown
as248 6218749 6219078 330 end-span PA5525 > probable transcriptional regulator Transcriptional regulators
as249 6245830 6245973 144 internal PA5551 < hypothetical protein Hypothetical, unclassified, unknown
as250 6247796 6247909 114 end-span PA5553 < atpC ATP synthase epsilon chain Energy metabolism
***Some asRNAs overlap with 2 genes.
****Coordinates validated by 5´and 3´-RACE experiments. 
* Coordinates and length of the sRNAs predicted by RNA-Seq data.
**The antisense sRNAs were categorize depending on their position with respect to the opposite gene as “start-span” (the asRNA spans over the start of the antisense gene), “internal” (the asRNA start and end within the antisense gene), or “end-
span” (the asRNA spans over the end of the gene). 
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Name Start* End* Length* Direction asRNA Fold change**
as165 4242856 4242966 111 < 0.12
as210 5473394 5473504 111 > 0.21
as94 2027457 2027571 115 < 0.26
as230 5785777 5785905 129 < 0.32
as77 1640773 1640948 176 > 0.38
as100 2128729 2128826 98 < 0.39
as42 977508 977658 151 > 0.42
as183 4781848 4781947 100 < 2.55
as130 3167934 3168030 97 > 2.66
as99 2121071 2121240 170 > 2.69
as123 3015850 3015969 120 < 2.90
as231 5799079 5799208 130 > 2.94
as115 2902292 2902391 100 < 3.30
as111 2756364 2756944 581 < 3.34
as112 2759171 2759360 190 < 3.88
as117 2946138 2946205 68 < 4.87
as244 6157855 6157964 110 < 11.33
as184 4842427 4842583 157 < 27.49
as6 182516 182617 102 < 0.09
as48 1060351 1060676 326 > 0.26
as104 2445134 2445251 118 > 0.32
as19 448929 449284 356 > 0.33
as119 2959629 2959767 139 < 0.36
as78 1698424 1698534 111 > 0.41
as120 2982707 2982848 142 < 2.06
as29 701233 701489 257 < 2.07
as163 4166790 4167046 257 < 2.20
as10 288493 288639 147 > 2.30
as200 5148538 5148668 131 > 2.33
as228 5725557 5725795 239 > 2.34
as195 5071575 5071963 389 < 2.51
asdnaA**** 1320 1784 465 < 2.79
as146 3612043 3612282 240 > 2.82
as51 1087094 1087222 129 > 2.85
asponA**** 5680819 5681167 349 < 2.94
as205 5356355 5356495 141 < 3.13
as162 4156819 4156946 128 < 3.24
as45 1027896 1028083 188 < 3.56
as135 3414435 3414491 57 < 4.21
as181 4773392 4773503 112 > 5.50
as221 5618584 5618634 51 > 6.08
as244 6157855 6157964 110 < 6.37
as32 749460 749562 103 < 6.84
as39 921673 921840 168 > 20.82
as152 3866017 3866206 190 < 21.77
as128 3119347 3119453 107 > 22.06
as6 182516 182617 102 < 0.08
as75 1588434 1588549 116 < 0.09
Supplementary Table 3. Antisense sRNAs differentially expressed.
asRNAs differentially expressed during AZI (10xMIC) treatment
asRNAs differentially expressed during AZT (3xMIC) treatment
asRNAs differentially expressed during CEF (3xMIC) treatment
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as210 5473394 5473504 111 > 0.12
as48 1060351 1060676 326 > 0.14
as83 1838134 1838246 113 < 0.16
as119 2959629 2959767 139 < 0.17
as19 448929 449284 356 > 0.20
as43 990194 990309 116 < 0.35
as138 3530607 3530794 188 > 0.37
as94 2027457 2027571 115 < 0.39
as235 5863452 5863719 268 > 0.43
as146 3612043 3612282 240 > 2.10
as29 701233 701489 257 < 2.17
as24 646779 646892 114 > 2.21
as200 5148538 5148668 131 > 2.22
as45 1027896 1028083 188 < 2.32
as192 5049739 5049879 141 < 2.45
as51 1087094 1087222 129 > 3.15
as4 35866 35974 109 > 4.02
as16 353325 353458 134 > 4.93
as213 5541691 5541800 110 < 7.18
as145 3593054 3593188 135 < 7.72
as129 3120806 3120915 110 < 12.58
as39 921673 921840 168 > 24.03
as56 1141250 1141364 115 < 32.30
as6 182516 182617 102 < 0.02
as92 2012282 2012454 173 > 0.05
as64 1484863 1485037 175 < 0.07
as169 4329401 4329645 245 > 0.07
as104 2445134 2445251 118 > 0.10
as157 4048252 4048377 126 > 0.11
as183 4781848 4781947 100 < 0.11
as131 3173549 3173835 287 < 0.13
as110 2756154 2756267 114 < 0.15
as23 557312 557569 258 > 0.17
as111 2756364 2756944 581 < 0.19
as231 5799079 5799208 130 > 0.20
as29 701233 701489 257 < 0.20
as21 544658 544778 121 < 0.21
as77 1640773 1640948 176 > 0.23
as19 448929 449284 356 > 0.23
as225 5684803 5684910 108 > 0.24
as165 4242856 4242966 111 < 0.24
as31 748895 749047 153 < 0.27
as12 291428 291543 116 > 0.31
as101 2314771 2314932 162 < 0.34
as48 1060351 1060676 326 > 0.34
as55 1135776 1135875 100 < 0.36
as38 898637 898918 282 > 0.37
as43 990194 990309 116 < 0.38
as94 2027457 2027571 115 < 0.40
as98 2120607 2120921 315 > 0.43
as138 3530607 3530794 188 > 0.47
as235 5863452 5863719 268 > 0.49
as9 263722 263909 188 < 0.49
as100 2128729 2128826 98 < 2.05
asponA**** 5680819 5681167 349 < 2.06
asRNAs differentially expressed during CIP (3xMIC) treatment
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as179 4763739 4763790 52 > 2.22
as208 5382370 5382497 128 < 2.48
as52 1098349 1098557 209 > 2.80
as26 659114 659270 157 > 2.84
as160 4092478 4092590 113 > 2.97
as163 4166790 4167046 257 < 3.05
as7 184720 184861 142 < 3.26
as24 646779 646892 114 > 3.35
as45 1027896 1028083 188 < 3.54
as181 4773392 4773503 112 > 3.69
as32 749460 749562 103 < 3.77
as115 2902292 2902391 100 < 4.45
asdnaA**** 1320 1784 465 < 4.67
as136 3508613 3508673 61 < 6.06
as4 35866 35974 109 > 6.41
as152 3866017 3866206 190 < 6.96
as170 4330879 4330989 111 < 10.94
as16 353325 353458 134 > 12.17
as128 3119347 3119453 107 > 16.61
as122 3013744 3013890 147 > 22.25
as129 3120806 3120915 110 < 24.88
as213 5541691 5541800 110 < 30.64
as6 182516 182617 102 < 0.02
as37 817964 818095 132 < 0.10
as19 448929 449284 356 > 0.11
as230 5785777 5785905 129 < 0.12
as201 5274032 5274193 162 > 0.14
as131 3173549 3173835 287 < 0.14
as64 1484863 1485037 175 < 0.18
as104 2445134 2445251 118 > 0.18
as235 5863452 5863719 268 > 0.19
as48 1060351 1060676 326 > 0.20
as83 1838134 1838246 113 < 0.20
as92 2012282 2012454 173 > 0.20
as12 291428 291543 116 > 0.21
as206 5375454 5375529 76 < 0.30
as9 263722 263909 188 < 0.30
as203 5296311 5296538 228 < 0.32
as42 977508 977658 151 > 0.32
asponA**** 5680819 5681167 349 < 0.32
as225 5684803 5684910 108 > 0.33
as112 2759171 2759360 190 < 0.33
as11 290529 290665 137 > 0.34
as55 1135776 1135875 100 < 0.34
as44 1026460 1026563 104 > 0.36
as61 1400645 1400720 76 > 0.36
as169 4329401 4329645 245 > 0.39
as82 1790530 1790650 121 > 0.42
as63 1474290 1474393 104 < 0.43
as81 1785747 1785881 135 > 0.45
as146 3612043 3612282 240 > 2.25
as119 2959629 2959767 139 < 2.30
as192 5049739 5049879 141 < 2.37
as90 1954335 1954415 81 < 2.72
as120 2982707 2982848 142 < 2.95
asRNAs differentially expressed during CO (3xMIC) treatment
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as78 1698424 1698534 111 > 3.04
as16 353325 353458 134 > 3.41
as221 5618584 5618634 51 > 3.87
as247 6183216 6183389 174 < 4.48
as205 5356355 5356495 141 < 4.96
as162 4156819 4156946 128 < 5.35
as57 1207482 1207531 50 < 5.44
as121 3005381 3005497 117 < 6.22
as25 654775 654912 138 > 6.25
as36 798624 798854 231 > 6.86
as20 521726 521838 113 > 36.01
as6 182516 182617 102 < 0.06
as48 1060351 1060676 326 > 0.35
as104 2445134 2445251 118 > 0.45
as19 448929 449284 356 > 0.45
as84 1911985 1912118 134 > 2.05
asdnaA**** 1320 1784 465 < 2.11
as29 701233 701489 257 < 2.28
as146 3612043 3612282 240 > 2.96
as174 4666087 4666202 116 < 3.31
as205 5356355 5356495 141 < 3.89
as143 3542803 3542997 195 > 4.70
as244 6157855 6157964 110 < 5.40
as120 2982707 2982848 142 < 5.79
as221 5618584 5618634 51 > 6.24
as145 3593054 3593188 135 < 6.51
as20 521726 521838 113 > 7.47
as39 921673 921840 168 > 9.95
as6 182516 182617 102 < 0.05
as19 448929 449284 356 > 0.09
as201 5274032 5274193 162 > 0.09
as77 1640773 1640948 176 > 0.09
as104 2445134 2445251 118 > 0.10
as235 5863452 5863719 268 > 0.14
as12 291428 291543 116 > 0.15
as131 3173549 3173835 287 < 0.16
as48 1060351 1060676 326 > 0.16
as55 1135776 1135875 100 < 0.19
as230 5785777 5785905 129 < 0.22
as138 3530607 3530794 188 > 0.26
as63 1474290 1474393 104 < 0.27
as169 4329401 4329645 245 > 0.27
as225 5684803 5684910 108 > 0.31
as220 5617657 5617793 137 > 0.33
as203 5296311 5296538 228 < 0.41
as31 748895 749047 153 < 0.44
as94 2027457 2027571 115 < 0.45
as23 557312 557569 258 > 0.45
asponA**** 5680819 5681167 349 < 0.48
as81 1785747 1785881 135 > 2.20
as146 3612043 3612282 240 > 2.62
as200 5148538 5148668 131 > 2.82
as16 353325 353458 134 > 3.57
as163 4166790 4167046 257 < 3.92
asRNAs differentially expressed during MP (3xMIC) treatment
asRNAs differentially expressed during H2O2 (1 mM) treatment
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as248 6218749 6219078 330 < 4.08
as29 701233 701489 257 < 4.51
as162 4156819 4156946 128 < 5.46
as130 3167934 3168030 97 > 14.81
as62 1455941 1456046 106 > 15.67
as213 5541691 5541800 110 < 15.76
as236 5868209 5868408 200 > 21.07
as6 182516 182617 102 < 0.12
as12 291428 291543 116 > 0.16
as19 448929 449284 356 > 0.20
as48 1060351 1060676 326 > 0.27
as55 1135776 1135875 100 < 0.33
as235 5863452 5863719 268 > 0.36
as74 1558500 1558752 253 < 0.41
as84 1911985 1912118 134 > 2.55
as214 5545002 5545131 130 > 2.71
as116 2905849 2905976 128 > 2.78
as36 798624 798854 231 > 3.58
as236 5868209 5868408 200 > 4.13
as204 5301771 5301838 68 > 6.66
as130 3167934 3168030 97 > 11.83
as62 1455941 1456046 106 > 12.37
as6 182516 182617 102 < 0.07
as104 2445134 2445251 118 > 0.09
as48 1060351 1060676 326 > 0.25
as94 2027457 2027571 115 < 0.29
as19 448929 449284 356 > 0.34
as138 3530607 3530794 188 > 0.39
as43 990194 990309 116 < 0.40
as92 2012282 2012454 173 > 0.42
as63 1474290 1474393 104 < 0.48
as55 1135776 1135875 100 < 0.50
as212 5532791 5532916 126 < 2.11
as181 4773392 4773503 112 > 2.31
as44 1026460 1026563 104 > 2.36
as162 4156819 4156946 128 < 2.47
as96 2113618 2113734 117 < 2.71
as143 3542803 3542997 195 > 2.79
asponA**** 5680819 5681167 349 < 2.83
as146 3612043 3612282 240 > 2.95
as91 1954420 1954469 50 < 3.14
as170 4330879 4330989 111 < 4.03
as221 5618584 5618634 51 > 4.17
as205 5356355 5356495 141 < 4.22
as16 353325 353458 134 > 4.25
as244 6157855 6157964 110 < 6.49
as129 3120806 3120915 110 < 21.17
as92 2012282 2012454 173 > 0.02
as78 1698424 1698534 111 > 0.04
as19 448929 449284 356 > 0.05
as165 4242856 4242966 111 < 0.07
as21 544658 544778 121 < 0.08
as12 291428 291543 116 > 0.10
asRNAs differentially expressed during NaCl (0.5 M) treatment
asRNAs differentially expressed during PP (3xMIC) treatment
asRNAs differentially expressed during TET (3xMIC) treatment
141
as6 182516 182617 102 < 0.13
as26 659114 659270 157 > 0.14
as61 1400645 1400720 76 > 0.15
as217 5584935 5585163 229 < 0.15
as94 2027457 2027571 115 < 0.16
asponA**** 5680819 5681167 349 < 0.18
as31 748895 749047 153 < 0.20
as120 2982707 2982848 142 < 0.24
as42 977508 977658 151 > 0.25
as157 4048252 4048377 126 > 0.26
as53 1119615 1119886 272 > 0.26
as29 701233 701489 257 < 0.28
as9 263722 263909 188 < 0.31
as23 557312 557569 258 > 0.33
as192 5049739 5049879 141 < 0.36
as250 6247796 6247909 114 > 0.40
as144 3592018 3592128 111 > 0.43
as206 5375454 5375529 76 < 0.47
as67 1499690 1499742 53 < 0.49
as74 1558500 1558752 253 < 2.30
as60 1394817 1395002 186 > 2.40
as11 290529 290665 137 > 2.43
as154 3944227 3944342 116 < 2.98
as111 2756364 2756944 581 < 3.03
as162 4156819 4156946 128 < 3.51
as104 2445134 2445251 118 > 3.72
as163 4166790 4167046 257 < 4.18
as239 5926819 5926963 145 > 4.37
as142 3540908 3541027 120 > 4.83
as203 5296311 5296538 228 < 5.44
as54 1135102 1135286 185 < 5.69
as236 5868209 5868408 200 > 6.63
as241 6090655 6090800 146 > 6.76
as30 718785 718934 150 > 6.97
as136 3508613 3508673 61 < 7.51
as210 5473394 5473504 111 > 7.66
as99 2121071 2121240 170 > 7.79
as107 2623295 2623503 209 < 9.26
as25 654775 654912 138 > 10.98
as16 353325 353458 134 > 11.47
as64 1484863 1485037 175 < 11.74
as216 5580862 5581109 248 < 12.15
as244 6157855 6157964 110 < 14.57
as112 2759171 2759360 190 < 14.91
as167 4327946 4328181 236 > 16.07
as88 1949036 1949142 107 > 19.62
as117 2946138 2946205 68 < 20.08
as49 1066483 1066610 128 > 20.16
as20 521726 521838 113 > 21.57
as76 1639661 1639805 145 > 24.33
as50 1073865 1074007 143 < 25.41
as134 3395484 3395684 201 > 26.97
as47 1056103 1056248 146 < 27.11
as115 2902292 2902391 100 < 42.28
as247 6183216 6183389 174 < 43.19
asRNAs differentially expressed during TOB (3xMIC) treatment
142
as92 2012282 2012454 173 > 0.07
as165 4242856 4242966 111 < 0.08
as42 977508 977658 151 > 0.11
as120 2982707 2982848 142 < 0.13
as6 182516 182617 102 < 0.14
as78 1698424 1698534 111 > 0.16
as19 448929 449284 356 > 0.17
asponA**** 5680819 5681167 349 < 0.18
as119 2959629 2959767 139 < 0.21
as74 1558500 1558752 253 < 0.25
as12 291428 291543 116 > 0.36
as63 1474290 1474393 104 < 0.37
as26 659114 659270 157 > 0.40
as206 5375454 5375529 76 < 0.40
as183 4781848 4781947 100 < 0.41
as21 544658 544778 121 < 0.45
as200 5148538 5148668 131 > 0.47
as31 748895 749047 153 < 0.48
as7 184720 184861 142 < 2.07
as214 5545002 5545131 130 > 2.31
as77 1640773 1640948 176 > 2.36
as195 5071575 5071963 389 < 2.40
as250 6247796 6247909 114 > 2.43
as39 921673 921840 168 > 2.46
as38 898637 898918 282 > 2.53
as146 3612043 3612282 240 > 2.55
as168 4328357 4328518 162 > 2.67
as203 5296311 5296538 228 < 2.79
as179 4763739 4763790 52 > 2.94
as176 4759525 4759686 162 > 3.38
as233 5824524 5824599 76 < 3.67
as107 2623295 2623503 209 < 3.75
as182 4780416 4780494 79 > 3.80
as247 6183216 6183389 174 < 3.82
as97 2113817 2113927 111 < 3.94
as115 2902292 2902391 100 < 4.15
as52 1098349 1098557 209 > 4.22
as45 1027896 1028083 188 < 4.34
as27 680736 680853 118 < 4.41
as50 1073865 1074007 143 < 4.57
as76 1639661 1639805 145 > 4.60
as95 2113335 2113442 108 < 5.62
as25 654775 654912 138 > 6.19
as138 3530607 3530794 188 > 6.37
as64 1484863 1485037 175 < 6.41
as99 2121071 2121240 170 > 7.55
as110 2756154 2756267 114 < 7.72
as62 1455941 1456046 106 > 7.76
as30 718785 718934 150 > 8.27
as236 5868209 5868408 200 > 9.24
as130 3167934 3168030 97 > 10.13
as96 2113618 2113734 117 < 11.00
as205 5356355 5356495 141 < 11.76
as93 2027111 2027193 83 < 14.45
as162 4156819 4156946 128 < 14.83
as16 353325 353458 134 > 18.51
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as71 1504553 1504676 124 < 20.05
as245 6158032 6158203 172 < 20.79
as118 2959226 2959347 122 > 27.44
as70 1503843 1503937 95 < 30.29
as244 6157855 6157964 110 < 37.70
as136 3508613 3508673 61 < 41.81
as20 521726 521838 113 > 51.70
as36 798624 798854 231 > 104.80
as6 182516 182617 102 < 0.02
as231 5799079 5799208 130 > 0.11
as78 1698424 1698534 111 > 0.05
as201 5274032 5274193 162 > 0.05
as75 1588434 1588549 116 < 0.10
as161 4110202 4110321 120 > 0.11
as190 5018832 5019000 169 > 0.11
as44 1026460 1026563 104 > 0.13
as121 3005381 3005497 117 < 0.15
as230 5785777 5785905 129 < 0.16
as212 5532791 5532916 126 < 0.18
as203 5296311 5296538 228 < 0.19
as82 1790530 1790650 121 > 0.20
as48 1060351 1060676 326 > 0.22
as26 659114 659270 157 > 0.24
as19 448929 449284 356 > 0.26
as7 184720 184861 142 < 0.27
as104 2445134 2445251 118 > 0.30
as43 990194 990309 116 < 0.31
as165 4242856 4242966 111 < 0.32
as216 5580862 5581109 248 < 0.32
as210 5473394 5473504 111 > 0.32
as23 557312 557569 258 > 0.32
as74 1558500 1558752 253 < 0.35
as81 1785747 1785881 135 > 0.36
as21 544658 544778 121 < 0.36
as42 977508 977658 151 > 0.37
as138 3530607 3530794 188 > 0.44
as235 5863452 5863719 268 > 0.47
as144 3592018 3592128 111 > 0.48
as55 1135776 1135875 100 < 0.49
as94 2027457 2027571 115 < 0.49
as9 263722 263909 188 < 0.56
as53 1119615 1119886 272 > 0.57
as92 2012282 2012454 173 > 0.70
as31 748895 749047 153 < 0.90
as60 1394817 1395002 186 > 1.51
as29 701233 701489 257 < 1.70
as67 1499690 1499742 53 < 1.83
as214 5545002 5545131 130 > 1.89
as142 3540908 3541027 120 > 2.00
as143 3542803 3542997 195 > 2.09
as200 5148538 5148668 131 > 2.39
as111 2756364 2756944 581 < 2.77
as38 898637 898918 282 > 2.91
as84 1911985 1912118 134 > 3.18
as68 1502841 1502987 147 < 3.27
asRNAs differentially expressed during early stationary phase
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as204 5301771 5301838 68 > 3.64
as110 2756154 2756267 114 < 3.67
as228 5725557 5725795 239 > 3.91
as168 4328357 4328518 162 > 3.91
as157 4048252 4048377 126 > 4.10
as101 2314771 2314932 162 < 4.12
as194 5055132 5055185 54 > 4.31
as158 4070600 4070735 136 > 4.60
as169 4329401 4329645 245 > 5.21
as112 2759171 2759360 190 < 5.25
as197 5101107 5101200 94 < 5.35
as249 6245830 6245973 144 > 7.19
as99 2121071 2121240 170 > 7.48
as135 3414435 3414491 57 < 7.76
as173 4619821 4619903 83 < 7.97
as177 4760853 4760902 50 > 8.22
asdnaA**** 1656 1813 158 < 8.70
as62 1455941 1456046 106 > 9.45
as238 5897008 5897057 50 > 11.15
as239 5926819 5926963 145 > 11.43
as195 5071575 5071963 389 < 12.18
as218 5585580 5585652 73 > 12.18
as148 3626660 3626776 117 < 12.90
as147 3625886 3625995 110 < 14.45
as221 5618584 5618634 51 > 14.92
as11 290529 290665 137 > 15.87
as182 4780416 4780494 79 > 16.64
as176 4759525 4759686 162 > 17.15
as34 784213 784303 91 < 18.57
as8 226915 226976 62 < 18.59
as151 3752069 3752155 87 > 20.20
as105 2550592 2550780 189 < 20.43
as196 5071970 5072154 185 < 21.03
as141 3540497 3540593 97 > 21.54
as232 5817430 5817493 64 < 22.70
as133 3357890 3357996 107 > 23.80
as186 4925623 4925733 111 > 23.83
as114 2818927 2819159 233 > 24.56
as149 3631510 3631629 120 < 25.52
as89 1953270 1953371 102 < 28.32
as87 1916046 1916172 127 < 28.79
as178 4761521 4761592 72 > 29.29
as223 5678557 5678652 96 > 30.13
as227 5720268 5720351 84 > 33.56
as199 5141781 5141969 189 > 34.59
as237 5896925 5897003 79 > 39.97
as145 3593054 3593188 135 < 42.93
as242 6135711 6135789 79 < 45.32
as109 2705716 2705781 66 < 50.81
as13 299094 299181 88 > 57.43
as56 1141250 1141364 115 < 66.44
as137 3517655 3517722 68 > 67.12
as229 5739066 5739203 138 > 72.49
as108 2701170 2701296 127 < 61.53
as122 3013744 3013890 147 > 55.57
as28 697609 697703 95 < 77.29
145
as164 4185534 4185601 68 < 70.65
as3 15121 15215 95 < 128.92
as189 5002347 5002404 58 < 71.99
as226 5699012 5699062 51 < 77.00
as59 1323807 1323918 112 > 70.06
as159 4087208 4087269 62 > 73.52
as222 5655041 5655112 72 < 79.82
as172 4616918 4616968 51 < 92.70
****Coordinates validated by 5´and 3´-RACE experiments. 
* Coordinates and length of the sRNAs predicted by RNA-Seq data.
** The fold change is calculated as the ratio of the intensities between the treated condition and the untreated control. Thus a fold 
change > 1 indicates that the sRNA is significantly more expressed in the treated condition. 
146
	   147 
Supplementary Figure 1. 5´RACE strategy used to identify 5´ends of 
primary and processed transcripts. 
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Supplementary Figure 2. 3´RACE strategy used to identify 3´ends of 
transcripts. 
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ABSTRACT 
 
Small RNAs are known to control diverse adaptation processes, where bacterial physiology is 
adjusted in response to environmental cues. In this study we investigated the role of sRNA OsiS 
that was recently identified in genome-wide search of sRNAs in P. aeruginosa. OsiS is highly 
transcribed during oxidative stress conditions. We show that by inducing the expression of OsiS 
the levels of the sRNA PhrS are greatly reduced. PhrS activates the translation of PqsR under low 
oxygen concentrations, which in turn activates the synthesis of PQS. Thus, OsiS links the oxygen 
levels to the production of quorum sensing (QS) molecules. We hypothesize that the interaction is 
by direct base-pairing between the two sRNAs, with a predicted recognition site of OsiS at the 
highly conserved-region of PhrS. However, more experiments are required to know the exact 
nature of the interaction between these two sRNAs. OsiS is, to the best of our knowledge, the first 
sRNA whose main function seems to be regulating the cellular levels of another sRNA.  
 
INTRODUCTION 
 
The opportunistic human pathogen 
Pseudomonas aeruginosa can cause severe 
infections, particularly in immuno-compromised 
and cystic fibrosis (CF) patients. Despite 
aggressive antibiotic therapy, a high number of 
CF patients suffer from chronic P. aeruginosa 
infections. The establishment of a chronic 
infection requires a high level of adaptation of 
the pathogen to the host environment (1,2).   
 
During the last decade many novel small 
regulatory RNAs (sRNAs) have been described 
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in different bacteria, including Escherichia coli, 
Listeria monocytogenes, Staphylococcus 
aureus, Helicobacter pylori, Vibrio cholerae and 
Pseudomonas aeruginosa (3-8). In P. 
aeruginosa, sRNAs are known to be involved in 
the regulation of virulence genes (RsmY/Z), 
carbon catabolite repression (CrcZ), iron 
metabolism (PrrF1, PrrF2, PrrH), and quorum 
sensing (PhrS) (9-13). Recently, we identified 
more than 500 novel intergenic sRNAs (8) and 
more than 200 novel antisense transcripts 
(unpublished data) using different RNA-Seq 
library protocols (14). Following this study, we 
used RNA-Seq to study the transcriptional 
response of P. aeruginosa under different 
stress conditions, including osmotic, oxidative 
and antibiotic stress (unpublished data). In this 
study we show that one of the novel sRNAs 
(named pant67 in (8) and OsiS in this study) is 
highly expressed during oxidative stress, and 
that its role is to downregulate the sRNA PhrS. 
 
PhrS is a 213-nt long sRNA, predicted by 
biocomputation (15,16) and isolated by an 
RNomics approach (7). PhrS is highly 
transcribed under low oxygen conditions, and 
its expression requires the oxygen-responsive 
regulator ANR (13). PhrS activates the 
translation of the pqsR gene by base-pairing 
with a short untranslated open reading frame 
(uof) to which the pqsR gene is translationally 
coupled (13). PqsR is one of the key QS 
regulators in P. aeruginosa and its synthesis 
induces the PQS synthetic operon pqsABCDE 
(17,18). Beside its function in inter-bacterial 
signaling, PQS is required for full synthesis of 
the P. aeruginosa virulence factor pyocianin, 
which can react with molecular oxygen to 
generate oxidative stress (19). In addition to its 
function as a regulatory RNA, PhrS encodes a 
highly conserved 37 amino-acid peptide (7). 
The peptide contains a predicted 
transmembrane segment and sub-cellular 
fractionation revealed that the peptide is indeed 
located in the cytoplasmic membrane. 
Sonnleitner et al. (2011) performed a BLASTN 
search with the DNA sequence of PhrS to 
identify homologues. This analysis revealed 
homologues of PhrS only in 12 different 
isolates of P. aeruginosa (13). Sonnleitner et al. 
(2011) performed another BLAST search with 
the amino acid sequence of the peptide 
encoded by PhrS, and found homologous 
amino acid sequences in several 
Pseudomonas species as well as in A. 
vinelandii (13). This analysis identified a highly 
conserved region of 12 nt downstream of the 
internal ORF of PhrS (13). In this study we 
show that the transcription of OsiS RNA is 
activated during oxidative stress, and that by 
inducing the expression of OsiS the levels of 
the sRNA PhrS are greatly reduced.  
 
MATERIALS AND METHODS 
 
Primers and adapters  
 
Supplementary Table S1 lists all primers and 
adapters used in this study. 
 
Plasmid construction 
 
The plasmids used in this study are listed in Table 
1. Plasmids for L-arabinose-inducible expression of 
asRNAs were constructed by amplification of 
plasmid pBAD33 (20) with primers F1-SacI and R1 
producing a PCR product of 1250 bp (F1-SacI 
introduces a SacI restriction site). For amplification 
of the asRNA insert, genomic DNA from strain 
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PAO1 was amplified with primers F2 and R2-XhoI 
(F2 starts with the sRNA +1 site and R2-XhoI 
introduces an XhoI restriction site). The 5´ends of 
primers F2 and R1 are complementary to each 
other. PCR synthesis by overlap extension (PCR-
SOE) was carried out by combining the 2 previously 
amplified products and running PCR for 10 cycles, 
after which primers F1-SacI and R2-XhoI are added 
and the reaction continues for another 30 cycles. 
The obtained product was digested with SacI and 
XhoI and cloned into the MCS of plasmid mini-CTX2 
(21). 
 
Bacterial strains 
 
The bacterial strains used in this study are listed in 
Table 1. The Pseudomonas aeruginosa PAO1 strain 
was used as wild-type strain. The E.	   coli	   CC118λpir	  
strain was used as cloning host (22). Strains pBAD-
osiS (Figure 2A) and pBAD-control were created by 
integration of plasmids pBAD-osiS and pBAD-
control, respectively, at the attB site of strain PAO1, 
followed by Flp-mediated excision of the plasmid 
backbone, as described in (21). The first nucleotide 
of the transcribed product is the +1 of the primary 
OsiS. This is an important consideration when 
cloning noncoding RNAs under the control of 
heterologous promoters, since altering the natural 
RNA start site may have unintended consequences 
for its function. The attB region was sequenced 
using primers Pser-up and Pser-down to make sure 
that the integration was successful and the plasmid 
backbone excised. 
 
 
Table 1. Strains and plasmids used in this study. 
 
 
 
 
Growth conditions 
 
Growth in Luria–Bertani (LB) broth (250 rpm, 37°C) 
or on LB plates at 37°C was used throughout this 
study. 
Stress exposure experiments. Overnight cultures of 
Pseudomonas aeruginosa PAO1 were diluted to a 
starting OD600 of 0.01 and grown to an OD600 of 0.5, 
at which 3xMIC ciprofloxacin or 1mM hydrogen 
peroxide was added. Concentrated stock solutions 
of H2O2 and ciprofloxacin were prepared fresh daily. 
Cells were harvested 1 hour after the addition of 
ciprofloxacin or hydrogen peroxide. RNA was 
extracted and used to make RNA-Seq libraries 
LIB<500. Experiments were performed in 
duplicates. 
Pulse-expression experiments.	  Overnight cultures of 
strains pBAD-osiS were diluted to a starting OD600 
of 0.01 and grown to an OD600 of 0.5, at which 
sRNA expression was induced with 1% L-arabinose. 
Cells were harvested after 30 min and 45 min of the 
induction. RNA was extracted and used to make 
RNA-Seq libraries LIB>100. Two sets of negative-
control conditions were used for comparison. In one, 
the control strain pBAD-control was induced with 
arabinose; in the second, cells containing the pBAD-
osiS construct were grown without arabinose 
induction. Experiments were performed in 
duplicates. 
 
RNA isolation 
 
Harvested cells were mixed immediately with 0.2 
volumes of STOP solution (95% ethanol, 5% 
phenol) and pelleted by centrifugation. Total RNA 
was extracted with Trizol (Invitrogen). Removal of 
DNA was carried out by treatment with DNase I 
(Fermentas) in combination with the RNase inhibitor 
RiboLock (Fermentas). The integrity of total RNA 
and DNA contamination were assessed with an 
Agilent 2100 Bioanalyzer (Agilent Technologies). 
 
Removal of 23S, 16S and 5S rRNAs 
 
The 23S, 16S and 5S rRNAs were removed by 
subtractive hybridization using the MICROBExpress 
kit (Ambion) with modifications as previously 
described (8) (14). Capture oligonucleotides 
complementary to the rRNAs of P.aeruginosa PAO1 
were used (Supplementary Table S1). Briefly, 5 µM 
of each capture oligonucleotide was used, for a total 
capture oligonucleotide concentration of 25 µM. 
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Compared with the standard protocol, 25% more 
capture oligonucleotides and magnetic beads were 
used. Removal of rRNAs was confirmed with an 
Agilent 2100 Bioanalyzer (Agilent Technologies). 
 
Library preparation and RNA sequencing 
 
Two different sequencing libraries (LIB>100 and 
LIB<500) were constructed as previously described 
(8,14). Each library type was prepared with RNA 
isolated from cells grown in duplicate for each 
condition studied. After each step the samples were 
validated using an Agilent 2100 Bioanalyzer (Agilent 
Technologies), and the final concentration was 
measured using a Qubit 2.0 Fluorometer 
(Invitrogen). The libraries were sequenced using the 
Illumina HiSeq2000 platform with a paired-end 
protocol and read lengths of 100 nt. 
LIB>100 library. This type of library contains 
transcripts longer than 100 nt and was prepared 
using the TruSeq RNA Sample Preparation kit 
(Illumina) as previously described (8,14). Briefly, the 
rRNA-depleted RNA is fragmented using divalent 
cations under elevated temperature. The cleaved 
RNA fragments are copied into cDNA using reverse 
transcriptase and random primers, followed by 
second-strand cDNA synthesis using DNA 
polymerase I and RNase H. After this step, 
transcripts shorter than 100 nt are not retained due 
to the purification performed with the Agencourt 
AMPure XP beads (Beckman Coulter Genomics). 
The cDNA fragments then go through an end repair 
process, 3’-addition of single ‘A’ bases and adapter 
ligation. This is followed by product purification and 
PCR amplification to generate the final cDNA 
library. 
LIB<500 library. This type of library is strand-specific 
and contains transcripts shorter than 500 nt. RNA 
size selection was performed by running total RNA 
on 10% polyacrylamide gels containing 10 M urea. 
Gel slices corresponding to RNAs up to 500 nt were 
excised, followed by elution of RNA in 0.4 M NaCl 
and precipitation with ethanol. The 5S rRNA was 
depleted as previously described, followed by 
treatment with Tobacco Acid Pyrophosphatase 
(Epicentre Technologies) at 37°C for 90 min. 
Tobacco Acid Pyrophosphatase (TAP) is used to 
convert 5′-triphosphate RNA into 5′-monophosphate 
RNA, which is important for correct adapter ligation. 
This was followed by treatment with RNase III 
(Ambion) for 10 min at 37°C to fragment the RNA. 
RNase III fragments RNA into smaller pieces 
containing a 5′-phosphoryl group and a 3′-hydroxyl 
group, which is important for specific adapter 
ligation in the next step. Sequential ligation of RNA 
3′ and 5′ adapters was performed using the 
adapters and enzymes from the TruSeq Small RNA 
Sample Preparation kit (Illumina). Next, reverse 
transcription followed by PCR amplification was 
performed to form cDNA constructs based on the 
RNA fragments ligated with 3′ and 5′ adapters, 
selectively enriching fragments with adapter 
molecules on both ends. The reverse transcription 
and subsequent PCR amplification were performed 
using the enzymes and reagents from the TruSeq 
Small RNA Sample Preparation kit (Illumina). 
Agencourt AMPure XP beads (Beckman Coulter 
Genomics) were used for the post-PCR clean-up. In 
this type of library the fragments corresponding to 
transcripts shorter than 100 nt are retained due to 
ligated RNA adapters that increase the length of the 
fragments by 125 nt. 
 
Data analysis 
 
Our analysis pipeline is described in detail in 
Gómez-Lozano et al (2013) (14). 
Briefly, sequencing reads were mapped onto the P. 
aeruginosa PAO1 genome using the Bowtie 2 short 
read aligner (23). Read alignments from Bowtie 2 
were handled using SAMtools (24). In order to 
obtain normalized expression intensities of the read 
coverage depth at each position in the genome, the 
number of reads in each replicate was normalized 
according to the total number of reads in the library, 
and expression intensities from replicate samples 
were averaged. A two-sample Student’s t-test was 
performed on the average expression of the 
transcripts to determine those with differential 
expression between the conditions tested (P-value 
< 0.05).  
 
Rapid Amplification of cDNA Ends (RACE) 
 
Schematic representations of the 5´ and 3´ RACE 
protocols can be seen in Supplementary Figures 1 
and 2. Supplementary Table 1 lists primers and 
adapters used. 
5´ RACE. 2 µg rRNA-depleted RNA was incubated 
with 10 U of Tobacco Acid Pyrophosphatase 
(Epicentre Technologies) at 37ºC for 1 h to convert 
RNA 5´ triphosphates in 5´ monophosphates. The 
same amount of control RNA was incubated under 
the same conditions in the absence of the enzyme. 
Reactions were stopped by phenol-chloroform 
extraction, followed by etanol-sodium acetate 
precipitation. Precipitated RNAs were redissolved in 
water, mixed with 500 pmol of 5´ RNA adapter, 
heat-denatured at 95ºC for 5 min, then quick-chilled 
on ice. A short RNA adapter was ligated was ligated 
with 50 U of T4 RNA ligase (Thermo Scientific) at 
37ºC for 1 h. Reactions were stopped by phenol-
chloroform extraction, followed by ethanol-sodium 
acetate precipitation. Precipitated RNAs were re-
dissolved in 20 µl water. Then 10 µl of 5´adapter-
ligated RNA was reverse-transcribed using 2 pmol 
of primer complementary to the sRNA (5´-GSP1) 
and the Thermoscript RT-PCR system (Invitrogen) 
according to the manufacturer’s instructions. 
Reverse transcription (RT) was performed in three 
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subsequent 20 min steps at 55ºC, 60ºC, and 65ºC, 
followed by treatment with RNase H. Primers were 
removed using the NucleoSpin Gel and PCR Clean-
up kit (Macherey-Nagel). The products of RT were 
amplified using 10 pmol of another primer 
complementary to the sRNA (5´-GSP2) and 10 pmol 
the 5´ adapter-specific primer, together with the 
Maxima Hot Start PCR Master Mix (Thermo 
Scientific) according to the manufacturer’s 
instructions. Negative controls were performed 
using the 5´ adapter-ligated RNA as template. The 
PCR products were resolved and purified using E-
Gel SizeSelect 2% Agarose gels (Invitrogen). 
Products were sequenced with 5´-GSP2 and 5´ 
adapter-specific primers by LGC Genomics GmbH 
(Germany). 
3´ RACE. 2 µg rRNA-depleted RNA was 
dephosphorylated with calf intestinal alkaline 
phosphatase (New England Biolabs) at 37ºC for 1 h. 
Reactions were stopped by phenol-chloroform 
extraction, followed by etanol-sodium acetate 
precipitation. Ligation was done as above with a 3´ 
RNA adapter with a 3´-inverted deoxythymidine (3´-
idT). RT was carried out as described, but with 10 
pmol of a single primer complementary to the 3´ 
RNA adapter. PCR amplification, band purification 
and sequence analysis was done as described 
above. All enzymatic treatments of RNA were 
performed in the presence of 20 units of RiboLock 
RNase Inhibitor (Thermo Scientific). 
 
Quantitative reverse transcriptase PCR (qRT-PCR) 
 
DNase-treated total RNA was reverse transcribed 
using gene-specific primers and the ThermoScript 
RT-PCR System (Invitrogen). Quantitative PCR was 
run using the Brilliant III Ultra-Fast SYBR Green 
qPCR Master Mix (Stratagene), the Strategene 
Mv3005P equipment and MxPro qPCR software. 5S 
rRNA gene was used as the normalizer. Three 
independent sets of experiments were performed. In 
all cases, controls lacking reverse transcriptase 
were included to assess DNA contamination. 
 
RESULTS 
 
OsiS is expressed under oxidative stress 
conditions. 
 
In a recent study, we found more than 500 
novel intergenic sRNAs (8) and more than 200 
novel antisense transcripts (unpublished data) 
using different RNA-Seq library protocols (14). 
Following this study, we used RNA-Seq to 
study the transcriptional response of P. 
aeruginosa under different stress conditions, 
including osmotic, oxidative and antibiotic 
stress (unpublished data). It was discovered 
that one of the novel sRNAs, OsiS, is highly 
expressed following ciprofloxacin (CIP) and 
hydrogen peroxide (H2O2) treatment. 
Ciprofloxacin is a fluoroquinolone antibiotic 
commonly used against P. aeruginosa 
infections. Ciprofloxacin inhibits DNA 
topoisomerase II and DNA topoisomerase IV 
activities, eventually leading to bacterial cell 
death. In addition, an increase of reactive 
oxygen species (ROS) in the bacterial cells in 
response to ciprofloxacin has been shown 
(25,26). Hydrogen peroxide is a common ROS 
produced by the host immune system, which P. 
aeruginosa exogenously encounters during 
infection (27-29). In our experiments, OsiS 
expression was not activated during exposure 
to NaCl, ß-lactams (piperacillin, ceftazidime, 
aztreonam, meropenem), aminoglycosides 
(tobramycin), macrolides (azithromycin), 
colistin or tetracycline. These results indicate 
that OsiS is activated during oxidative stress, 
as caused by H2O2 and ciprofloxacin. As seen 
in Figure 1B the levels of OsiS are higher after 
CIP exposure (fold change 99.99±36.37) than 
after H2O2 (fold change 9.34±0.04). This is 
most likely due to the concentration of CIP and 
H2O2 used in the experiments, which was lethal 
in the case of CIP (3xMIC, 0,375 µg/ml) and 
sub-lethal in the case of H2O2 (1 mM).  
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Figure 1. Changes in transcriptional response upon ciprofloxacin (3xMIC) and hydrogen peroxide (1 
mM) treatment. A. The PAO1 R- and F- type pyocin loci. All the pyocin locus, with the exception of the 
pyocin repressor gene prtR, are upregulated upon ciprofloxacin and hydrogen peroxide treatment. The osiS 
gene (green arrow) is located between the genes prtR and prtB. B. Changes in expression of OsiS upon 
ciprofloxacin (3xMIC) and hydrogen peroxide (1 mM) treatment. The coordinates of the primary and 
processed versions of OsiS (assessed by 5´-RACE) are marked with green arrows. C. Predicted secondary 
structures of OsiS (primary and processed) predicted with sfold (30). 
 
 
Pulse-expression of OsiS leads to down-
regulation of PhrS. 
 
The osiS gene is located in between the genes 
prtR and prtB in the R- and F- type pyocin loci. 
The R- and F- type pyocin loci are upregulated 
upon H2O2 and CIP treatment with fold changes 
similar as those of OsiS (Figure 1A). Pyocins 
are bacteriocins produced by P. aeruginosa 
that have been shown to kill both a diversity of 
P. aeruginosa strains in addition to a number of 
Campylobacter species N. gonorrhea, N. 
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meningiditis, H. ducreyi, P. fluorescens, 
P.putida and B. cepacia complex (31-36).	  
Some P. aeruginosa strains do not produce 
both R- and F- types of pyocins, however all 
known strains produce at least one of the two 
types (37,38). DNA damage, and therefore the 
bacterial SOS response, is believed to trigger 
the induction of pyocins. Some studies have 
shown that the R- and F- type pyocin genes are 
upregulated during both lethal and sublethal 
treatment with CIP (39) and during H2O2  
exposure (40).  
 
Based on the above mentioned, our initial 
hypothesis was that OsiS was involved in the 
regulation of pyocin production during oxidative 
stress conditions. To investigate this further, 
OsiS was pulse-expressed with an inducible 
promoter and its immediate effects studied by 
RNA-Seq. In these experiments OsiS 
expression was restricted to a construct 
inserted at the attB site containing osiS under 
the control of the heterologous pBAD promoter, 
which is only induced in the presence of 
arabinose (Figure 2A). Inserting the construct 
at a specific site of the genome has several 
advantages over using a plasmid-based 
system. Since the integration vector used in 
this study is equipped with FRT sites (see 
Materials and Methods), it allows Flp-mediated 
excision of the plasmid backbone. Thus, our 
engineered strains are devoid of any selection 
marker and the experiments can be done 
without using any selective pressure. Different 
copy-numbers in the strains to be compared 
can be an issue when working with plasmid-
based system, but that represents no problem 
when working with chromosomal integrations. 
Furthermore, genomic DNA and plasmid DNA 
differ in their degree of supercoiling, a state of 
DNA that has been shown to play a major role 
in regulation of gene expression (41). 
 
 
Figure 2. A. The pBAD-osiS construct inserted at the attB site of strain pBAD-osiS. The first nucleotide of 
the transcribed product is the +1 of the primary OsiS. B. Fold change in OsiS levels after induction with L-
arabinose. The levels of OsiS were measured both with RNA-Seq and RT-qPCR. 1% L-arabinose was 
added to induce the expression of OsiS when OD600 reached 0.5. The OsiS level was detected after the 
expression of OsiS was induced for 30 and 45 min. Strain pBAD-control was used as the control. For the RT-
qPCR experiments, the expression was normalized to the level of 5S rRNA in each sample. 
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In pulse-expression analysis, the first 
nucleotide of the transcribed product should be 
the +1 of the primary transcript to be pulse-
expressed. This is an important consideration 
when cloning sRNAs under the control of 
heterologous promoters, since altering the 
natural RNA start site may have unintended 
consequences for its function. Thus, 5´- and 3´-
RACE experiments were performed to 
accurately map the boundaries of OsiS. From 
the RNA-Seq data OsiS appeared as a 113-nt 
transcript (674,098-674,210) (Figure 1B). 
However, differential 5´-RACE experiments 
revealed that the start site of OsiS was located 
53 bp upstream. This result fitted well with the 
prediction of -10 and -35 σ70 promoter elements 
(Supplementary figure S3). 3´-RACE results 
were consistent with RNA-Seq data. Thus, the 
primary transcript of OsiS is 166-nt long 
(674,045-674,210). The predicted structures of 
both primary and processed OsiS are shown in 
Figure 1C. The RNA-Seq data revealed that 
OsiS was already processed after 30 min of 
pulse-expression of the primary transcript of 
OsiS.  
 
Cells carrying the pBAD-osiS construct were 
grown to mid-log phase in LB and treated with 
1% arabinose for 30 and 45 min, respectively. 
Two sets of negative-control conditions were 
used for comparison. In one, the control 
construct, pBAD-control was induced with 
arabinose; in the second, cells containing the 
pBAD-osiS construct were grown without 
arabinose induction. Total RNA was extracted 
from all cultures and processed for RNA-Seq 
analysis (see Materials and Methods). The 
gene expression profiles were compared in two 
ways: (i) induced pBAD-osiS-containing cells 
were compared to induced pBAD-control-
containing cells, and (ii) uninduced pBAD-osiS-
containing cells were compared to induced 
pBAD-osiS-containing cells. The results for the 
two types of comparisons showed consistent 
results, with the exception of the expected 
differences for arabinose-inducible genes. The 
expression levels of OsiS obtained after 
induction were investigated both by RT-PCR 
and RNA-Seq (Figure 2B), obtaining similar 
results. The fold change of OsiS 30 and 45 min 
after the induction were 10.2 and 18.0, 
respectively. These fold changes are slightly 
higher than those obtained upon treatment with 
1 mM H2O2.  
 
Table 2 shows the list of genes significantly up- 
or downregulated after 30 and 45 min of pulse-
expression of OsiS. The main effect after 30 
min was the dramatic downregulation of PhrS 
levels (fold change -79.7). PhrS activates the 
translation of the pqsR gene. PqsR is one of 
the key QS regulators in P. aeruginosa and its 
synthesis induces the PQS synthetic operon 
pqsABCDE (17,18). In fact, the pqsABCDE 
genes are downregulated 45 min after OsiS 
induction (fold changes between -1.6 and -2.1). 
Some of the genes controlled by PqsR are also 
downregulated upon OsiS pulse-expression, 
with greater effects after 45 min than after 30 
min: the phenazines biosynthesis genes 
phzA1B1, required for pyocianin production 
(42), and the phnAB genes, encoding the 
enzymes required to convert chorismate to 
anthranilate, the PQS precursor (43). Some of 
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the genes required for exoenzyme S production 
are also dowregulated. Interestingly, the genes 
rhlI and rhlR are also mildly downregulated in 
our experiments, and it has been shown that 
PQS induces the transcription of genes rhlI and 
rhlR (44). The outer membrane protein OprG 
was also more than 2-fold downregulated. 
Strikingly, only one gene, the 
polyhydroxyalkanoate synthesis gene phaF, 
increased its levels after OsiS overexpression. 
The levels of sRNA P5 are also reduced 
significantly, but unfortunately the role of this 
sRNA is still unknown. These results indicate 
that OsiS provides a link between oxygen 
levels and QS, by downregulating the levels of 
the sRNA PhrS during oxidative stress 
conditions.   
 
Table 2. Transcripts up- and downregulated upon osiS overexpression. 
 
 
OsiS conservation and interaction with 
PhrS  
 
It is clear from the transcriptomic results that 
OsiS lowers the levels of PhrS. However, the 
question of how these two sRNAs interact is 
not answered by the RNA-Seq data. The 
interaction could be by direct base-pairing 
between the sRNAs, or OsiS could be directly 
affecting some other transcript or protein that 
regulates PhrS. Sonnleitner et al. (2011) 
performed a BLASTN search to identify PhrS 
homologues. This analysis revealed 
homologues of PhrS in 12 different isolates of 
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P. aeruginosa (13). Interestingly, the same kind 
of analysis indicated that OsiS is conserved in 
the exact same 12 isolates (Figure 3). This 
indicates that OsiS and PhrS have evolved 
together in the same isolates. 
 
 
Figure 3. Genetic organization of phrS and osiS regions in all the P. aeruginosa strains in which these 
sRNAs are found. White arrows represent the sRNAs and grey ones represent flanking genes.  
 
 
To identify a potential annealing site between 
OsiS and PhrS the IntaRNA program (45) was 
used. As shown in Figure 4, this analysis 
predicted a recognition site of OsiS upstream 
and at the highly conserved-region of PhrS. 
This highly conserved region of PhrS also 
base-pairs with the leader sequence of the 
upstream open reading frame (uof), which is 
co-transcribed with pqsR, activating the 
translation of PqsR (13). This suggests that the 
interaction between OsiS and PhrS might be by 
direct base-pairing. However, more 
experiments are required to know the exact 
nature of the interaction between these two 
sRNAs.  
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Figure 4. Predicted interaction sites between OsiS and PhrS. The secondary structures of OsiS and PhrS 
are shown on the left. The structure of PhrS is adapted from (13). The predicted interaction sites were 
predicted by the IntaRNA algorithm (45) and are boxed in red. The base-pairing interaction is depicted on the 
right. Part of the highly conserved region of PhrS is required for the interaction. The start and stop codons of 
the 37-aa peptide encoded by PhrS are underlined in black. 
 
DISCUSSION 
 
Under conditions that generate oxidative 
stress, OsiS is highly expressed. We have 
shown that 30 min of induction of the 
expression of OsiS produces a significant 
downregulation in the levels of PhrS. Also, 
many of the downregulated genes after 45 min 
of induction of OsiS are PqsR-dependent. 
These results indicate that OsiS provides a link 
between oxygen levels and QS, by 
downregulating the levels of the sRNA PhrS 
during oxidative stress conditions.  Thus, OsiS 
is another sRNA that responds to oxygen levels 
in bacteria, such as PhrS in P. aeruginosa (13), 
RgsA in P. fluorescens (15), OxyS, FnrS and 
MicF in E. coli (46-49), and RliB in L. 
monocytogenes (50). 
 
The osiS gene is located in the R- and F- type 
pyocin loci. DNA damage, and therefore the 
bacterial SOS response, triggers the induction 
of pyocins. Some studies have shown that the 
R- and F- type pyocin genes are upregulated 
during both lethal and sublethal treatment with 
CIP (39) and during H2O2  exposure (40). In our 
study the R- and F- type pyocin loci are 
upregulated upon H2O2 and CIP treatment with 
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fold changes similar as those of OsiS. 
However, OsiS does not seem to be involved in 
the regulation of pyocin production. It is 
interesting to note that OsiS is located in a 
genomic region that gets transcriptionally active 
during the same conditions as OsiS. 
 
Figure 5 shows our current model of the 
regulatory function of OsiS. During oxidative 
stress conditions the sRNA OsiS is transcribed 
at high levels. The high levels of OsiS induce 
the downregulation of the sRNA PhrS. In 
addition, the oxygen-responsive regulator ANR, 
which is required for PhrS transcription, is not 
active. On the contrary, during low oxygen 
conditions, OsiS is not transcribed, ANR is 
active and PhrS is highly transcribed (7,13). 
PhrS activates the translation of the pqsR 
gene. PqsR is one of the key QS regulators in 
P. aeruginosa and its synthesis induces the 
PQS synthetic operon (17,18). The PhrS-
mediated stimulation of PQS synthesis leads to 
an increased production of pyocianin. 
Pyocianin is a virulence factor that can be 
reduced by NAD(P)H or glutathione, and in its 
reduced form can react with oxygen, forming 
ROS (19). The ROS produced by the synthesis 
of pyocianin might be a signal that activates 
OsiS transcription and ANR inactivation, in 
order to regulate the levels of sRNA PhrS and 
in consequence the production of PQS. 
 
We have shown that expression of OsiS results 
in downregulation of PhrS levels, but how do 
these two sRNAs interact with each other? The 
interaction could be by direct base-pairing, or 
OsiS could be directly affecting some other 
transcript or protein that, in turn, downregulates 
PhrS. The DNA sequences of OsiS and PhrS 
are conserved in the same strains of P. 
aeruginosa, indicating that these two sRNAs 
might have evolved in parallel. We have 
predicted a recognition site of OsiS upstream 
and at the highly conserved-region of PhrS. 
This highly conserved region of PhrS has been 
shown to base-pair with the leader sequence of 
the upstream open reading frame of pqsR, 
activating the translation of PqsR (13). Based 
on this, we hypothesize that OsiS and PhrS 
interact by direct base-pairing. However, more 
experiments are required to know the exact 
nature of the interaction between these two 
sRNAs. 5´-RACE analysis has shown that OsiS 
is found in the cell as a processed transcript, 
which lacks a hairpin of 53 nt at the 5´ end with 
respect to the primary transcript of OsiS. It 
would also be interesting to know whether the 
primary or the processed version of OsiS is the 
one responsible for the PhrS downregulation. 
The oxygen-responsive regulator ANR controls 
the synthesis of PhrS by promoting its 
transcription during low-oxygen conditions, but 
is the transcription of PhrS also affected by 
OsiS in the presence of high-oxygen tension? 
Or does OsiS affect the stability of PhrS? Also, 
is the Hfq chaperone required for the 
interaction of the two sRNAs? We are currently 
carrying out experiments to study the steady-
state levels of PhrS after OsiS induction, in the 
presence and absence of Hfq. 
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Figure 5. Current model of PhrS regulation by the sRNA OsiS. When oxygen is limited, there is no 
expression of OsiS and the ANR protein gets activated. The activated ANR is required for the transcription of 
the phrS gene, which leads to a higher production of PQS. PQS activates the production of pyocianin, which 
can react with molecular oxygen to generate oxidative stress. Under conditions that generate oxidative 
stress, OsiS is highly expressed, which produces a severe downregulation in the levels of PhrS. In addition, 
ANR is not active and does not promote the synthesis of PhrS.  
 
 
In addition to its function as a regulatory RNA, 
PhrS encodes a highly conserved 37 amino-
acid peptide (7). The peptide contains a 
predicted transmembrane segment and sub-
cellular fractionation revealed that the peptide 
is indeed located in the cytoplasmic membrane 
(7). However, the PhrS peptide does not affect 
the release of PQS, and it is therefore unknown 
whether it acts within the same regulatory 
circuit as the PhrS sRNA or even if it has any 
cellular function (13). OsiS could be 
downregulating PhrS in order to lower the 
levels of the PhrS peptide, and not only affect 
the PhrS base-pairing function. Moreover, OsiS 
could be regulating some protein or some other 
transcripts at the level of translation and 
therefore its effect could not be assessed by 
RNA-Seq. Proteomic analysis are currently 
being carried out to address these questions. 
 
Under hypoxic conditions, PQS production is 
limited. PhrS is assumed to counteract the low 
levels of PQS at reduced or fluctuating oxygen 
tensions by stimulating the expression of pqsR 
(13). Thus, the role of sRNA OsiS is to 
“counteract the counteracting effect” of sRNA 
PhrS at high oxygen tension. Thus both OsiS 
and PhrS respond to oxygen levels and allow 
the fine-tuning of PQS synthesis. So what is 
the biological implication of oxygen-dependent 
fine-tuning of PQS? In laboratory conditions, 
the growth rate of mutants deficient in PhrS 
production is the same as the wild-type strain, 
though the deletion mutant produced less 
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pyocianin (13). We could not produce a strain 
lacking the OsiS gene, however over-
expression of OsiS does not affect any 
apparent phenotype. During infection, P. 
aeruginosa is subject to constant shifts in 
oxygen tension due to the human airway 
structure, biofilm formation, antibiotic treatment 
and the host immune response. P. aeruginosa 
faces oxygen limitation when growing in the 
lower airway mucus of CF patients (51). In 
addition P. aeruginosa can form biofilms that 
contain multicellular structures that show strong 
oxygen gradients (52-54). Some antibiotics 
routinely used against P. aeruginosa infections, 
like ciprofloxacin, produce an increase of ROS 
in the bacterial cells (25,26). A variety of 
studies have shown that P. aeruginosa 
encounters ROS in the lungs of CF patients 
due to the exaggerated, sustained and 
extended inflammatory response, characterized 
by influx of neutrophils and high concentrations 
of interleukin-8 (27-29,55-57). We infer that P. 
aeruginosa most likely needs a tight and fine-
tuned regulation of the mechanisms that allow 
adapting to shifts in oxygen tension, and that 
the sRNA OsiS is involved in this kind of 
regulation by responding to high oxygen 
tension and regulating the levels of sRNA 
PhrS. Thus, fine-tuning regulators as PhrS and 
OsiS make no extraordinary difference in 
controlled and steady laboratory conditions, 
however we hypothesized that they might be 
pivotal for a fast and fine-tuned regulation of 
the mechanisms necessary to survive during 
adaptation to an environment with such 
fluctuating levels of oxygen tension as the one 
inside the host.  
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Supplementary Table S1. Primers and adapters used in the study. 
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Supplementary Figure S1-A. 5´RACE strategy used to identify 5´ends of 
primary and processed transcripts. 
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Supplementary Figure S1-B. 3´RACE strategy used to identify 3´ends of 
transcripts. 
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Supplementary Figure S2. Organization of the osiS region in P. aeruginosa 
PAO1. The transcription start site of the primary transcript of OsiS was 
assessed by 5´-RACE. 
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